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CHAPTER 1 
MOLECULAR BIOLOGY OF RNA TUMOR VIRUSES 
1.1. INTRODUCTION 
One of the fundamental problems of cancer research is to discover how and 
why a normal cell becomes a cancer cell. At the present time, overwhelming 
evidence is accumulating that certain viruses are able to induce the neoplastic 
transformation of cells. The genome of these tumor inducing viruses consists of 
either deoxyribonucleic acid (DNA) or ribonucleic acid (RNA). The mechanism of 
neoplastic transformation of cells after infection with DNA or RNA tumor viruses 
is still largely unknown. 
The Rauscher murine leukemia virus belongs to the group of RNA tumor vi-
ruses and causes an erythroid leukemia in mice. The aim of our studies was to 
investigate the synthesis of virus-specific proteins in cells infected with the 
Rauscher leukemia virus. It is obvious, that detailed studies on this step in 
the replication cycle, contribute to our knowledge on the expression of viral 
information in cells infected with RNA tumor viruses. 
We were able to identify the virus-specific mRNA species associated with 
polyribosomes isolated from cells infected with Rauscher murine leukemia virus. 
In addition, definite proof for their biological function as messenger RUA was 
provided by experiments showing the cell-free synthesis of virus-specific poly-
peptides under the direction of isolated virus-specific messenger RNA fractions. 
1.2. RNA TUMOR VIRUSES 
As an introduction to the experimental work presented in this thesis, we 
will provide a comprehensive review on some aspects of the biochemistry and 
the replication mechanism of RNA tumor viruses. For more detailed studies the 
reader is referred to some excellent reviews on various aspects of RNA tumor 
virology, namely on the history (1,2), its morphology and biochemistry (2-9), 
its biology (10), the interaction between virus and host (2,10,11), the DNA 
provirus hypothesis (12) and the origin and evolution of RNA tumor viruses 
(13-16). · 
All RNA tumor virus particles have coimion structural features: the 
virions have a roughly spherical shape with a diameter of 60 to 150 nm; they 
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consist of a spherical nucleoid complex covered by an outer envelope made of 
a unit membrane (17,18). According to the fine structural organization of 
mature virus particles, RNA tumor viruses are classified in two distinct 
groups: (1) B-type particles of mouse mammary tumor virus with an eccentric 
nucleoid enclosed within a unit membrane envelope, containing large surface 
spikes, and (2) C-type particles of the leukosis-sarcoma viruses with a cen-
trally located spherical nucleoid, enclosed within a unit membrane envelope 
containing knob like structures (17,18). The viral envelope is acquired 
during the budding of the virions from the cell surface (1). 
The genome is a single stranded RNA molecule of 60-705, which is dis-
sociated at elevated temperatures or in the presence of dimethylsulfoxide 
into subum'ts of approximately 3x10 molecular weight (19-22). The replica-
tion of the RNA genome involves a DNA intermediate (DNA provirus) (12) and 
the virions themselves contain a 'DNA polymerase' system (reverse trans-
criptase) capable of transcribing the viral genome into small pieces of DNA 
(23,24). 
Virus particles with the biochemical features (i.e. virions containing 
60-70S RNA and a 'DNA polymerase' system) and morphological properties of RNA 
tumor viruses have been isolated from a wide variety of species including 
reptiles, birds, mice, rats, hamsters, cats, pigs, cows, sheep, monkeys, apes 
and also from man. Some of these viruses produce tumors, particularly leuke-
mias, lymphomas, sarcomas or mammary carcinomas, whereas the oncogenic poten-
tial of many other isolates has still not been established. 
Several lines of evidence suggest that the chromosomal DNA of cells of 
most or all avian and mammalian species contains multiple copies of nucleic 
acid sequences that can code for the production of RNA tumor virus particles. 
The early findings of Gross (25), suggesting the transmission of murine leu-
kemia virus (MuLV) by germ cells, have now been confirmed and extended to 
other type-C viruses by numerous groups of investigators. All strains of 
mice have the capacity to produce MuLV or certain viral antigens (26-29) and 
genetic studies show that the capacity to produce MuLV, seggregates accor-
ding to Mendelian laws (28,30-33). By hybridization experiments, sequences 
complementary to type C-type viral RNA were detected in the cellular DNA of 
all normal avian and mammalian cells tested (34-40). Virus-free cell lines 
from chickens and different mammalian species can begin to release C-type 
viruses (endogenous viruses) either spontaneously or after treatment with 
chemical inducers (41-47). Together, these findings are strong arguments for 
the genetic transmission of C-type RNA viruses within the high molecular 
weight DNA of normal cells of maimals and birds. 
Inbred mouse strains have been shown to contain three biological dis­
tinguishable classes of inducible endogenous viruses (48-51). At least one 
class of these endogenous C-type viruses has been shown to be oncogenic in 
mice (52,53). It is, however, possible that other biological distinct endo­
genous viruses are not tumori gem" с for their natural host. An obvious fea­
ture of the endogenous viruses is the close relation, as measured by hybri­
dization, to the DNA of the progenitor cells (16). The RNA genome of exoge­
nous viruses also hybridizes, although to a limited extent, with the DNA 
genome of uninfected host cells indicating that the RNA genome of the latter 
group of type-C viruses is more distantly related to the host DNA genome 
(16). Thus, speculation on the origin of the genome of exogenous RNA tumor 
viruses leaves two possibilities: Either an independent piece of genetic 
information acquired a virus-host relationship with a vertebrate at some 
stage of the evolution and picked up certain host sequences in the process, 
or a host sequence was released at some time from the vertebrate genome and 
has developed the semi-autonomous virus-host relation of present-day RNA 
tumor viruses (16). 
The presence of genetic information for type-C viruses in cellular 
genes of numerous species suggests that these 'virogenes' are related to 
each other in the same way as their natural hosts are related, based upon 
geological or anatomical criteria. Evidence in support of this suggestion 
has been provided by Benveniste and Todaro (54), showing that sequences re­
lated to those of endogenous baboon type-C virus were present in the cellu­
lar DNA from tissues of other Old World monkeys, of apes and man. Besides, 
at some point during the evolution endogenous type-C viruses have also been 
transferred between species that are only distantly related, such as mouse 
and pig or primate and cat (37,55). This was established by hybridization 
experiments, showing for example that type-C viral sequences present in pig 
cellular DNA are partially homologous to those found in the mouse cellular 
DNA (37). 
Since oncogenic type-C viruses [simian sarcoma virus (Si-SV) (56) and 
gibbon ape leukemia virus (Ga-LV) (57)1 have been isolated from naturally 
occurring tumors of subhuman primates, it may be suspected that similar 
viruses are involved in the etiology of tumors in man. Electron microscopic 
investigations, however, of biopsies of human tumors failed to provide 
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convincing evidence for the existence of human type-C viruses. Other, more 
succesfully, attempts have been made to identify human type-C viruses by bio-
chemical methods. Several groups were able to demonstrate that neoplastic 
cells, obtained from human leukemias, lymphomas, sarcomas and breast or skin 
cancers contained vi ral-related RNA and particles containing a 'DNA polyme-
rase' system compiexed to high molecular weight RNA (58-65). The 'DNA poly-
merase' detected in human leukemic cells was shown to be inmunologically re-
lated to the 'DNA polymerase' from oncogenic RNA viruses from subhuman pri-
mates (66,67). An even more interesting finding is the presence of proteins 
specifically related to structural antigens of type-C viruses from subhuman 
primates and a endogenous cat virus in normal human tissues and in neoplasias 
of human origin (68,69). Recently, several investigators have succeeded in 
isolating type-C viruses from human tumor cells grown in vitro (70-73). Ini-
tial results indicate that these isolates are related to oncogenic type-C 
viruses of subhuman primates (Ga-LV and Si-SV) (70-73). 
These findings support the proposition that RNA tumor virus related 
components exist in human neoplastic cells. However, the role of these parti-
cles in human oncogenesis has still to be resolved. 
1.3. MURINE LEUKEMIA AND SARCOMA VIRUSES 
The type-C viruses can be classified into two groups: (1) the nontrans-
forming leukemia or helper viruses which productively infect fibroblast cell 
cultures and (2) the transforming or sarcoma-producing viruses which produce 
a morphological transformation of fibroblast cultures. 
Gross (74) demonstrated in 1951 that cell-free filtrates from leukemic 
mouse tissue could induce leukemia and lymphosarcomas after inoculation into 
newborn mice of inbred strains with a low incidence of spontaneous leukemia. 
The isolation of the Gross leukemia virus was followed within a few years by 
other murine leukemia virus strains: the Graffi strain, a myeloid leukemia 
virus; the Friend and Rauscher leukemia viruses, inducing a erythroblastosis-
like disease and the Moloney leukemia virus, inducing lymphatic leukemia 
(74-78). 
Murine sarcoma viruses have been isolated from mice or rats infected with 
extracts of either mice or rats with a virus-induced leukemia. The first murine 
sarcoma virus was isolated by Harvey (79). After prolonged passage of the 
Moloney strain of murine leukemia virus in rats, a virus isolate was obtained 
from leukemic rats, that induced pleomorphic sarcomas and erythroblastosis 
when inoculated into newborn mice. Subsequently, Moloney (80) reported the 
isolation of a murine sarcoma virus (Moloney strain) from a rhabdomyosarcoma, 
which developed in newborn mice after inoculation with high doses of the 
Moloney strain of murine leukemia virus. The Kirsten strain of murine sarcoma 
virus was isolated by passage of the Kirsten murine erythroblastosis virus in 
rats (81). The isolation of murine sarcoma viruses from extracts of naturally 
occurring sarcomas has also been reported (82,83). 
Infectious murine sarcoma virus isolates are mixtures of two viruses, 
the original leukemia virus and the transforming sarcoma virus. Attempts to 
separate the sarcoma inducing capacity from the ability to induce leukemias 
were unsuccessful, leading to the recognition that the mouse sarcoma viruses 
are defective for replication. They can only replicate in the presence of a 
helper leukemia virus, to yield MSV-(MLV) pseudotypes (84,85). However, it 
has been possible to infect fibroblast cells with sarcoma virus particles 
containing the genetic information for the production of cellular transfor­
mation but not for complete viral replication (85,86). These cells, which 
are isolated at terminal dilutions of sarcoma virus stocks, do not produce 
infectious sarcoma virus particles. When the MSV transformed nonproducer 
cells are superinfected with a helper virus, the cells release a mixture of 
transforming and nontransforming virus particles (85,36). 
1.4. THE NUCLEIC ACID COMPONENTS OF RNA TUMOR VIRUSES 
Most biochemical studies on the nucleic acid components of RNA tumor 
viruses are concerned with the RNA genome of avian type-C viruses. Since 
the genome of the avian viruses shares many structural properties with that 
of the murine RNA tumor viruses, we decided to discuss the nucleic acid 
componertts of both virus groups. 
1.4.1. The fast sedimenting RNA component 
The purified RNA of RNA tumor viruses consists of a class of high mole­
cular weight RNA with a sedimentation coefficient of 60-70S (corresponding 
to a molecular weight of 10 χ 10 ) and a second class of RNA with a sedimen­
tation value of 4-7S (19,20,88-90). RNA preparations of purified avian 
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myeloblastosis virus contain also minor amounts of 18S and 28S RNA (91-93). 
Since the presence of ribosomes within virions has been reported, these are 
most likely the source of the 18S and 28S RNA species (94). 
When the 60-70S RNA component is denatured by heat or dimethylsulfoxide, 
the sedimentation coefficient decreases to 30-40S (3 χ IO6 M
r
) (21,22,95-97). 
Therefore, it was suggested that the 60-70S RNA was segmented and contained 
3-4 30-40S RNA subunits linked together by hydrogen bound regions (21). The 
alternative possibility, decrease of the sedimentation value of denatured 
60-70S RNA due to an extreme conformational change, could not be excluded 
(97). However, evidence in favor of the postulated subunit structure of the 
60-70S RNA was recently provided by several groups of investigators. They 
employed length measurements of the denatured RNA in the electron microscope, 
a method independent of the hydrodynamic properties of the RNA. The results 
indicate that the 60-70S RNA consists of at least two subunits of 30-40S RNA 
with a molecular weight of about 3 χ IO6 (98-102). The 60-70S RNA is less 
suitable for length measurements, because of its extensive secondary struc­
ture. However, by utilizing the gene-32 procedure of Delius (103) for 
spreading of RNA molecules, length measurements on the 60-70S RNA became pos­
sible (98). By this method the 60-70S RNA is mildly denatured and extended. 
The RNA-gene-32 protein complexes exhibited a network structure, consisting 
of several linear molecules held together at many different points. An average 
length was estimated corresponding with a molecular weight of 6 χ 10 (98). 
This molecular weight value is about 3 χ 10 lower than the molecular weight 
based on sedimentation velocity studies. The difference may be due to partial 
dissociation of the 60-70S RNA under the conditions chosen for incubation of 
the viral RNA and the bacteriophage T4 gene-32 protein. 
Two interesting questions, why the two to -four 30-40S RNA subunits are 
linked together in a 60-70S RNA complex and how these subunits are linked 
together, still require an answer. Concerning the latter problem indirect 
evidence suggests that several low molecular weight (4-7S) RNA molecules may 
be involved (see below). The assembly process of the subunit RNA molecules 
in a 60-70S RNA aggregate probably starts during the budding process at the 
plasma membrane and is completed within 30 min after release of the virions 
(104,105). Cheung et ál (104) found that the RNA of Rous sarcoma virus par-
ticles, harvested at 5 min intervals sedimented in a rather broad peak at 
55-60S, with a shoulder at 30-40S, whereas virus harvested at hourly 
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intervals contained 60-70S RNA. The presence of 30-40S RNA in immature (rapid 
harvest) virus was confirmed by Canaani et al (105). They detected predomi-
nantly 30-40S RNA in virus particles collected within 3 min intervals. More-
over, when freshly harvested virus was incubated in vitro at 40 for 5 to 
15 min, most of the 30-405 RNA was converted to 60-70S RNA. Therefore, it 
seems likely that the 30-40S RNA subunits are precursors of the 60-705 RNA. 
1.4.1.1. Présence of poly (A) in the viral RNA 
Most messenger RNAs from eukaryotic cells contain poly(A)-rich sequences 
of various lengths (60-200 nucleotides) at their 3' ends (106-110). The pre-
cise role of poly(A) in the transport of mRNA from nucleus to cytoplasm and 
the translation of mRNA is still unknown. Poly(A) stretches of about 200 nu-
cleotides long (60,000 daltons) have also been found in the 60-705 RNA of RNA 
tumor viruses (111-114). The number of these poly(A) stretches in the high 
molecular weight RNA has been calculated from the poly(A) content of the 60-705 
RNA. Assuming that the 60-705 RNA consists of 3-4 30-405 RNA subunits, it 
followed that there is about one large poly(A) track for each viral 30-405 RNA 
subunit (111,112,115).Determination, however, of the binding capacity of 
native and denatured viral RNA to oligo(dT)-cellulose or poly(U)-sepharose 
revealed that 90% of the 60-705 RNA but only 65% of the 30-405 RNA was bound 
to the columns at high ionic strength (116,117). This indicates that about 
one out of three 30-405 RNA subunits contains no or very short segments of 
poly(A). The presence of large poly(A) tracks within the 30-405 RNA chains 
seems unlikely, since the hydrodynamic and electrophoretic properties of the 
30-405 RNA were not affected by digestion of poly(A) sequences with RNAase H 
in the presence of poly(dT) (117). The experimental approach, however, leaves 
the possiblity that internal oligo(A) sequences are present, which resist 
digestion with RNAase H at low ionic strength and 38 . Indirect experimental 
evidence indeed suggests that Α-rich sequences other than the poly(A) of 
200 nucleotides are present within the 30-405 RNA (117). The presence of a 
few internal oligo(A) sequences, too short to be detected with oligo{dT)-
cellulose chromatography, is the most likely explanation for the apparent 
discrepancy in the number of poly(A) tracks per 30-405 RNA as mentioned 
above. 
Like the poly(A) of eukaryotic messengers and other viral RNAs, the 
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poly(A) of tumor virus RNA is located at the 3' end of this molecule (115, 
117-119). It has been shown by end group analysis, that the viral poly(A) 
consists of a homogeneous segment containing one adenosine per 180 to 190 
AMP residues (115,118). Identification of the nucleotides adjacent to the 
poly(A) track indicates that most of the 30-40S RNA chains have a common 31-
terminal nucleotide sequence -GiCUTJAjggA^ (115,118). Interesting is that 
pyrimidine residues also precede the poly(A) track of several marañalian mes-
sengers (106,120). 
More recently the S'-terminal structure of many mammalian mRNAs and 
viral RNAs has been studied (121-128). The 30-40S RNA of RNA tumor viruses 
(129,130) like mammalian messengers and other viral RNAs, contains a blocked 
methylated S'-terminal sequence of the type m G(5')ppp(S')Xn (cap structure). 
The viral RNA subunits contain in addition to the cap structure about ten 
methylated adenosine nucleotides (m A) at internal positions, which is also 
a characteristic structural feature of mRNA from eukaryotic cells (127,130). 
The presence in messenger RNAs of methylated nucleotides and in particular a 
blocked methylated 5'-terminal structure seems to be required for efficient 
translation in vitro and presumably also in vivo (123,128). 
1.4.1.2. Genome of traneformation defective avian RNA tumor viruses 
Gel electrophoresis of the 30-40S RNA subunits from uncloned avian sar-
coma viruses revealed that this RNA could be separated into two classes of 
RNA species, called a and b subunits (131). The 30-40S RNA of the size class 
a is 10-15% larger than the corresponding molecules of size class b (132). 
The 30-40S RNA isolated from transformation defective (td) viruses and all 
avian leukosis viruses consists only of b subuaits (131,133). Whereas both 
a and b subunits were detected in uncloned isolates of avian sarcoma viruses, 
only RNA molecules of size class a were found in cloned avian sarcoma virus 
(134). The presence of a and b subunits in uncloned stocks of avian sarcoma 
viruses has been found to originate from nontransforming variants, which 
arise spontaneously during replication of avian sarcoma viruses (134). This 
spontaneous loss of transforming ability correlates with the loss of the 
larger a subunits (133,134). Consequently,Duesberg et al (134) suggested 
that the a subunit of avian sarcoma viruses contains the genetic information 
necessary for transformation of chicken fibroblast cells, whereas the 
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b subunit of transformation defective viruses lacks this information. In a 
recent study Wang et al (351), reported the location of sarcoma-specific oli­
gonucleotides on the RNA of three nondefective (nd) avian sarcoma viruses. 
The sarcoma-specific oligonucleotides were identified by comparison with the 
RNA of corresponding td viruses. Based on the map position it was estimated 
that the nucleotide sequences concerned with transformation were located be­
tween 6.6 and 20% from the poly(A) end of the viral RNA. It follows that the 
sarcoma-specific nucleotide sequence comprises 300,000 to 450,000 daltons. 
This calculation is in accordance with the size difference between the α and 
b subunits. In addition they detected a heteropolymeriс sequence of 140,000 
molecular weight, which starts at the poly(A) end and is partially or comple­
tely shared by transforming and transformation defective viruses. 
Competitive hybridization studies of the sequence relationship between 
RNA of avian sarcoma, transformation defective and avian leukosis viruses 
indicate that these viruses have the majority of nucleotide sequences in com­
mon (135,136). All sequences of the nontransforming viruses were found in RNA 
of avian sarcoma virus, whereas only 70-90% of sarcoma virus sequences were 
represented in the RNA of transformation defective and leukosis viruses. 
1.4.1.3. RNA of murine sarcoma viruses 
As already mentioned, most murine sarcoma viruses were isolated after 
prolonged animal to animal passage of several stocks of murine leukemia viruses. 
Moloney sarcoma virus (Mo-SV) arose on mouse passage of Moloney leukemia virus 
(Mo-MuLV), whereas the Harvey (Ha-SV) and Kirsten (Ki-SV) sarcoma viruses arose 
on rat passage of Mo-MuLV and Ki-MuLV, respectively. These murine sarcoma 
viruses are replication defective and synthesis of infectious progeny virus is 
dependent upon the presence of an associated helper leukemia virus. 
Based on hybridization experiments it could be established that: (1) Ki-SV 
and Ha-SV contain distinct sets of nucleic acid sequences, one set is con­
tained in the corresponding murine helper virus (Ki-MuLV and Mo-MuLV), a second 
set in rat type-C helper virus and a set of extra sequences, which are not 
found in mouse or rat type-C viruses; (2) Mo-SV contains sequences of the ho­
mologous leukemia virus of mouse origin (Mo-MuLV) and large sequences not re­
presented in the Mo-MuLV RNA (137-139). These hybridization data suggest that 
Ki-SV and Ha-SV arose by a recombination event between Ki-MuLV and Mo-MuLV, 
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respectively and genetic information in rat cells, during passage of these 
viruses in rats (138). 
As in the avian system a size difference has been observed between non-
defective and defective viruses. Maisel et al (140) have shown that the size 
of the RNA of the replication defective murine sarcoma viruses (2.3 χ 10 M ) 
с
 г 
is approximately 2 χ 10 daltons smaller than of their respective helper 
leukemia viruses (2.5 χ 10 M ). These results have been confirmed by Tsuchida 
r g 
et al (141,142), showing the presence of 30S RNA (2.3 χ 10 M
r
) in virus iso­
lates containing an excess of Mo-SV over Mo-MuLV. 
The [ 3H]-DNA product of the Ki-SV(Ki-MuLV) RNA-dependent DNA polymerase, 
can be used as probe to study the virus-specific RNA species in cells infec­
ted with both Ki-SV and Ki-MuLV. However, by eliminating from this DNA probe 
all sequences related to the mouse helper virus (Ki-MuLV), a probe of sarcoma-
specific (Ki-SV) DNA sequences is obtained (143). With such transcripts 
Tsuchida et al (143) found a complementary 305 RNA species only in mouse cells 
nonproductively transformed by the Ki-SV, whereas no RNA was found related to 
the helper MuLV. After 5'-bromodeoxyuridine treatment these cells were trigge­
red to release both sarcoma and helper type-C viruses [Ki-SV(Ki-MuLV)] . With 
the MuLV-specific DNA probe a major 35S RNA component and a minor 30S RNA 
component were detected in the induced cells. The Ki-SV-specific DNA probe hy­
bridized with the 30S RNA only. 
We already mentioned that Ki-SV has specific sequences in common with rat 
type-C virus. These sequences have presumably been acquired during the rat to 
rat passage of the original Ki-MuLV. All experimental evidence suggests that 
these common sequences reside in the 30S RNA. RNA molecules of this size were 
detected, utilizing the Ki-SV-specific DNA probe not only in spontaneously rat 
type-C virus producing rat cells, but more surprisingly also in normal 'virus 
free' rat cells (144). Thus, strongly suggesting that the murine sarcoma virus-
specific 30S RNA arises by a stable recombination between the original leukemia 
virus and genetic information of rat or mouse. 
1.4.1.4. Sequence complexity of the 60-7OS RNA 
Since the 60-70S RNA genome of RNA tumor viruses consists of 2-4 subunits 
of 30-40S RNA it is important to establish whether these subunits are identi­
cal (polyploid genome) or different (haploid genome) with regard to their 
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nucleotide sequence. A sequence complexity of about 9 χ 10 M was found by 
hybridization of excess 60-70S RNA to the complementary DNA probe (145,146) 
and thus argues for a haploid genome. However, fingerprint analysis of unique 
oligonucleotides obtained after nuclease digestion of 60-70S RNA, yields a 
unique sequence molecular weight of 3 χ 10 (147-150). A molecular weight of 
3 χ 10 is also consistent with the results of studies on defective avia ι 
type-C viruses with deletions in genes coding for the transformation product(s) 
and the envelope glycoprotein (151). Most data, therefore, suggest that the 
nucleotide sequences of the 30-40S RNA are repeated two to four times and 
appear to rule out the possibility that each RNA subunit is completely dif­
ferent. The reason for the discrepancy between the kinetic and physical 
complexity analysis is still unknown. 
1.4.1.5. Evidence for the messenger properties of the genome of RNA tumor 
viruses 
Like most eukaryotic messenger RNAs the genome of RNA tumor viruses 
contains S'-terminal tracts of poly(A) and a blocked methylated S'-terminus. 
These properties already suggest that the viral RNA genome functions as mes­
senger RNA. This notion is supported by several lines of experimental eviden­
ce: (1) The 60-705 RNA and the 30-40S RNA subunits of avian and murine RNA 
tumor viruses direct the synthesis of virus-specific polypeptides of low 
molecular weight in an E.aoli cell-free system (152-154, this thesis); (2) 
More recently, native and denatured 60-705 RNA have been shown to serve as 
messenger in eukaryotic cell-free systems (155-158) and in Xenopus oocytes 
(159); (3) Virus-specific RNA sequences were detected in polyribosomes of 
virus producing cells, by hybridization with labeled DNA complementary to 
the viral genome. One of the virus-specific RNA species from polyribosomes 
corresponds in size to the 30-40S subunit RNA (160-163, this thesis) and 
contains poly(A) (this thesis); (4) Both the 30-40S viral RNA subunits of 
Rauscher murine leukemia virus (R-MuLV) and the 30-40S mRNA of R-MuLV pro­
ducing cells, direct the synthesis of a similar set of virus-specific poly­
peptides in mammalian cell-free systems (157, this thesis). 
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1.4.2. The low moleculca· weight viral RNA 
RNA tunrar viruses contain in addition to the 60-70S RNA complex 30 to 
100 molecules of low molecular weight 4-7S RNA. This lat ter class consists 
of distinct RNA species with sedimentation values of 4S, 5S and 7S (21,91, 
93,95,352-354). 
1.4.2.1. 4S RNA 
The virion 4S RNAs exhibit the structural and functional properties of 
cellular tRNA. The viral 4S RNA fraction contains RNA species with amino 
acceptor activity (91,164,352) and fingerprints of the viral 4S RNA indicate 
the presence of modified pyrimidines and methylated bases characteristic of 
cellular tRNA (165,166,354). This obvious similarity with host tRNA strongly 
suggests that the viral tRNAs are host derived and become incorporated within 
virions during the budding process at the cell membrane. It is, therefore, 
striking that the viral tRNAs do not represent a random assortment of cellular 
tRNA species and that different RNA tumor viruses probably contain the various 
tRNAs in different proportions (167,168,352). In contrast, there exists a 
clear consistency in the relative amounts of tRNA species associated with 
virions from different isolates of one particular strain (164,169,170,352). 
In addition, the 45 RNA fraction of Rous sarcoma virus and Rous associated 
virus, both grown in chick embryo fibroblasts, have even been reported to 
contain different populations of tRNA (168). One of the most prevalent tRNA 
species in virions is methionyl tRNA (tRNAMetIV) (168,170-172). 
Apart from the class of 4S RNA which occurs free within the virions, 
avian and probably also murine RNA tumor viruses contain 4S RNA associated 
with the high molecular weight viral RNA. Most of this 4S RNA is released 
from the 60-70S RNA by thermal denaturation and this dissociation occurs over 
a rather broad range of temperatures (165,166,173,354). As the free 4S RNA 
class, the 60-705 associated 4S RNA exhibits the structural and functional 
features characteristic of transfer RNA (166,174,354). The 4S RNA constitutes 
3-4% of the 60-705 RNA complex or the equivalent of 12 to 20 molecules per 
60-705 RNA (175,354). 
The transcription of the 60-70S genome of RNA tumor viruses by the en-
dogenous 'DNA polymerase' is a primer dependent reaction (176). The primer 
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is a low molecular weight RNA molecule, hydrogen bonded to the 60-70S RNA, and 
provides a free З'-OH terminus for the initiation of the DNA synthesis (176-
183). By thermal denaturation of the viral RNA it could be shown that the 
primer remains attached to the template at a temperature (65 ), which com­
pletely dissociates the 60-70S RNA into its subunits (177,181). However, de­
naturation of the viral genome at higher temperature (80 ) results in loss of 
80-90% of the template activity (177,180,181). Loss of template activity oc­
curred over an identical temperature range as the release of one low molecular 
weight RNA molecule (131). This particular RNA species appears to be the prin­
cipal primer for the DNA polymerase in avian RNA tumor viruses (181,182) and 
has been shown to be identical to tryptophan tRNA (tRNA T r p) (175,182-187). 
tRNA p is the most abundant small RNA associated with the 60-70S RNA complex 
(175). A tRNA species with similar properties has also been found among the 
free low molecular weight viral RNA species, in normal chicken cells and in 
maimnalian cells (182,183,185). Further support for the primer function of 
tRNA r p has been provided by reassociation studies of either free, 60-70S 
associated or cellular tRNA and the dissociated 60-70S RNA, lacking template 
activity. These experiments show that of all tRNA species only tRNA r p selec­
tively reassociates with a limited number (2-4) of sites on the viral genome 
(186,187). After reannealing, the template activity for the reverse trans­
criptase is almost completely restored (186,187). The ability of tRNA p to 
act as a primer is further substantiated by the observation that of all tRNAs 
of normal chicken cells or avian myeloblastosis virus, only tRNA r p and 
tRNA e IV are able to bind with high affinity to the reverse transcriptase, 
although the latter was bound less efficiently (188). The binding could be 
prevented after treatment of the enzyme with antibody against the reverse 
transcriptase, suggesting that highly specific site(s) on the enzyme are in­
volved in the binding of tRNA p (188). Thus, at least one of the different 
tRNAs within virions of avian RNA tumor viruses, and presumably also of RNA 
tumor viruses of other species, appears to have a specific function in the 
replication cycle. 
Another interesting tRNA selectively associated with the 60-70S RNA of 
avian RNA tumor viruses is tRNA-6 I, which can be formylated with E.aoli 
transformylase (172). All four isoaccepting methionyl tRNAs are present, 
both free and associated with the 60-70S RNA complex. However, especially 
tRNAf was found in association with the high molecular weight viral 
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RNA (172). 
The reason for the association of tRNA species, other than tRNA rp, with 
the 60-705 virus genome, the significance of the inclusion of tRNA species 
within the virions as free molecules and whether they participate in any step 
of the life cycle of RNA tumor viruses still requires elucidation. 
1.4.2.2. 5S and 7S RNA 
Two additional low molecular weight classes of RNA, 55 and 75 are found 
free and associated with the 60-705 RNA of RNA tumor viruses (173,175,353,354). 
Both the free and the 60-705 associated 55 RNA molecules are identical in base 
composition to 55 RNA isolated from the large ribosomal subunit of eukaryotic 
cells (354). The number of 55 RNA molecules associated with the 60-705 RNA 
has been estimated to be 3 to 4 (354). These molecules are released from the 
60-705 RNA complex at a Tm value identical to that needed for dissociation of 
the high molecular weight RNA, which is significantly higher than that for 
most 45 RNA species (189,354). Therefore, it is not surprising that the 55 
RNA can be reannealed to the high molecular weight subunits of the viral RNA 
(186). These observations suggest that 55 RNA may function as linker of the 
RNA subunits to form the 60-705 RNA complex. 
Likewise, a small number of 75 RNA molecules (5-10) is present within 
the virions (353). Fingerprints of nuclease digested 75 RNA from avian RNA 
tumor viruses and 75 RNA from uninfected chick fibroblast cells were identi­
cal, suggesting that the viral 75 RNA is also derived from the host (190). 
The Τ value for release of 75 RNA from the 60-705 RNA of murine RNA tumor 
viruses is almost identical to that of 55 RNA (189). Consequently, the 75 
RNA species is also candidate for the function of linker of the subunits of 
the 60-705 viral RNA. 
1.5. PROTEINS OF MURINE LEUKEMIA VIRUSES 
The structural proteins of murine leukemia viruses (MuLV) have been 
studied by various techniques including Polyacrylamide gel electrophoresis 
(191-198), gel filtration in 6M guanidine hydrochloride (GuHCl) (196,198, 
199), isoelectric focusing (193,200) and chromatography on phosphocellulose 
(197). According to the proposed nomenclature (201) virion proteins are 
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designated according their molecular weight in thousands with the abbreviation 
'p' for protein and 'gp' for glycoprotein. The molecular weights of the smal-
ler proteins are designated by the results of GuHCl gel filtration, whereas 
the apparent molecular weight of the viral glycoprotein is estimated by sodium 
dodecyl sulfate electrophoresis. 
Whereas the structure and properties of the viral RNAs of avian and mam-
malian viruses are so related that we have discussed them together, it should 
be noted that the proteins of avian and mamnalian type-C viruses are immuno-
logically different. Although certain avian proteins apparently correspond to 
certain mamnalian counterparts as far as function or localization in the 
virion is concerned, we confine ourselves in this introduction to the mammalian 
type-C viruses with a special emphasis on the murine viruses. 
Purified virions contain six major proteins, when analysed by gel filtra-
tion: gp69/71, gp45, p30, pl5, pl2 and plO. In addition to these major proteins 
a large number of minor protein bands can be seen when the purified virus pre-
parations are analysed by Polyacrylamide gel electrophoresis (197). Many of 
these minor bands may well be derived from the host cell and thus may not be 
coded for by the viral RNA. 
Following treatment with detergents MuLV particles can be separated into 
the viral core particles and the viral membranes (Fig. 1). The major consti-
tuents of the viral core preparation are the low molecular weight proteins 
p30 and plO, whereas pl5 is present in low and variable amounts (203). MuLV 
protein pl2 is not found in core preparations and its location in the virion 
is still uncertain. The major glycoprotein gp69/71 is most probable the main 
structural component of the knob-like surface projections of the viral enve-
lope (195,216). After further degradation of the viral core structure a ribo-
nucleoprotein complex can be isolated containing plO and trace amounts of 
p30 (203). 
Based on immunological studies of mammalian RNA tumor viruses, the anti-
genic determinants of the virion proteins have been classified into three 
categories: (1) species-specific determinants, shared by polypeptides from 
different isolates of type-C viruses from one animal species; (2) type-
specific determinants of polypeptides, by which strains of type-C viruses 
within a given species can be distinguished; (3) interspecies-specific de-
terminants· of polypeptides, which are common among type-C viruses of different 
animal species. It should be noted that one viral protein may contain 
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Fig. 1. Electron micrographs of Rauscher leukemia virus particles and the 
virus substructures. (A) Thin section of a virus pellet prepared from the 
plasma of Swiss mice infected with Rauscher leukemia virus (magnification 
36,400 x.). Thin section of a pellet of virus particles treated with 0.002% 
sodium dodecyl sulfate and ether; (B) core fraction (magnification 69,600 x.); 
(C) viral envelope fraction (magnification 22,400 x.); (D) viral envelope 
fraction (magnification 107,300 x.). Thin sections were stained with uranyl 
acetate and lead citrate. Electron micrographs prepared by Drs W.J.M, van de 
Ven, Department of Biochemistry, University of Nijmegen, Nijmegen, The 
Netherlands. 
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different antigenic detenninants belonging to different categories. The 
various antigenic determinants are especially of interest to study the 
relatedness of mammalian type-C viruses in view of the origin and evolution 
of these viruses. 
1.5.1. Major etruatural protein p30 
The major structural protein p30 constitutes approximately 20-30% of 
the total proteins of MuLV (202). It is a neutral protein (193), which pro-
bably constitutes the core shell of the virus (203). The tryptic peptides of 
p30 from several strains of MuLV show a strong homology, with only 3 to 4 
differences per peptide map (204). This strong homology is also reflected in 
the amino acid sequence of the first 24 residues (205). Only one amino acid 
difference (position 4) was found between the pSO's from different mouse 
type-C viruses. In addition, mouse p30 contains specific amino acid sequences 
(highly conserved regions) homologous with p30 from type-C viruses of other 
mammalian species as cat, rat, apes and Old World monkeys (205). The close 
relation among pSO's from different strains of MuLV and the presence of se-
veral highly conserved regions in the p30's of type-C viruses of genetically 
distant animals is further emphasized by the results from immunological 
studies. The majority of the antigenic determinants of the MuLV pSO's is 
species-specific (206-208) and thus restricted to this group of viruses. In 
addition, several interspecies antigenic determinants are present (conserved 
regions), which are shared in different degree by type-C viruses from other 
mammalian species (196,197,206,208-211). A third class of antigenic determi-
nants, comprises the type-specific regions in p30 (208,212). The type-speci-
fic determinants represent highly variable regions of amino acid sequences in 
p30, providing the base for differentiation between different strains of 
murine leukemia viruses. 
1.5.2. Major envelope glycoproteins 
Murine leukemia viruses contain one major glycoprotein component with an 
apparent molecular weight of 70,000 (192,199,213-215). By high resolution 
Polyacrylamide gel electrophoresis in the presence of sodium dodecyl sulfate, 
this major glycoprotein could be resolved into two components with 
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approximate molecular weights of 69,000 and 71,000 (197). Further, several 
investigators reported the presence of a minor glycoprotein component with a 
molecular weight around 45,000-60,000 (192,199,213-215). At this time, it 
has not been examined whether the two larger (gp69/71) and the smaller 
(gp45-60) viral glycoproteins are related. Based on iimunological data it 
seems likely that the 69,000 and 71,000 daltons proteins have an identical 
or highly related primary structure (202). The 45,000-60,000 Mr component is 
either derived from the larger glycoprotein gp69/71 or is a host-specific 
protein. 
The viral glycoproteins have been shown to be the main constituents of 
the MuLV surface knobs, located on the external membrane (195,216). The ef-
ficient neutralization of Rauscher and Friend murine leukemia virus by mono-
specific anti sera prepared against purified gp69/71 confirms the envelope 
localization of the glycoproteins (217). The antigenic determinants of the 
major glycoprotein gp69/71, are predominantly type-specific and species-
specific determinants, and a small fraction was shown to be interspecies-
specific (197,208,218). This indicates that the primary structure of the 
polypeptide moiety of the glycoprotein, is partially conserved among type-C 
viruses from different species. 
1.5.3. Protein plS 
The low molecular weight protein pl5 is one of the minor structural 
components of murine leukemia viruses and is considered to be located in the 
viral core (203). Protein pl5 has been found in all murine leukemia viruses 
studied, with the exception of the Kirsten strain (219). Serological studies 
have shown that pl5 is immunologically distinct, from the other viral pro-
teins: gp69/71, p30, pl2 and plO (220,221). Most antigenic determinants in 
pl5 of Rauscher and Moloney murine leukemia virus are type-specific (80-90%), 
whereas determinants shared with other murine type-C viruses (species-
specific) and type-C viruses from other mammalian species are only minor com-
ponents of the total antigenic specificities of this protein (219,221,222). 
In addition to these three categories of antigenic determinants, subclasses 
of species-specific determinants have been detected: one class common to two 
murine type-C viruses (Rauscher and Friend) and a second class common to 
three murine type-C viruses (Rauscher, Friend and Moloney) (219,222). Chemical 
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analysis by tryptic peptide mapping of the purified pl5 proteins of Rauscher, 
Moloney and Gross murine leukemia virus, revealed large differences between 
the individual pl5 proteins (223). This observation is consistent with the 
immunological finding that pl5 is highly type-specific. 
Recently, a new murine viral protein has been described, designated as 
pl5(E), which is distinct from pl5 as demonstrated by serological and bio-
chemical methods (198). Based on the reactivity of natural antibody of mice 
to intact murine leukemia virions and the identification by Polyacrylamide 
gel electrophoresis of pl5(E) as one of the main proteins in the immunecomplex, 
this protein has been located in the viral envelope (E) (224). 
1.5.4. Protein pl2 
The 12,000 molecular weight protein (pl2) of murine leukemia viruses is 
an acidic protein, which probably contains some carbohydrate (8,196). Protein 
pl2 is not found in viral core preparations and is consequently thought to 
represent a surface constituent of the virus (203). Antiserum directed against 
Friend murine leukemia virus pl2 does not react with other virus proteins 
(196). In contrast, for the Kirsten strain as well as for the Moloney strain 
of murine leukemia virus a cross reaction between the proteins plO and pl2 
has been reported (219). Studies on the antigenic properties of pl2 indicate 
that this protein is mainly type-specific. Protein pl2 contains also species-
specific determinants but no interspecies-specific antigenic reactivity (196, 
212,225). The pl2 protein of Rauscher murine leukemia virus exhibits a strong 
cross reactivity with Friend murine leukemia virus but much less with Moloney 
murine leukemia virus; therefore, a third class of antigenic determinants is 
likely to be present (196,212,225). The analysis of the tryptic peptides of 
the individual pl2 proteins of Rauscher, Moloney and Gross murine leukemia 
virus revealed almost no homology between the pl2's of the three virus 
strains (223). 
1.5.5. Protein plO 
The smallest protein of murine leukemia viruses plO is strongly basic and 
represents' the main protein component of the ribonucleoprotein complex (203, 
220). Examination of the antigenic determinants of plO from Friend murine 
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leukemia virus has shown that this molecule is strongly species-specific in 
its serological reactivity (196). This iimunological finding is consistent 
with the high degree of homology among the tryptic peptide maps of plO from 
different murine leukemia virus strains (223). No interspecies reactivity 
could be demonstrated (196). 
The serological and chemical analysis of the low molecular weight pro-
teins of different murine leukemia virus strains show a striking homology 
among the individual p30 and plO proteins and in contrast, lack of homology 
among the pl5 and pl2 proteins of these strains. The results suggest that 
the genes coding for p30 and plO tolerate hardly mutations, whereas those 
coding for pl5 and pl2 are apparently more accesible to viable mutations. 
The role of the structural proteins in the replication cycle, the assembly 
and the structural composition of murine leukemia viruses is still largely 
unknown. The presence, however, of p30 in the viral core shell, the tight 
association of the basic protein plO with the viral RNA and the low tolerance 
for mutations suggest that these proteins have a specific function in the 
core architecture. 
1.6. THE PROTEINS OF RAUSCHER LEUKEMIA VIRUS AS STUDIED BY SODIUM DODECYL 
SULFATE POLYACRYLAMIDE GEL ELECTROPHORESIS: EVIDENCE FOR THE HETERO-
GENEITY OF SOME LOW MOLECULAR WEIGHT PROTEINS 
In this paragraph we shall discuss some of our experiments on the pro-
teins of the Rauscher leukemia virus (R-MuLV). Rat embryo fibroblast cells 
(REF) productively infected with R-MuLV were labeled with (_ Sjmethionine 
or [ Hjglucosamine and the radioactive virus was purified on density gra-
dients. Fig. 2A shows the separation of the virion proteins on Polyacrylamide 
gels run at neutral pH in the presence of sodium dodecyl sulfate. The gel 
pattern of [ sj methionine labeled proteins shows that p30 and pl5,pl2 were 
the main virion proteins, whereas all other components represented minor 
constituents of the R-MuLV virion (compare Fig. 2B). One protein component 
with an apparent molecular weight of 70,000, which contained the highest 
amount of [ ^glucosamine, corresponds in size with the major viral glyco-
protein described by other investigators (192,199,213-215). In addition, 
two [ sj methionine labeled proteins with approximate molecular weights of 
50,000 and 90,000 contained minor amounts of sugar residues. 
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Fig. 2. Polyacrylamide gel electrophoresis in the presence of sodium dodecyl 
sulfate of Rauscher murine leukemia virus proteins. Rat embryo fibroblast 
cells (REF) productively infected with R-MuLV were labeled for 16 h with one 
of the following radioactive precursors, [ QJ amino acids, [ H] glucosamine or 
L sjmethionine. Virus was isolated from the cell supernatant fluids as des­
cribed (88). Electrophoresis of the virion proteins was performed in 10% 
acrylamide gels in the presence of 0.1% sodium dodecyl sulfate, using the 
neutral buffer system as described by Weber and Osborn (258). Gels were run 
at a constant current of 8 mA per gel. After electrophoresis gels were frac­
tionated by slicing and the amount of radioactivity was determined as des­
cribed in section 2.2.5. (A) Proteins of R-MuLV labeled with [35s] methionine 
or [ HJ glucosamine and separated on parallel gels; (B) proteins of R-MuLV 
labeled with [ cj amino acids. 
The [ HJ glucosamine label, which did not comigrate with Ρ s]methionine 
labeled peaks may represent glycolipids or free carbohydrates. Comparison of 
the proteins of virus labeled with [ cj amino acids (Fig. 2B) with those 
labeled with (_ Sjmethionine (Fig. 2A), revealed that almost no [35s] methionine 
labeled protein was present in the 10,000 M
r
 region of the gel. Thus, indica­
ting that plO contained no or a very low number of methionine residues. 
Since slight differences in electrophoretic mobility are not visualized 
when radioactive proteins are localized by slicing of gels, analysis of the 
separation of radioactive virion proteins was performed by contact exposure 
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Fig. 3. Polyacrylamide gel electrophoresis of the proteins of Rauscher murine 
leukemia virus isolated from d i f fe rent ce l l l i nes . Rat embryo f ibrob last ce l ls 
(REF) or bone marrow cel ls from BALB/c mice (JLS-V9) productively infected 
with R-MuLV were labeled for 16 h with [ c ] amino acids or [ Sj methionine. 
Radioactive proteins of pur i f ied virus preparations were separated by elec-
trophoresis in 10% acrylamide gels as described in the legend to Fig. 2. 
After electrophoresis longitudinal sl ices of the gels were dried and exposed 
to Kodak X-ray f i l m as described in section 2.2.5. (a) Autoradiogram of the 
protein pattern of [ SJ methionine labeled R-MuLV isolated from JLS-V9 c e l l s ; 
(b) [14c]amino acid labeled R-MuLV from JLS-V9 c e l l s ; (c) [35s] methionine 
labeled R-MuLV from REF c e l l s ; (d) [14c] amino acid labeled R-MuLV from REF 
ce l l s . 
of dried gels to X-ray f i l m . Fig. 3 shows the autoradiographic analysis of 
protein patterns of R-MuLV isolated from d i f fe ren t cel l l i nes , namely a bone 
marrow ce l l l ine of BALB/c mice (JLS-V9) and a rat embryo f ibroblast ce l l 
l i ne (REF). Most v i r ion proteins were present in virus isolates from both ce l l 
l ines . This observation indicates that , although several proteins may be host 
derived, they represent character ist ic components of R-MuLV par t ic les . St r ik ing 
i s , that in addit ion to plO, also one of the components designated as pl5,pl2 
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was poorly labeled with radioactive methionine. 
The resolution of both high and low molecular weight proteins in the 
same gel is possible when gels are constructed, consisting of linear gradients 
of increasing acrylamide concentration. In addition, resolution is further 
improved by using a discontinuous buffer system as described by Laemmli (259), 
instead of the phosphate buffer system used before. For this experiment virus 
was isolated from the plasma of leukemic mice and from the supernatant fluids 
of JLS-V9 or REF cells grown in the presence of radioactive precursors. The 
protein patterns of these virus preparations are shown in Fig. 4. The most 
obvious feature of this analysis is the high degree of similarity among the 
protein patterns of the three R-MuLV isolates. Protein bands, designated χ 
and y, were always more prominent in virus preparations from JLS-V9 cells 
(Fig. 4b and d) than in those derived from REF cells or plasma of leukemic 
mice (Fig. 4a,c,e). One of these components, namely protein x, is presumably 
identical to the precursor protein of the low molecular weight structural com­
ponents (Van Zaane, personal conmunication). In the low molecular weight region 
protein plO, which was previously considered to be a single protein component, 
appeared to be resolved in two or even three protein molecules with slightly 
different mobilities. This observation suggests that plO consists of 2-3 pro­
tein molecules with different primary structure or, more likely, that these 
components were formed by proteolytic cleavage of plO or inaccurate processing 
of the precursor protein containing plO. The most rapidly migrating components 
and a component, which is most likely identical to the viral structural protein 
pl5 (based on gel filtration in the presence of 6M GuHCl), were poorly labeled 
with radioactive methionine. 
1.7. ENZYMES WITHIN RNA TUMOR VIRUS PARTICLES 
Purified preparations of RNA tumor viruses contain numerous enzymes, such 
as ATPase, nuclease, DNA ligase, phosphatases, RNA methylases and amino acyl 
synthetases (see for review Temin and Baltimore, 5). Since avian myeloblastosis 
virus core particles are able to synthesize virus-specific polypeptides in 
vitro, it is obvious that all enzymes needed for protein synthesis and even 
ribosomes are associated with these virions (226). These enzymes are most 
likely derived from the host cell. However, one virion enzyme, the viral 'DNA 
polymerase', is coded for by the viral RNA (227,228). 
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Fig. 4. Proteins of Rauscher murine leukemia virus separated in Polyacrylamide 
gels, constructed with a l inear 10.5-16X acrylamide gradient. Proteins of 
p u r i f i e d virus preparations were separated by Polyacrylamide gel electrophore­
sis in the discontinuous buffer system according to Laemmli (259). Separating 
gels containing a 10.5-165Ó l inear gradient of acrylamide were constructed as 
described in section 5.2.8. After electrophoresis, gels were stained with 
Coomassie B r i l l i a n t Blue (section 2 .2 .5 . ) . Gels containing radioactive pro-
teins were sl iced long i tud ina l ly , dried and exppsed to Kodak X-ray f i l m . 
(a) Proteins of R-MuLV isolated from the plasma of leukemic mice (stained 
ge l ) ; (b) Autoradiographic analysis of the protein pattern of R-MuLV isolated 
from JLS-V9 cel ls grown in the presence of L CJamino acids; (c) [ cjamino 
acid labeled R-MuLV from REF ce l l s ; (d) [35s] methionine labeled R-MuLV from 
JLS-V9 c e l l s ; (e) [35s]methionine labeled R-MuLV from REF ce l l s . 
The v i ra l 'DNA polymerase', also called reverse transcr iptase, is located in 
the v i ra l core and u t i l i z e s the v i ra l 60-70S RNA as a template to synthesize 
small DNA fragments Г(-) strands!, which are covalently bound to a tRNA primer 
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molecule (23,24,176,179). The purified enzyme also exhibits RNAase H activity, 
which specifically degrades the RNA moiety of RNA-DNA hybrids (236-238). Al-
though, definitive experimental proof is lacking, it is assumed that RNAase H 
activity is required to displace the RNA template from the RNA-DNA hybrid, 
allowing synthesis of double stranded DNA. The next step in reverse transcrip-
tion of the viral RNA is the synthesis of (+) stranded DNA. The viral 'DNA 
polymerase' utilizes the (-) DNA strands as template, yielding double stranded 
DNA molecules (229-231). 
The 'DNA polymerase' of murine leukemia virus is a single polypeptide 
with a molecular weight of 70,000 to 80,000 (232-237). The immunological cross 
reactions observed between structural proteins of different mammalian type-C 
viruses is also characteristic for the 'DNA polymerase' of these viruses. Most 
prominent are those antigenic determinants shared by the individual enzymes 
of type-C viruses from one mammalian species (211,239,240). Besides, several 
distinct sets of interspecies antigenic determinants are present on the 'DNA 
polymerase' molecule of type-C viruses from different mammalian species (211, 
239,240). 
1.8. REPLICATION CYCLE OF RNA TUMOR VIRUSES 
The knowledge on the replication cycle of RNA tumor viruses is largely 
derived from studies on the virus replication in sensitive cells grown in 
tissue culture. 
(1) The initial step in the replication cycle of RNA tumor viruses is the 
attachment of virions to specific receptors on the cell membrane. After the 
virus has penetrated into the cytoplasm the virion is uncoated. 
(2) The next event is the cytoplasmic synthesis by the viral 'DNA polymerase' 
of the provirus DNA (241-243). The first replicative intermediates detected 
within a few hours after infection are (-)stranded DNA transcripts of the 
viral RNA genome (244,247). Subsequently, the cytoplasmic synthesis of 
(+)stranded DNA molecules follows catalyzed by the same enzyme and using the 
(-)DNA strand as a template (224,247). Analysis of the newly synthesized DNA 
in the cytoplasm of infected cells, indicates the presence of linear and 
open circular duplex DNA molecules of the size of the subunits (or smaller) 
of the viral genome (242,244,246,248). These molecules are partially single 
stranded consisting of (-)DNA strands complexed with shorter segments of the 
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subsequently synthesized (+)DNA strands (246). After transport to the nucleus 
the viral DNA forms closed circular, supercoiled DNA molecules of a molecular 
weight of 5-6 χ 10 , which is about twice the molecular weight of the viral 
subunit RNA (244,245,248). The integration of the newly synthesized DNA into 
the cell genome has been demonstrated by Varmus (241). Whether integration 
occurs at specific sites of the host genome has still to be resolved. 
(3) The next step is the synthesis of virus-specific RNA and proteins. The 
virus-specific RNA is presumably transcribed from the integrated provirus DNA 
by a host enzyme. This step is inhibited by a-amanitin (249,250 and Gielkens 
unpublished observations) an inhibitor of the cell nuclear form II DNA-depen-
dent RNA polymerase (251), which is considered to be responsible for mRNA 
synthesis. The newly synthesized virus-specific RNA is processed and adenylated 
in the nucleus and transported to the cytoplasm. The major virus-specific RNA 
in the cytoplasm is identical in size to the virion 35S subunit RNA, but lower 
molecular weight RNA has also been found (160-163). The association of these 
virus-specific RNA species with polyribosomes indicates that they function as 
messenger RNA (160-163). Both free and membrane-bound polyribosomes are in­
volved in the virus-specific protein synthesis (162,163,252). Although this 
virus-specific protein synthesis has not been studied in detail, convincing 
evidence exists that the low molecular weight structural proteins of RNA tumor 
viruses are made as a part of large precursor polypeptides, which are cleaved 
by proteolytic enzymes to yield the functional protein molecules (253-257). 
Several virus-specific antigens appear on the cell surface as a result 
of the infection with RNA tumor viruses (see for review, 6). It has been 
shown that at least some of these cell-surface antigens, induced by murine 
leukemia viruses are coded for by the viral genome (202). 
(4) The assembly process has not yet been studied in detail by biochemical 
methods. Electron microscopic studies have shown that the assembly of virion 
proteins and RNA into a nucleoid occurs at the plasma membrane, from which 
virions bud, thus acquiring their outer envelope. 
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CHAPT:R 2 
TRANSLATION OF THE HIGH MOLECULAR WEIGHT RNA OF RNA TUMOR VIRUSES AND 
EUKARYOTIC MESSENGER RNA IN THE E.COLI CELL-FREE SYSTEM 
2.1. INTRODUCTION 
In 1970, Baltimore (24) and Temm (23), reported that after treatment 
with nomonic detergents avian and murine RNA tumor viruses were able to in-
corporate deoxynucleoside triphosphates into DNA. The observations that this 
reaction was sensitive to RNAase and the synthesized DNA was complementary to 
the viral 60-70S RNA, led to the conclusion that the viral 'DNA polymerase' 
utilizes the 60-70S RNA as template (229,269). 
Apart from the function of the 60-705 RNA as template for the synthesis 
of complementary DNA, it was not known, whether the viral RNA was also able 
to function directly as a messenger in a protein synthesizing system. For 
that reason we attempted to translate the viral RNA in cell-free systems from 
manmalian sources. However, under conditions in which globin and o-crystallin 
mRNAs are very actively translated in their encoded proteins, no evidence was 
obtained for the synthesis of polypeptides coded for by the viral RNA, when 
the cell-free products were analyzed by Polyacrylamide gel electrophoresis. 
In order to avoid any misunderstanding at this point, it should be mentioned 
here that translation of the RNA of RNA tumor viruses in mammalian and other 
eukaryotic systems is detectable after immunoprecipitation of the synthesized 
products with antisera against purified virus as is described later in this 
thesis. The first indication that the RNA of RNA tumor viruses does function 
as messenger was provided by Siegert et al (152). These investigators have 
shown that the 60-70S RNA of avian myeloblastosis virus is able to direct the 
synthesis of virus-specific polypeptides in the bacterial cell-free system 
from E.eoli. Consequently, we attempted to translate the high molecular 
weight 60-705 RNA and the 30-40S subumt RNA from Rauscher murine leukemia 
virus (R-MuLV), mouse mammary tumor virus (MTV) and avian myeloblastosis 
virus (AMV) in such a prokaryotic system. 
In the present chapter evidence will be provided that in the cell-free 
system of E.eoli the viral RNA genome of these RNA tumor viruses directs the 
synthesis of polypeptides, which are specific for each particular viral RNA. 
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Furthermore, it was found that small mammalian mRNAs as the globin 9S and 
a-crystallin 14S mRNA are not translated in the prokaryotic system in their 
encoded polypeptides under the conditions employed. 
2.2. MATERIALS AND METHODS 
2.2.1. Cells and virus 
The JLS-V5 eel 1-1 i ne, derived from BALB/c mice spleen and thymus cells 
(261), infected with and producing Rauscher murine leukemia virus, was grown 
in monolayer in Eagle's Minimal Essential Medium completed with 10% calf 
serum, penicillin (100 I.U. χ ml" ) and streptomycin (50 vg χ ml" ). For the 
isolation of radioactive virus, cells in logarithmic phase were labeled for 
16 h with 2.5 yCi χ ml" of [ cjamino acids (54 mCi χ ma torn" ) or 5 uCi x ml" 
of L sjmethionine (32-41 Ci χ mmol" ). Virus was isolated by density gradient 
centrifugation as described by Duesberg et al (88). 
2.2.2. Bacteria and Phage Ml2 preparation 
Esoheriaia coli strain K12 AB301 (F , λ +, met", his", RNAase J - ) , was 
used for the cultivation of bacteriophage M12 as well as for the preparation 
of cell-free extracts. Cells were grown in M-9 medium at 37°, with vigorous 
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aeration until the culture had reached a density of 3 χ 10 cells χ ml 
(262). Preparation and purification of phage M12 was performed by Dr. R.N.H. 
Konings (Department of Molecular Biology, University of Nijmegen, Nijmegen, 
The Netherlands). 
2.2.3. Isolation of the viral RM 
Plasma from leukemic Swiss mice or leukemic chickens (generous gift of 
Dr. J.W. Beard, Duke University, Durham, N.C., USA) was clarified by centri­
fugation at 12,000 χ g for 10 min at 4° in a Servali RC2-B preparative cen­
trifuge. The supernatant fraction was layered on top of a discontinuous gra­
dient consisting of 3 ml 65% (w/v) sucrose in TNE (10 mM Tris.HCl, pH 7.4 at 
20°, 100 mM NaCl and 1 mM EDTA) and 10 ml of 20% (w/v) sucrose in TNE (88). 
After centrifugation at 94,000 χ g for 90 min at 4° in the SW 27 rotor, virus 
present on the 65% sucrose cushion was collected, diluted by the addition of 
2 volumes of TNE and pelleted by centri fugation at 150,000 χ g for 45 min at 
4° in a Spinco type-Ti 50 rotor. 
Purified mouse mammary tumor virus of (C3H/HeA χ 020)F, mice was a ge­
nerous gift of Dr. P. Hageman (Antoni van Leeuwenhoekhuis, Amsterdam, The 
Netherlands). 
For the isolation of RNA, pelleted virions were resuspended in 1 ml of 
10 m Tris.HCl, pH 8.0 at 20°, 100 mM NaCl, 1 mM EDTA and 1% 2-mercaptoetha-
nol and subsequently incubated for 30 min at 37° in the presence of 1% sodium 
dodecyl sulfate and 500 wg χ ml" of RNAase free pronase. After incubation 
two volumes of extraction buffer (10 mM sodium acetate pH 5.0, 100 mM NaCl 
and 1 mM EDTA) were added and the viral RNA was deproteinized with two 
volumes of phenol-chloroform (1:1) saturated with extraction buffer (263). 
After two extractions with phenol-chloroform, the aqueous layer was reextrac-
ted with two volumes of chloroform-isoamylalcohol (100:1) and RNA present in 
the aqueous phase was precipitated by the addition of 0.1 volume of 1 M 
sodium acetate pH 5.2 and two volumes of ethanol at -20°. 
High molecular weight viral RNA (60S) was isolated by centrifugation in 
isokinetic glycerol gradients, 15.0-30.2% (w/v), containing TNE. Tubes were 
spun at 200,000 χ g for 4.5 h at 4° in an SB 283 rotor of the IEC centrifuge. 
RNA profiles were recorded with a continuous flow monitoring system using an 
LKB optical unit, coupled to a logarithmic recorder. RNA from the 50-70S 
region of the gradient was recovered by precipitation with ethanol at -20°. 
2.2.4. Cell-f ree protein syntheeis 
Pre-incubated S-30 from the RNAase I E.aoli strain and phage M12 RNA 
(sedimentation value 27S) purified on sucrose gradients was prepared by Dr. 
R.N.H. Konings as previously described (264,265). Globin 9S and a-crystallin 
14S mRNA were a gift of Dr. A.J.M. Berns of our laboratory. 
The incubation mixture contained per ml: 50 nmoles of each of the added 
unlabeled amino acids, 50 umoles Tris.HCl, pH 7.8 at 20°, 10 ymoles of mag­
nesium acetate, 70 umoles NH^Cl, 8 pmoles 2-niercaptoethanol, 0.25 mg E.coli 
tRNA, 5 umoles ATP, 0.3 ymoles GTP, 5 pinoles PEP, 8 pg pyruvate kinase, 0.24 
ml of pre-incubated S-30 extract containing 10 mg χ ml" of ribosomes, 
100-125 yCi [35s]methionine (32-41 Ci χ imol"1) or 30-80 pCi [14c]amino acids 
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(54 mCi χ matonf ) and 300-700 pg of viral or messenger RNA. Incubation was 
performed at 37° for 30 min in a volume of 60 μΐ. 
After incubation the reaction was terminated in one of the following 
ways: 
1. For the determination of the amino acid incorporation a 10 μΐ aliquot of 
the reaction mixture was diluted with 0.5 ml of 0.1 Ν K0H, incubated at 37 
for 15 min and the radioactive polypeptide chains were precipitated with 5% 
trichloroacetic acid in the presence of 100 \¡g of carrier bovine serum albu-
min. Subsequently, the precipitate was collected on Whatman GF/C filters and 
washed with Ъ% trichloroacetic acid. The acid precipitable radioactivity was 
counted in the Packard Tri-carb Liquid Scintillation Spectrometer using a 
toluene based scintillator. 
2. For the analysis of newly synthesized polypeptides on Polyacrylamide gels, 
the incubation mixture was diluted with 60 μΙ of 0.2 M Tris-HCl, pH 7.8 at 
20° and incubated for an additional 15 min at 37 in the presence of 10 yg 
of pancreatic RNAase and 10 mM EDTA. Then, trichloroacetic acid was added to 
a final concentration of 5% and the precipitate was collected by centrifuga-
tion at 12,000 χ g. The precipitated proteins were subsequently washed three 
times with 5% trichloroacetic acid and three times with cold aceton at 0°. 
The final precipitate was dissolved in gel electrophoresis buffer according 
to Laemmli (259), and heated for 3 min at 95°. 
3. For the separation of released polypeptides from ribosome-bound peptidyl-
tRNA, the incubation mixture was quickly cooled to 0°, diluted with 200 yl 
of TMK (10 mM Tris-HCl, pH 7.8 at 20°, 5 mM magnesium acetate, 80 mM KCl and 
1 mM 2-mercaptoethanol) and analyzed on a sucrose gradient, consisting of a 
linear gradient of 10-20% (w/v) sucrose in TMK on top of a linear gradient 
of 20-30% (w/v) sucrose in 10 mM Tris-HCl, pH 7.8 at 20°, 80 mM KCl, 10 mM 
EDTA, pH 7.4 at 20° and 1 mM 2-mercaptoethanol. Tubes were spun at 4° for 6 h 
at 200,000 χ g in an SW 41 rotor. After centri fugati on, the bottom of the 
tube was punctured and nine-drop fractions were collected. Trichloroacetic 
acid precipitable radioactivity was determined from 25 yl aliquots of each 
fraction as described before. To pooled fractions of released polypeptide 
chains (top), stripped polypeptide chains in the EDTA part of the gradient 
and to the resuspended pellet fraction, E.aoli S-30 was added as carrier and 
the labeled material was prepared for Polyacrylamide gel electrophoresis as 
described before. 
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2.2.5. Polyacrylamide gel eleatrophoreeie 
For sodium dodecyl sulfate Polyacrylamide gel electrophoresis according 
to the method of Laemmli (25), gels were cast in 8.0 χ 0.5 cm cylindrical 
glass tubes. The resolving gels contained 12.5% acrylamide, 0.33% N.N1-
methylene-bisacrylamide, 0.025% Ν,Ν,Ν'.N'-tetramethylethylenediami ne (TEMED), 
0.1% ammonium persulfate, 0.1% sodium dodecyl sulfate and 0.275 M Tris.HCl, 
pH 8.5. Shortly before use a spacer gel was applied containing 4% acrylamide, 
0.11% N,N'-methylene-bisacrylamide, 0.05% TEMED, 0.1% ammonium persulfate, 
0.1% sodium dodecyl sulfate and 0.125 M Tris.HCl, pH 6.8. Other solutions 
were: electrode buffer, 0.2 M glycine, 25 mM Tris, 0.1% sodium dodecyl sul­
fate; final sample buffer, 60 mM Tris.HCl, pH 6.8, 2% sodium dodecyl sulfate, 
5% 2-mercaptoethanol and 10% glycerol." 
Electrophoresis was performed at 2 mA per gel at room temperature, until 
the bromophenol blue marker reached the bottom of the gel tube. After elec­
trophoresis gels were stained in 0.2% Coomassie Brilliant Blue in methanol: 
water:acetic acid (50:43:7 v/v) for 1 h at 37 and destained overnight in 
methanol:water:acetic acid (50:875:75 v/v) at 37°. 
The distribution of radioactivity in gels was determined according to one 
of the following procedures: 
(1) Gels were cut transversely in slices of 1 mn. The gel fragments were 
transferred to vials containing 300 μΐ NCS solution (NCS:H20, 90:10 v/v) and 
incubated overnight at 50 . Subsequently, 10 ml of a toluene scintillator 
was added and the amount of radioactivity was determined in the Packard Tri-
carb liquid Scintillation Spectrometer. 
(2) When [ cj and [ Hjamino acid labeled proteins were separated in the same 
gel, 1 mm slices of this gel were dried and processed with the aid of the 
Tri-carb Sample Oxidizer (Packard Model 305). By this method the [Зн] and 
L CJlabel s can be measured separately. 
(3) Gels were sliced longitudinally, dried under vacuum on a piece of Whatman 
3 MM filter paper and radioactive bands were located by autoradiography using 
Kodak RP-Royal X-omatic film. 
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2.3. STIMULATION OF AMINO ACID INCORPORATION BY RNA TUMOR VIRUS RNA AND 
MAMMALIAN MESSENGER RNA 
Addition of deprotei ni zed total virus RNA of R-MuLV, MTV or AMV to the 
cell-free system from E.ooli resulted in a significant stimulation of labeled 
amino acids in acid precipitable radioactivity (Table 1). 
TABLE 1 
Stimulation of amino acid incorporation by viral RNA and eukaryotic RNA 
preparations in the E.ooli cell-free system 
RNA added [14C 
(cpm 
Exp I none 
Phage M12 
R-MuLV 
R-MuLV 60S 
MTV 
Ribosomal 
18S 
Ribosomal 
28S 
amino acid 
incorporated) 
1016 
25,386 
2116 (4020)* 
3856 (5498) 
4066 (4772) 
1208 
1226 
Exp 
Exp 
II 
III 
RNA added 
none 
Phage M12 
R-MuLV 
Globin 9S 
α-crystal 1 
14S 
none 
Phage M12 
AMV 
s] methionine 
(cpm incorporated) 
5820 
138,866 " 
8784 (14,398) 
8960 (10,102) 
in 
6506 (7290) 
2898 
153,622 (143,322) 
11,322 (17,186) 
To each 60 μΐ incubation mixture 4 yg RNA and 5 uCi (Exp I) I Cj amino acid 
mixture (54 mCi χ matom" ) or 8 uCi (Exp II and Exp III) [ Sj methionine 
[32 Ci χ mmole (Exp 11), 41 Ci χ шоіе (Exp III)J was added. After 30 min 
incubation at 37° the reaction was terminated and trichloroacetic acid pre­
cipitable radioactivity was determined from 5 μΐ aliquots of the incubation 
mixture. 1 pmol of incorporated |_ sjmethionine corresponds to 40,000 cpm. 
Values obtained after denaturation of the RNA at 65° are given in 
parentheses. ' 
This stimulation of the amino acid incorporation could be enhanced by heat 
denaturation of the viral RNAs at 65°, prior to addition to the cell-free 
system. This effect was most pronounced for the denatured RNAs of AMV and 
R-MuLV. 
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When the E.coli cell-free system was progranmed with purified 60-70S RNA 
of R-MuLV a higher stimulation of amino acid incorporation was observed as 
that with the total viral RNA. This was probably, at least in part, due to an 
inhibitory effect of the low molecular weight viral 4-5S viral RNA, present 
in the total viral RNA preparation, on the translation of the 60S RNA. Eviden­
ce for this assumption was derived from the fact that this low molecular 
weight RNA fraction also inhibited the translation of phage M12 RNA (266). 
For comparison we examined the effect of gl obi η and α-crystal lin mes­
senger RNA on the amino acid incorporation. Whereas a significant stimulation 
of amino acid incorporation was observed in response to 9S globin mRNA, which 
was even enhanced by denaturation, the effect of a-crystallin 14S mRNA, 
coding for the Ap-chain of a-crystallin, was almost negligible. In a control 
experiment, no significant stimulation was observed after addition of either 
18S or 28S ribosomal RNA to the cell-free system. 
2.4. ANALYSIS OF THE PRODUCTS SYNTHESIZED UNDER THE DIRECTION OF RAUSCHER 
LEUKEMIA VIRUS RNA AND PHAGE M12 RNA 
To examine whether the addition of R-MuLV to an E.aoli cell-free lysate 
gives rise to the synthesis of specific polypeptides, the in vitro synthesized 
products were subjected to electrophoresis on Polyacrylamide gels containing 
sodium dodecyl sulfate. For comparison products synthesized in the endogenous 
E.aoli system were run in a parallel gel. 
From the results presented in Fig. 5A it can be concluded that several 
distinct polypeptides were made in response to the native R-MuLV RNA, with 
molecular weights ranging from 10,000 to 45,000. Most of these products were 
absent in the gel pattern of polypeptides synthesized in the endogenous sys­
tem. Co-electrophoresis of the in vitro products, directed by the denatured 
viral RNA, with radioactive proteins from purified R-MuLV virions, indicated 
that at least two polypeptides in the low molecular weight region of the gel 
(slice no. 52-71) coincided with native viral proteins (Fig. 5B). Furthermore 
additional polypeptides were synthesized which migrated to the 30,000 M 
region (slice no. 32-40). The effect of denaturation of R-MuLV RNA on the 
translation is striking. It resulted in the appearance of a polypeptide of 
approximately 45,000 M
r
 (slice no. 24-27) which was present in trace amounts 
only among the cell-free products directed by the native R-MuLV RNA 
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Fig. 5. Analysis of the polyneptides synthesized under the direction of 
R-MuLV RNA by Polyacrylamide gel electrophoresis. (A) Polypeptides synthesi­
zed in the absence (o -- o) and presence (· — ·) of R-MuLV RNA. (В) Compa­
rison by co-electrophoresis of the polypeptides synthesized in vitro under 
the direction of denatured R-MuLV RNA (· — t) with the viral proteins 
labeled with |_ cjamino acids (o -- o). Incubation in the presence of [ HJ 
histidine. After electrophoresis the gels were sliced in 1 mm sections and 
the amount of radioactivity was determined as described in section 2.2.5. 
(Fig. 5A and B). 
In order to obtain more accurate data about the size and number of the 
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synthesized products, autoradiographic analysis of dried gels was performed. 
114 I Translation of denatured R-MuLV RNA in the presence of either | Clamino 
I 35 I 
acids or 1 S|methionine led to the synthesis of mainly two polypeptides, 
with molecular weights of 15,000 and 45,000 (Fig. 6b and е.). For comparison 
Fig. 6. Autoradiogram of the polypeptides synthesized under the direction of 
R-MuLV RNA and separated by sodium dodecyl sulfate Polyacrylamide gel elec­
trophoresis. Products of the endogenous E.aoli system (a) and (d); with de­
natured R-MuLV RNA (b) and (e); with phage M12 RNA (g). Virion proteins of 
R-MuLV labeled with L cj amino acids (c) or [ sj methionine (f). Incubation 
in the presence of L cjamino acids (a) and (b), in the presence of Г sj me­
thionine (d), (e) and (g). 
the gel patterns of viral proteins labeled with L cj amino acids (Fig. 6c) 
andL sjmethionine (Fig. 6f) are included. It is obvious that from those 
polypeptides which were made in vitro only the 15,000 M polypeptide has an 
identical electrophoretic mobility as one of the proteins, i.e. pl5, of mature 
virus, labeled with [ Cjamino acids (Fig. 6c). From previously performed 
experiments it was known that [ sj methionine was present at most in trace 
amounts in the virion protein pl5 (Fig. 6f). Therefore, it was surprising 
that the 15,000 M
r
 polypeptide, synthesized in vitro was labeled with[ sj 
methionine. In first instance, this finding seemed to be in contrast to the 
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assumption that both polypeptides were identical. Since it is known, however, 
that all phage specific polypeptides, which are synthesized in cell-free 
systems from E.aoli, start with the amino acid N-formyl methionine (267-270), 
it is plausible to assume that [ sjmethionine was introduced as N-terminal 
amino acid in the in vitro synthesized 15,000 M polypeptide, by the initia-
j-nnAfMet tor tRNA 
Addition of M12 RNA to the E.aoli lysate led to the synthesis of two 
major polypeptides with molecular weights of approximately 12,000 (coat) and 
60,000 (RNA synthetase) (Fig. 6g). Moreover a substantial number of polypep­
tides of intermediate molecular weights were discernible, which presumably 
arose by incomplete translation of the synthetase cistron (262). Therefore, 
it is likely that the R-MuLV RNA directed polypeptides migrating to the 
30,000 M
r
 region and faster than 15,000 M resulted from premature polypeptide 
chain termination. 
Since the RNA present in the R-MuLV virion, consists of high and low 
molecular weight RNA species, experiments were performed to investigate 
whether any difference could be established between the polypeptides synthe­
sized under the direction of total RNA and the purified 60S RNA component of 
the virion. Analysis of the cell-free products revealed that both RNA prepara­
tions directed the synthesis of the same set of polypeptides (Fig. 7a and c). 
Fig. 7. Comparison of the polypeptides 
synthesized in the E.aoli cell-free sys­
tem under the direction of the high 
molecular weight RNA component or a total 
« . RNA isolate from R-MuLV. (a) Products of 
^ the system, supplemented with R-MuLV RNA; 
(b) with denatured R-MuLV RNA; (с) with 
native 60S R-MuLV RNA; (d) with denatured 
60S R-MuLV RNA; (e) with M12 RNA. Incuba­
tion in the presence of С amino acids. 
15,000— 
30,000-
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Moreover the cell-free synthesis of the 45,000 M polypeptide was enhanced 
after heat denaturati on of both RNA preparations (Fig. 7b and d). 
Finally, to establish whether the newly synthesized polypeptides media-
ted by the viral RNA wore released from polyribosomes, we analyzed the cell-
free incubation mixtures programmed with R-MuLV RNA on a "strip"-gradient. 
Fig. 8 exhibits that about 50X of trichloroacetic acid precipitable radio-
activity remained at the top of the gradient, representing released poly-
peptide chains. Twentyfive percent was stripped from ribosomes in the EDTA-
containing part of the gradient and 25 percent sedimented together with 
ribosomes to the bottom of the gradient. A similar result was obtained with 
M12 RNA directed polypeptides (Fig. 8). The gel analysis of the polypeptides 
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Fig. 8. Analysis of polypeptides syn-
thesized under the direction of phage 
M12 RNA and R-MuLV RNA on 'strip' 
gradients. Preparation of the samples 
from cell-free incubation mixtures 
and the 'strip' gradients was des-
cribed in section 2.2.4. Distribution 
of radioactive products synthesized 
under the direction of phage M12 RNA 
(о — о) and R-MuLV RNA (# — ·). 
30,000-
15,000-
І 
III 
a b e d 
Fig. 9. Autoradiograph of Polyacryl­
amide gels showing the polypeptide 
patterns of different fractions of the 
'strip' gradient, (a) Polypeptides 
synthesized under the direction of 
R-MuLV RNA; (b) R-MuLV RNA directed 
products in the top fraction of the 
'strip' gradient; (c) in the strip 
fraction (c); in the bottom fraction 
(d). 
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which were released during protein synthesis, stripped from ribosomes by EDTA 
or which remained attached to ribosomes is shown in Fig. 9. It is evident 
that a large proportion of the 15,000 M polypeptide was recovered in the 
gradient fractions containing released polypeptide chains, whereas the 
45,000 M polypeptide was virtually absent in this fraction (Fig. 9b). The 
latter polypeptide was only recovered from the pellet fraction of the gradient 
(Fig. 9d). 
From the results presented in this section we may conclude that addition 
of R-MuLV RNA to an E.ooli lysate gave rise to the synthesis of several poly­
peptides. One major in vitro product of 15,000 molecular weight comigrates 
with the R-MuLV virion protein pl5. A second prominent polypeptide with a 
molecular weight of 45,000 was revealed after denaturation of the viral RNA. 
Finally, the 60S viral RNA contains all the genetic information necessary to 
code for the polypeptides made in the in vitro system. 
2.5. MAGNESIUM ION DEPENDENCE OF THE CELL-FREE PRODUCTS MADE IN RESPONSE TO 
RAUSCHER LEUKEMIA VIRUS RNA AND PHAGE M12 
The effect of the magnesium ion concentration on the incorporation by 
the E.ooli lysate of [ sjmethionine into acid precipitable products in res­
ponse to the addition of R-MuLV RNA and phage M12 RNA is shown in Fig. 10. 
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.2+ Fig. 10. Effect of Mg concentration on R-MuLV RNA (A) and phage M12 RNA (В) 
directed incorporation of [_ sj methionine. Conditions for incubation were as 
2+ described in section 2.2.4., with the exception of the Mg concentration. 
2+ The Mg ion dependence of the incorporation was similar for both viral mes-
2+ 
sengers and optimal stimulation of amino acid incorporation occurred at Mg 
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concentrations between 8 and 11 mM. This indicates that optimal ionic condi-
tions for the translation of the mammalian viral RNA were employed. This con-
clusion was confirmed by the analysis of polypeptides made in response to the 
2+ R-MuLV RNA at different Mg ion concentrations, on Polyacrylamide gels (Fig. 
11, 1-8). It is obvious that both the 15,000 and 45,000 M polypeptides were 
30,000 
15,000 mil iiM 
4 6 8 9 10 11 12 14 
M g concentration ( m M ) 
Fig. 11. Polyacrylamide gel electrophoresis of the R-MuLV-specific products 
En-
synthesized at different Mg concentrations. 
2+ 
only synthesized at Mg ion concentrations of 8 to 11 mM. When a similar 
analysis was performed with the phage M12 RNA directed polypeptides a diffe-
2+ 
rential effect of Mg on the synthesis of coat protein and RNA synthetase 
2+ 
was observed (Fig. 12, 1-8). Altering of the Mg ion concentration between 
6 and 14 mM did not significantly affect the synthesis of coat protein, 
whereas a high rate of formation of RNA synthetase was observed only at 8 to 
2+ 9 mM Mg . This finding is essentially identical to the observation of 
2+ Zagôrski et al (271) that alteration of the Mg ion concentration could 
determine which gene of f2 RNA was translated in the in vitro system. We 
have not examined which step of protein synthesis was affected at suboptimal 
2+ Mg concentrations. 
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Fig. 12. Polyacrylamide gel electrophoresis of the phage M12-specific products 
2+ 
synthesized at different Mg concentrations. 
2.6. SYNTHESIS OF SPECIFIC POLYPEPTIDES DIRECTED BY AVIAN MYELOBLASTOSIS 
VIRUS RNA AND MOUSE MAMMARY TUMOR VIRUS RNA 
Additional evidence for the reliability of the -in vitro translation of 
R-MuLV RNA could be obtained if we were able to demonstrate that addition of 
RNA from other RNA tumor viruses to the E.aoli system led to the synthesis 
of polypeptides which differed in molecular size from the R-MuLV specific 
products. Therefore, we compared the cell-free products mediated by native 
or denatured AMV or MTV RNA with those synthesized in response to R-MuLV RNA. 
Native MTV RNA gave rise to the synthesis of a substantial number of 
polypeptides in the molecular weight range of 8000 up to 60,000 (Fig. 13b). 
The distribution of radioactive bands in the gel shows that at least some 
of the MTV RNA directed polypeptides did not coincide with those mediated by 
R-MuLV RNA (Fig. 13f). Denaturation of MTV RNA did not result in a strong 
enhancement of the synthesis of a particular polypeptide (Fig. 13c), as was 
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Fig. 13. Comparison of the polypeptides synthesized under the direction of 
MTV RNA with those of R-MuLV RNA by Polyacrylamide gel electrophoresis. 
(a) Virion proteins of MTV (stained gel); (b) E.eoli system supplemented 
with MTV RNA; (с) with denatured MTV RNA; (d) with M12 RNA; (e) endogenous 
products; (f) with R-MuLV RNA; (g) with denatured R-MuLV RNA. Incubation in 
the presence of [ cjamino acids. 
observed in case of R-MuLV RNA (Fig. 13g). Among the in vitro products made 
in response to MTV RNA at least one major polypeptide (14,000 M ) was detec­
ted (Fig. 13b and c), which corresponded in molecular size to protein pl4 of 
purified MTV virions (Fig. 13a). This latter polypeptide migrated always 
slightly faster than the R-MuLV RNA directed polypeptide of 15,000 molecular 
weight. Finally, among the polypeptides synthesized in vitro in response to 
MTV RNA, another prominent band was always visible comigrating with the 
buffer front, and was perhaps the result of early artificial termination. 
Fig. 14c shows the electrophoretic profile of the products synthesized 
in the in vitro protein-synthesizing system programmed by AMV RNA. One dis­
tinct polypeptide was synthesized with a molecular weight of approximately 
19,000, which was absent in the gel analysis of the endogenous products 
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Fig. 14. Comparison of the polypeptides 
synthesized under the direction of AMV 
RNA with those of R-MuLV RNA by Poly-
acrylamide gel electrophoresis, (a) En-
dogenous products of the E.aoli cell-
free system; (b) with denatured R-MuLV 
RNA; (с) with denatured AMV RNA; (d) 
= P ^ with phage M12 RNA. (e) Virion proteins 
_ p l 2 of AMV (stained gel). Incubation in the 
— p
 '
p
 presence of [ SJ methionine. 
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(Fig. 14a) and the R-MuLV RNA directed polypeptides (Fig. 14b). This 19,000 
M polypeptide is most probably identical in size to the AMV virion protein 
pl9 (Fig. 14e). Denatured AMV RNA directed the synthesis of a similar set of 
polypeptides (not shown). 
From these results, one may conclude that the cell-free system from 
E.ooli gives rise to different sets of newly synthesized polypeptides when 
programmed with the RNAs of different RNA tumor viruses. 
2.7. TRANSLATION OF EUKARYOTIC mRNA IN THE E.COLI CELL-FREE SYSTEM 
The E.aoli system has also been used to test the cell-free translation 
of mammalian messengers. Although a specific stimulation of protein synthesis 
by mammalian mRNA fractions was observed, in most reports no convincing 
evidence was provided that these messengers were faithfully translated (272-
275). Actually, the results of only one report suggest that in response to 
an 8S messenger RNA fraction from rabbit reticulocytes, material was synthe-
sized having properties of rabbit globin (275). 
Since the purified globin 9S and α-crystal lin 14S mRNA were available, 
we were interested to investigate whether both messenger fractions were 
faithfully translated in the E.aoli system. In section 2.3. we established 
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that addition of globin 9S mRNA to the E.aoH lysate resulted in a stimulation 
of the amino acid incorporation, whereas this stimulation was negligible in a 
lysate programmed with the a-crystallin 14S mRNA. Sodium dodecyl sulfate Poly­
acrylamide gel analysis of the products synthesized in vitro in response to 
both messengers, revealed that no polypeptides were made which correspond in 
size to globin or the A2-chain of a-crystallin (Fig. 15a-d, i and j). However, 
we cannot exclude that in response to both messengers small polypeptides were 
made, which were lost during preparation of the synthesized products for gel 
analysis. 
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Fig. 15. Autoradiogram of the polypeptides synthesized under the direction of 
globin 9S and a-crystallin 14S mRNA. (a) Products synthesized under the direc­
tion of globin 9S mRNA; (b) with denatured globin 9S mRNA; (c) with a-crystal­
lin 14S mRNA; (d) with denatured a-crystallin 14S mRNA; (e) with R-MuLV RNA; 
(f) with denatured R-MuLV RNA; (g) endogenous E.coli products; (h) with phage 
M12 RNA. Incubations in the presence of L sjmethionine. (i) Products synthe­
sized under the direction of globin 9S mRNA; (j) with o-crystallin 14S mRNA; 
(k) with R-MuLV RNA; (1) endogenous E.aoli products. Incubations in the 
presence of [ cjamino acids, α stands for a-crystallin, g stands for globin. 
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2.8. DISCUSSION 
Evidence was provided, that the RNA isolated from three nonrelated RNA 
tunrar viruses was able to funtion as messenger RNA in a cell-free lysate from 
E.coli. In response to the individual viral RNA preparations of R-MuLV, MTV 
and AMV specific sets of products were synthesized. Moreover, comparison of 
the gel patterns of the in vitro products with the virion proteins suggest, 
that in response to each particular viral RNA at least one polypeptide was 
made, which corresponds in size to one of the virion proteins. Additional 
evidence that the 15,000 molecular weight polypeptide, mediated by R-MuLV 
RNA is coded for by the viral RNA has been provided by Salden (personal com-
munication). He was able to demonstrate that the latter polypeptide could be 
precipitated with a rabbit antiserum directed against purified R-MuLV. More 
recently Twardzik et al (154) reported the translation of AKR-murine leukemia 
virus (AKR-MuLV) RNA in cell-free extracts from E.aoli. These authors des-
cribed the synthesis of one major polypeptide of 30,000 Mr and two minor pro-
ducts of about 9000 and 12,000 M . Furthermore, employing antiserum directed 
against MuLV they showed that about 40% of the newly synthesized polypeptides 
could be precipitated. However, no further analysis was performed on the pre-
cipitated proteins. Since both the RNA from AKR-MuLV and R-MuLV, code for 
antigenic homologous proteins it is conceivable that a similar set of group-
specific polypeptides was synthesized under the direction of both viral RNAs. 
On the other hand, we have never observed the synthesis of a polypeptide 
which corresponded in size with the major group-specific antigen p30. This 
discrepancy is most probably due to differences in the analysis of the newly 
formed products. Whereas the location of the radioactive polypeptides as de-
termined by slicing of the gels suggests that part of the products made in 
vitro comigrated with the virion protein p30 (Fig. 5B), autoradiographic 
analysis (Fig. 6b and e) clearly shows that the slices in question actually 
comprised three to four bands with slightly different electrophoretic mobili-
ties. For the present time it is, therefore, extremely hard to compare the 
results of this group with our data. We are concerned with a similar problem, 
if we try to compare our findings on the translation of AMV RNA with those of 
Siegert et al (152). These authors claimed that addition of AMV RNA to the 
E.aoli lysate gave rise to the synthesis of polypeptides, which corresponded 
in size and relative amount to the AMV virion antigens p27, pl9, pl5 and pl2. 
44 
The radioactive pattern of the polypeptides synthesized in vitro was determined 
by slicing of the gels. Employing immunodiffusion analysis, it could further 
be demonstrated that one of these proteins synthesized in vitro was antigeni-
cally related with pl2. Our electropherograms reveal that we can confirm the 
synthesis of a polypeptide with the approximate size of pl9; however, we can-
not support their finding that p27, pl5 and pl2 were also synthesized. As 
mentioned before, this discrepancy is most probably due to differences in the 
procedure by which radioactive protein bands were localized in the gel. Our 
results clearly show that location and resolution of radioactive bands in 
Polyacrylamide gels are greatly improved, by employing autoradiographic ana-
lysis in stead of gel slicing, and subsequent counting. 
More recent studies on the synthesis of RNA tumor virus-specific proteins 
in cells labeled in vivo, showed that mature virion proteins arise by proteoly-
tic cleavage of high molecular weight precursor polypeptides (253-257). More-
over, by employing specific antisera it became possible to detect the virus-
specific polypeptides synthesized under the direction of purified RNA of 
several RNA tumor viruses in cell-free extracts of mammalian origin (155-158). 
With respect to the synthesis of R-MuLV-specific polypeptides Naso et al (155) 
claimed that R-MuLV RNA mediated the synthesis of two classes of polypeptides 
(140,000-185,000 and 50,000-75,000 Mr) in a S-30 system derived from R-MuLV 
infected JLS-V5 cells. Both classes of polypeptides were larger than the 
group-specific antigens of mature virions. On the other hand,Sal den et al 
(157) demonstrated that in response to R-MuLV RNA mainly two polypeptides 
(65,000 and 72,000 Mr) were synthesized, sharing common amino acid sequences 
with the virion protein p30. No mature virion proteins were detected after 
cell-free incubation'of the R-MuLV RNA. Cell-free translation of the 60-705 
RNA of an avian RNA tumor virus (Rous sarcoma virus) also led to the formation 
of a high molecular weight precursor (76,000 M ) of the mature virion proteins 
(156). 
In view of these results we feel that, although the E.ooli system is ca-
pable to translate the viral messenger RNA with fidelity, the newly synthesized 
polypeptides were most probably only fragments of the virion precursor poly-
peptides. The reason for this may be: 
1. Initiation of polypeptide synthesis occurred at internal sites of the mes-
sage, resulting in the synthesis of products of limited size. 
2. Small fragments arose by premature termination of protein synthesis caused 
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by degradation of the viral RNA by nucleases. 
3. Newly synthesized polypeptides of high molecular weight were rapidly pro-
cessed by proteolytic enzymes, present in the lysate. 
Evidence for the first two alternatives was provided by experiments of Rekosh 
et al (276) demonstrating the synthesis of a heterogeneous mixture of virus-
specific polypeptides in the molecular weight range up to 60,000 when the 
E.aoli cell-free system was programned with poliovirus RNA. Initiation of 
polypeptide synthesis started on at least eight distinct sites on the viral 
RNA and gradient analysis of the viral RNA after incubation in the cell-free 
system indicated that the RNA was rapidly degraded. We have not examined which 
of these alternatives is applicable to the translation of the RNA of RNA 
tumor viruses. However, additional support for our notion that at least one 
of the polypeptides directed by AMV RNA, may be identical to the virion pro-
tein pl9 is derived from the observation of Eisenman et al (256) that pl9 is 
located closest to the N-terminal end of the precursor polypeptide (76,000 M ) 
of the mature virion proteins. The location of pl9 nearest to the N-terminal 
side, makes it likely that the efficiency of translation of this part of the 
genome is highest. This supposition is consistent with our observation that 
pl9 was the major product mediated by the RNA of AMV. 
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CHAPTER 3 
VIRUS-SPECIFIC MESSENGER RNA IN FREE AND MEMBRANE-BOUND POLYRIBOSOMES 
OF CELLS INFECTED WITH RAUSCHER MURINE LEUKEMIA VIRUS 
3.1. INTRODUCTION 
In cells infected with RNA tumor viruses several virus-specific proteins 
are synthesized, including the internal capsid proteins, virion envelope pro-
teins, the RNA-dependent DNA polymerase and, presumably, proteins responsible 
for the transformation of the infected cells. It is important to characterize 
the virus-specific mRNA(s) involved in the synthesis of these virus-specific 
proteins. Moreover, in view of the fact that we did not observe the transla-
tion of native or denatured 60-70S RNA of Rauscher murine leukemia virus 
(R-MuLV) in maimalian cell-free systems, we were interested to examine whether 
the 60-70S RNA or the 35S subunit RNA of R-MuLV function as messenger, and 
whether mRNAs exist in sizes other than that of the viral genome. 
RNA tumor viruses contain an enzyme capable of transcribing DNA from the 
60-70S viral RNA. The DNA products synthesized by the endogenous 'DNA poly-
merase' appear to be a mixture of single-stranded DNA and double-stranded DNA 
(229). However, when the synthesis of double-stranded DNA is inhibited by in-
cubation of detergent-treated virus in the presence of actinomycin D, preferen-
tially single-stranded DNA complementary to the viral RNA is synthesized (231, 
277,278). This single-stranded DNA represents a complete and relatively uniform 
copy of the entire viral genome (160,279) and, therefore, constitutes an ex-
tremely sensitive hybridization probe for the detection of virus-specific RNA 
in cells infected with RNA tumor viruses (280-234). 
Hybridization of unlabeled RNA, fractionated according to size, from cells 
tranformed by the Moloney strain of murine sarcoma virus with the labeled viral 
DNA probe indicated the presence of two size classes of virus-specific RNA, 35S 
and 20S (285). A similar analysis of avian sarcoma virus (RSV) infected cells 
revealed that the intracellular virus-specific RNA was heterogeneous in size 
sedimenting between 4S and 50S (286). However, evidence for virus-specific RNA 
species in association with functioning polyribosomes was still lacking. 
In this chapter we report the presence of Rauscher murine leukemia virus-
specific RNA sequences in free and membrane-bound polyribosomes from cells 
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chronically infected with this virus. In addition, we examined the size of the 
virus-specific mRNAs associated with the various polyribosomal preparations. 
3.2. MATERIALS AND METHODS 
3.2.1. Cella and virus 
The JLS-V9 cell line, derived from bone marrow cells of BALB/c mice in­
fected with and producing Rauscher leukemia virus (R-MuLV) was grown as mono­
layer in Eagle's Minimal Essential Medium completed with 10% calf serum, 
penicillin (100 I.U. χ ml" ) and streptomycin (50 ug χ m l ) (287). 
3.2.2. Experimental conditions 
In order to minimize the possibility of RNAase contamination, all glass--
ware was sterilized by dry heat and all buffers, sucrose and glycerol solutions 
used during handling and isolation of polysomes and RNA were sterilized by 
autoclaving. All solutions were handled with sterile glass pipettes. 
Buffers to be used at 4 were standardized to the desired pH with con­
centrated HCl at 4°. All manipulations were performed at 0-4° unless otherwise 
stated. Centrifugation gravity values quoted are the average g-values generated 
at particular speeds of rotation. 
3.2.3. Cell fractionation and isolation of free and membrane-bound poly­
ribosomes 
In order to obtain a maximal yield of polyribosomes, fresh growth medium 
and cycloheximide (0.1 pg χ ml" ) were added 180 and 20 min, respectively, 
before harvesting of the cells (288,289). Cells were trypsim'zed at 37° and 
cooled rapidly with crushed frozen isotonic medium (35 mM Tris-HCl, pH 7.5, 
146 mM NaCl). 
Cells were collected by 5 min centrifugation at 1000 χ g and washed three 
times with isotonic medium. Two ml of pelleted cells were suspended in 13 ml 
of hypotonic medium containing 10 mM Tris-HCl, pH 7.4, 15 mM KCl, 1.5 mM 
magnesium acetate and 2 mM 1,4 dithioerythritol. All media used in this and 
further isolation steps contained 100 wg χ ml" of RNAase inhibitor from 
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bovine eye-lens, purified on DEAE-cellulose (kindly provided by Dr. W.G.M. 
van de üroek of our laboratory). After 15 min swelling, cells were disrupted 
by 20 strokes of a Dounce homogenizer (B pestle). Nuclei and unbroken cells 
were removed by 10 min centri fugation at 700 χ g. 
Polyribosomes associated with membranes were isolated by flotation in 
discontinuous sucrose gradients. Ten ml of the postnuclear supernatant was 
made 2.2 M in sucrose by the addition of 90% (w/v) sucrose and transferred to 
tubes of the Spinco type-SW 27 rotor. Eight ml of 1.8 M sucrose in TMK (50 mM 
Tris-HCl, pH 7.8, 80 mM KCl, 5 mM magnesium acetate and 1 mM 1,4 dithioery-
thritol) and 8 ml of 1 M sucrose in TMK were layered on top of the 2.2 M 
sucrose cushion. Centri fugati on was performed at 95,000 χ g for 3 h. The mem­
brane layer on top of the 1.8 M sucrose cushion was removed and the membranes 
were soldbilized by addition of a mixture of nonidet P-40/deoxycholate (1:1) 
to a final concentration of 0.5%. The released polyribosomes were further 
purified by centri fugation through a layer of 4 ml of 2 M sucrose in TMK for 
18-24 h at 95,000 χ g in a SW 27 rotor. 
For the isolation of free polyribosomes, 2 ml of the postnuclear super­
natant was diluted with 6 ml TMK and centri fuged at 13,000 χ g for 5 min in a 
Spinco type-Ti 50 rotor. The supernatant was layered on a discontinuous sucrose 
gradient consisting of 8 ml 1 M sucrose in TMK on top of 4 ml 2M sucrose in 
TMK and centrifuged for 18-24 h at 95,000 χ g in a SW 27 rotor. 
3.2.4. Isolation of total polyribosomes 
A mixture of free and membrane-bound polyribosomes (total polyribosomes) 
were isolated as described previously (288). Cells were collected and washed 
as described in section 3.2.3. To the pelleted cells 2% nonidet P-40 in high 
salt buffer (50 mM Tris-HCl, pH 8.5, 225 mM KCl, 8 mM magnesium acetate, 2 mM 
1,4 dithioerythritol and 100 yg χ ml" of RNAase inhibitor) was added and the 
cells were lysed by 10 strokes of a tight fitting Dounce homogenizer (B 
pestle). Nuclei and cell debris were removed by centrifugation at 12,000 χ g 
for 5 min in a Spinco type-Ti 50 rotor. The isolation of polyribosomes from 
the supernatant was performed as described for free polyribosomes in section 
3.2.3. 
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3 . 2 . 5 . Sucrose-gradient aentrifugation of purified polyribosomes 
Polyribosomal pellets were resuspended in TMK, layered on 20-30.7% 
(w/v) isokinetic sucrose gradients in TMK and centrifuged at 5 in an SB 283 
rotor of an IEC centrifuge for 60 min at 200,000 χ g. Polyribosomal profiles 
were recorded with a continuous flow monitoring system using an LKB optical 
unit, coupled to a logarithmic recorder. To each fraction of the gradient 20 μα 
of E.ooli tRNA was added as carrier and the polyribosomes were precipitated 
with 0.1 volume of sodium acetate pH 5.2 and 2 volumes of ethanol at -20 . 
Messenger RNP was released from purified polyribosomes, resuspended in 
TMK, by the addition of neutralized EDTA to a final concentration of 15 mM. 
Polyribosomes treated with EDTA were analyzed in 20-30.7% (w/v) isokinetic 
sucrose gradients in 50 mM Tris-HCl, pH 7.8, 80 mM KCl and 1 mM 1,4 dithio-
erythritol. Centri fugation conditions were as mentioned before. 
3.2.6. Extraction and analysis of polyribosomal RNA 
Nucleic acid from the resuspended polyribosomal pellets or from gradient 
fractions was extracted with phenol-chloroform according to Perry et a l (263). 
Polyribosomal suspensions in extraction buffer (10 mM Tris-HCl, pH 8.0 at 20 , 
100 mM NaCl, 1 mM EDTA and 0.5% sodium dodecyl sulfate) were rapidly deprotei-
nized after addition of 2 vol. of phenol-chloroform (1:1) saturated with ex­
traction buffer. The water phase was reextracted twice with chloroform-iso-
amylalcohol (100:1). After centrifugation, RNA was precipitated from the 
aqueous phase with 0.1 vol. of 2M sodium acetate pH 5.2 and 2 vol. of ethanol 
at -20°. 
The extracted RNA was dissolved in TNE 7.4 (10 mM Tris-HCl, pH 7.4, 100 mM 
NaCl, 1 mM EDTA) containing 0.5% sodium dodecyl sulfate, layered onto a 
15-30.2% (w/v) isokinetic glycerol gradient in TNE and centrifuged at 5° in an 
SB 283 rotor at 200,000 χ g for 9 h. RNA profiles were monitored with the aid 
of an LKB optical unit. 
3.2 .7 . Synthesis of the virus-speoific cDNA probe 
The viral cDNA probe used to detect intracellular viral RNA was prepared 
by the endogenous reaction of R-MuLV virus isolated from plasma of virus 
5C 
infected Swiss mice. Transcription of the viral RNA was performed in the 
presence of actinomycin D, to inhibit synthesis of double-stranded DNA (231, 
277,278). 
Purified R-MuLV 200-300 yg χ ml" , isolated as described in section 
2.2.3., was added to an 1 ml incubation mixture containing 50 mM Tris-HCl, 
pH 8.3 at 20°, 6 mM MgCl,, 60 mM NaCl, 10 mM 1,4 dithioerythritol, 0.2 mM 
c
 _i 
each of dATP and dTTP, 0.015% (v/v) nonidet P-40, 100 yg χ ml actinomycin 
D and 0.02 mM of [VJdCTP and [3H]dGTP. Enzyme reactions were incubated at 
37° for 4-6 h. The reaction was stopped by addition of 3 Μ Κ0Η to a final 
concentration of 0.3 M, the solution was kept at 37° for 18 h and finally 
neutralized with 0.1 vol. of 3 M HCl. After addition of sodium dodecyl sul­
fate to a final concentration of 0.5%, the reaction mixture was passed over 
a Sephadex G-50 column equilibrated with 50 mM tri ethyl ammoni urn bicarbonate 
buffer, pH 7.0. Samples from the eluted fractions were assayed for trichloro­
acetic acid precipitable radioactivity and those fractions which contained 
labeled DNA were pooled and lyophilized. The lyophilized material was resuspen-
ded in distilled water, 200 yg E.coli tRNA was added as carrier and nucleic 
acids were precipitated by addition of 0.1 vol. 2 M NaCl and 2 vol. of ethanol 
at -20°. The specific activity of the cDNA was about 7500 cpm χ ng . 
It is of importance to mention that the synthesis of cDNA by the endoge­
nous reverse transcriptase reaction, is strongly dependent on the nonidet 
P-40 concentration (290). Therefore, we determined in test experiments the 
amount of virion protein optimal at a particular nonidet P-40 concentration. 
3.2.8. Purifiaation of Aspergillus oryzae single-strand specific nuclease 
Aspergillus oryzae Ъ, single-strand specific nuclease was purified from 
crude α-amylase powder essentially as described (291,292). Five g of crude 
amylase was dissolved in 200 ml column buffer (0.02 M КР0., pH 6.9 and b% 
glycerol) and the insoluble material was removed by low speed centri fugati on. 
The supernatant was applied to a DE-52 column equilibrated in column buffer. 
After rinsing the column with buffer until the effluent was colorless, nuclease 
was eluted with a linear 0-0.4 M NaCl gradient in column buffer, with 400 ml 
total volume. Those fractions with high single-strand specific nuclease acti­
vity were diluted with glycerol to a final concentration of 50% and stored 
at -20°. 
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3.2.9. Nueleic aaid hybridization 
Annealing of viral and polyribosomal RNA with [ HJcDNA (750 cpm) was 
performed at 65° in 0.2 M phosphate buffer, pH 7.0 and 0.5% sodium dodecyl 
sulfate. Reactions were carried out in volumes of 10 yl in sealed microcapil-
lary tubes. The extent of hybridization was assessed by measuring resistance 
to Aspergillus огугае single-strand specific nuclease. The reaction mixture 
contained in a volume of 1 ml, 100 mM sodium acetate buffer, pH 4.5, 1 mM 
ZnSO-, 10 vg denatured calf thymus DNA and sufficient S, nuclease to degrade 
this amount of DNA. The samples were incubated for 30 min at 45°, followed by 
addition of 40 yg yeast tRNA and precipitated with 5% trichloroacetic acid. 
Precipitates were collected on millipore filters, dried and counted in the 
Packard Tri-carb Liquid Scintillation Spectrometer. 
3.3. ASSOCIATION OF VIRUS-SPECIFIC RNA WITH FREE AND MEMBRANE-BOUND 
POLYRIBOSOMES 
To study the presence of virus-specific RNA sequences in free and membrane-
bound polyribosomes, an isolation procedure was chosen, by which cross contami­
nation of both types of polyribosomes was prevented. Contamination of free po­
lyribosomes with membrane-bound polyribosomes was precluded by centri fugati on 
of the 13,000 χ g supernatant of the cell-lysate through a 2 M sucrose layer. 
In addition, by flotation of the polyribosomes associated with membranes 
through a layer of 1.8 M sucrose any contamination with free polyribosomes 
was eliminated. 
The optical profiles of both classes of polyribosomes, monitored after 
centri fugation in isokinetic sucrose gradients, were practically identical 
(Fig. 16 A and B). From these gradients, fractions were collected and the 
polyribosomes were deprotei ni zed with phenol-chloroform. The content of virus-
specific RNA in each fraction was determined by hybridization with the labeled 
single-stranded DNA copy of the viral RNA (cDNA). For that purpose the RNA 
from each fraction was dissolved in the same volume of distilled water and 
samples of equal volume from these RNA solutions were taken for the hybridi­
zation reactions. When the two hybridization patterns of viral cDNA, RNA from 
free and membrane-bound polyribosomes were compared, it appeared that approxi­
mately six times as much of the former RNA had to be used to match the level 
52 
40 
30 
2 0 
J IO 
1 
- Free polynboecrneo 
,eos 
/~-°-\ 
/ \, 
. / / ^ ^ v 
~^K , 
± 
ί ι ο 
Ci 
ho 
t 
20 
10 
г Membrane-bound pelyriboeome* 
jeos 
/ \ » 
\ ^ / ~ " \ 
A 
. 
• 
ï ^ l · 
В 
-
S«-
1 ti 
Λ
 TI 
I i 
* 1 
< 2 
ло 
3 0 
20 
10 
- Free polyribosome» + EDTA 
| 6 0 3 
-
• 
•i k. 
С 
25 
20 
- IS 
16 
0 5 
40 
30 
20 
10 
Г 
ДНптіЬгапе-tound polyribosome«. EDTA D 
• 
• 
A V J \ : 
5 Ю 
fraction number 
5 10 
fraction number 
Fig. 16. Virus-specific RNA in free and membrane-bound polyribsomes of R-MuLV 
infected cells. Free and membrane-bound polyribosomes or ribonucleoprotein 
particles released by EDTA treatment of these polyribosomes were analyzed in 
isokinetic sucrose gradients (section 3.2.5.). Fractions of 0.3 ml were col­
lected and the polyribosomes were precipitated with ethanol. After extraction 
of the RNA, aliquots of each fraction were hybridized with R-MuLV cDNA. 
(A) Free polyribosomes; (B) membrane-bound polyribosomes; (C) free polyribo­
somes dissociated by EDTA; (D) membrane-bound polyribosomes dissociated by 
EDTA. 
of hybridization with the latter RNA. This observation indicates that of both 
types of polyribosomes membrane-bound polyribosomes were especially enriched 
with virus-specific sequences. Hybridization of cDNA occurred with RNA from 
free and membrane-bound polyribosomes of all size classes and followed almost 
the optical profile of the ribosomes (Fig. 16 A and B). The highest absolute 
amount of virus-specific RNA was associated with polyribosomes with sedimen­
tation values of 300-400S. However, when the same amount of RNA from each 
polyribosomal fraction was used in the hybridization reaction maximal hybridi­
zation, the highest relative amount, was found in polyribosomes with sedimen­
tation values of 450-550S (Fig. 17). These sedimentation values correspond 
with polyribosomes containing 13-18 ribosomes per message. 
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Fig. 17. Distribution of virus-specific RNA sequences in polyribosomes isola­
ted from R-MuLV infected cells by detergent treatment. A mixture of free and 
membrane-bound polyribosomes was prepared by lysis of cells in the presence 
of nonidet P-40 as described in section 3.2.4. After lysis of the cells, nu­
clei and cell debris were removed by low speed centri fugation at 750 χ g for 
5 min. The supernatant was directly layered onto an 20.0-30.7% (w/v) isokine­
tic sucrose gradient in TMK buffer and centrifuged at 5 in an SB 283 rotor 
of the IEC centrifuge for 45 min at 200,000 χ g. Fractions of 0.8 ml were 
collected and polyribosomes were precipitated with ethanol. From each fraction 
an equal amount of RNA was hybridized with the R-MuLV specific cDNA probe. 
To provide evidence that the virus-specific RNA sedimenting with poly­
ribosomes represented virus-specific mRNA in functioning polyribosomes, 
aliquots of the free and membrane-bound polyribosomes were treated with 15 mM 
EDTA. By this procedure, polyribosomes are dissociated and the mRNA is re­
leased as mRNP particle. Fig. 16 С and D show that no virus-specific RNA was 
recovered from the original polyribosomal region of the gradient. All hybri-
dizable RNA was released and displaced towards the top of the gradient. 
Therefore, it is unlikely that the virus-specific RNA associated with poly­
ribosomes is due to virion (core) particles co-sedimenting with polyriboso­
mes. From these experiments we conclude that the virus-specific RNA 
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associated with free and membrane-bound polyribosomes of R-MuLV infected 
^ells, is identical to the viral mRNA fraction. 
3.4. CHARACTERIZATION OF THE VIRUS-SPECIFIC mRNA 
In order to determine the size of the virus-specific mRNA species asso-
ciated with polyribosomes, RNA was extracted from total polyribosomes and 
the purified free and membrane-bound polyribosomes. Following centrifugation 
of the extracted RNA through isokinetic glycerol gradients, the separate 
fractions were assayed for virus-specific RNA by hybridization with the la-
beled R-MuLV DNA probe. In a preliminary experiment we established that no 
significant hybridization occurred in the 60-70S region of gradients resol-
ving particles with sedimentation values up to 100S (not shown). 
Fig 18A illustrates the size distribution of hybridizable RNA extrac-
ted from a mixture of free and membrane-bound polyribosomes (total poly-
ribosomes) A rather heterogeneous distribution of virus-specific RNA was 
observed, with two predominant peaks in the 35S and 20-22S regions of the 
gradient. In addition a shoulder of hybridizable RNA was detected in the 14S 
region. The 35S RNA associated with polyribosomes corresponds in size with 
the virion RNA subumt, visualized by denaturation of the virion 60-70S RNA 
(22,97). The same three classes, 35S, 20-22S and 14S, of virus-specific RNA 
were found in purified free and membrane-bound polyribosomes (Fig. 18B and C) 
Whereas the 20-22S and 14S RNAs species were minor components only of the 
virus-specific RNA in free polyribosomes, they constituted the major part of 
the hybridizable RNA of membrane-bound polyribosomes. 
The presence of similar virus-soecific mRNA species in free and membra-
ne-bound polyribosomes allows several explanations: 
1. Virus-specific mRNA from either type of polyribosomes may code for diffe-
rent polypeptides, despite the similarity of the S values in both populations. 
2. The same viral polypeptides are synthesized on both types of polyribosomes; 
Polypeptide synthesis starts on free polyribosomes and after the nascent 
chains have been elongated to a certain length polyribosomes become membrane-
bound. 
The first explanation is unlikely, since virus-specific RNA from both 
classes of ribosomes hybridized to 100% with the labeled DNA probe In order 
to get some evidence for the second possibility, RNA from free and 
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Fig. 18. Size distribution of R-MuLV specific RNA associated with polyribo-
somes. Free, membrane-bound and total polyribosomes were deproteinized with 
phenol. The extracted RNA was dissolved in TNE buffer containing 0.5% sodium 
dodecyl sulfate and analyzed in isokinetic glycerol gradients (section 3.2.6). 
Fractions of 0.4 ml were collected and precipitated with ethanol after addi-
tion of 20 vg E.coli tRNA as carrier. The relative amount of virus-specific 
RNA in each fraction was determined by hybridization with R-MuLV cDNA. 
(A) RNA from total polyribosomes; (B) RNA from membrane-bound polyribosomes; 
(C) RNA from free polyribosomes. 
56 
membrane-bound polyribosomes of different gradient fractions (see insets of 
Fig. 19A, В and С and Fig. 19D, E and F) was isolated and analyzed in glyce­
rol gradients. In all size classes of free polyribosomes three discrete RNA 
β 12 16 
fraction number 
β 12 
fraction number 
Fig. 19. Size distribution of R-MuLV-specific RNA associated with free and 
membrane-bound polyribosomes of different size classes. The sedimentation 
profiles of isolated free and membrane-bound polyribosomes in 20-30.7% (w/v) 
isokinetic sucrose gradients are depicted in the insets. Fractions from 
these gradients were pooled as indicated by the hatohed areas. After depro-
teinization of the polyribosomes, the purified RNA was analyzed on isokine­
tic glycerol gradients (section 3.2.6.). Fractions of 0.6 ml were collected, 
and the RNA was precipitated with ethanol after addition of 20 ug E.coli 
tRNA as carrier. The relative amount of virus-specific RNA in each fraction 
was determined by hybridization with the R-MuLV-specific cDNA. 
species with sedimentation values of 35S, 20-22S and 14S were present 
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(Fig. 19A, В and С). However, the lower molecular weight RNA species were 
present in a higher content in small polyribosomes (1-6 ribosomes) than in 
large polyribosomes (more than 6 ribosomes). This is in agreement with the 
theoretical expectation that small messengers are associated with less ribo­
somes than larger messengers. The picture obtained from material derived 
from membrane-bound polyribosomes was quite different (Fig. 19D, E and F). 
Almost no hybridizable RNA was found in the 35S region of that gradient, 
when polyribosomes up to six monomers were analyzed (Fig. 19D). Furthermore, 
it was found that the ratio of virus-specific 35S RNA to the smaller virus-
specific RNAs of 14S and 20-22S was higher in the larger size classes of the 
polyribosomes (Fig. 19B and C). This effect was particularly pronounced in 
membrane-bound polyribosomes with more than 13 monomers, whereas for free 
polyribosomes an almost similar distribution was observed for polyribosomes 
with 6-13 and larger than 13 monomers. 
If the distribution of virus-specific RNA species in different size 
classes of membrane-bound polyribosomes is representative for the situation 
in vivo, these results suggest that the viral polypeptide synthesis directed 
by the 35S messenger may start on free polyribosomes, which thereafter, be­
come attached to membranes. Our results do not allow any conclusion concer­
ning the mechanism which may be operative for the 14S and 20-22S RNA species. 
The results presented were not significantly affected if the pretreatment of 
the cells with 0.1 ug/ml of cycloheximide was omitted. 
3.5. RELATIVE AMOUNTS OF VIRUS-SPECIFIC MESSENGER RNA IN POLYRIBOSOMES 
The percentage of polyribosomal RNA representing virus-specific sequen­
ces can be computed by comparison of the half-C t values of polyribosomal 
and viral RNA (Table 2). The values indicated that about 0.2 percent of the 
RNA of total polyribosomes was virus-specific. Fan and Baltimore (160) found 
that in uninfected JLS-V9 cells approximately 0.02 percent of the cytoplasmic 
RNA was hybridizable with the R-MuLV DNA probe, whereas approximately 0.25 
percent of the cytoplasmic RNA of Moloney murine leukemia virus infected 
JLS-V9 cells was virus-specific. Thus, hybridization data for Moloney leuke­
mia virus infected JLS-V9 cells agree well with our calculations of the 
virus-specific RNA content of polyribosomes from R-MuLV infected JLS-V9 
cells. Finally, our results show that the relative content of virus-specific 
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RNA was 5 to 10 fold higher in membrane-bound polyribosomes than in free 
polyribosomes. 
TABLE 2 
VIRUS-SPECIFIC RNA IN POLYRIBOSOMES 
RNA 
60S R-MuLV 
Free polyribosomes 
Membrane-bound 
polyribosomes 
Total polyribosomes 
Half-C
r
t 
(mole-sec/liter) 
1.58 χ 10"2 
3.16 χ 101 (3.98 χ 101) * 
5.63 (3.98)* 
7.95 
% virus-specific 
RNA 
100 
0.05 (0.04)* 
0.30 (0.40)* 
0.20 
RNA was isolated from free, membrane-bound and total polyribosomes. Increa-
3 
sing amounts of each RNA fraction were hybridized to 800 cpm of H -labeled 
R-MuLV-specific cDNA. The percentage of DNA hybridized was plotted in a semi-
logarithmic graph against the product of RNA concentration χ time (C t). The 
proportion of virus-specific sequences in the polyribosomal RNA was calculated 
by comparison of the C
r
t values at which 50% of the maximal hybridization was 
obtained with the half С t of the 60S RNA of R-MuLV. 
RNA isolated from polyribosomes of cells pretreated with 0.1 yg/ml of 
cycloheximide. 
3.6. DISCUSSION 
Most cell fractionation procedures for the isolation of free and membra­
ne-bound polyribosomes from tissue culture cells have the disadvantage of 
giving low yields of membrane-bound polyribosomes. A substantial proportion 
of polyribosomes is removed together with nuclei and cell debris at 750 χ g. 
From the JLS-V9 cell line only 5 to 10 percent of the polyribosomes could be 
recovered as membrane-bound polyribosomes. Nevertheless, our results obtain­
ed after cell lysis in the presence of detergents (Fig. 18A) indicate that 
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we have isolated a representative sample of the total population of membrane-
bound polyribosomes, at least as far as the total content of hybridizable 
sequences in mRNA is concerned. Moreover, in chapter 5 a different technique 
was employed for the isolation of both types of polyribosomes, yielding 
20-30 percent of the polyribosomes as membrane-bound polyribosomes and no 
result obtained with this technique was in conflict with the conclusion ar­
rived in the present chapter. 
While this work was in progress Vecchio et al (293) reported the finding 
of virus-specific RNA and nascent polypeptides in free and membrane-bound 
polyribosomes from cells replicating the Moloney strain of murine sarcoma-
leukemia virus ["Mo-SV (Mo-MuLV)l. Moreover, they calculated that polyriboso­
mes bound to membranes contained between 4 and 5 times more virus-specific 
RNA than free polyribosomes. Their results are in agreement with our data 
presented in this chapter. 
Sedimentation analysis of the RNA associated with total polyribosomes 
derived from R-MuLV infected JLS-V9 cells indicated the presence of three 
discrete size classes of virus-specific RNA with estimated molecular weights 
of 3 χ 10 6 (35S), 1.0-1.5 χ IO6 (20-22S) and 0.4 χ IO6 (14S). However, after 
separation of cellular ribosomes in free and membrane-bound polyribosomes a 
striking difference in the size distribution of hybridizable RNA associated 
with both types of polyribosomes was observed. Whereas one major virus-spe­
cific RNA species (35S) was detected in free polyribosomes, three major size 
classes (35S, 20-22S and 14S) were found in membrane-bound polyribosomes. 
It should be mentioned that the hybridization profile does not neces­
sarily reflects the actual distribution of virus-specific RNA sequences and 
allows only a qualitative interpretation. A quantitative analysis is ob­
tained if two criteria are fulfilled: all of the RNA sequences detectable 
with the cDNA must be present in each fraction and these sequences must be 
in excess of the DNA probe (160). We were able to demonstrate that 100% hy­
bridization was possible with RNA sedimenting in the 35S and 20-22S region. 
Moreover, the concentration of RNA in the hybridization reaction was always 
in excess of the DNA probe. The above criteria were, therefore, at least 
partially met. 
After this work was finished, several reports on the identification of 
virus-specific mRNA in cells infected with murine and avian RNA tumor viru­
ses were published (160-162). The most prominent virus-specific mRNA species 
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associated with polyribosomes was identical in size to the viral RNA-subunit 
(30-40S). Furthermore, all investigators reported that isolated polyribosomes 
contained a second fraction of virus-specific RNA with sedimentation values 
of 20-30S. The distribution of virus-specific mRNA species between free and 
membrane-bound polyribosomes has been studied by Shanmugan et al (162). They 
found that free polyribosomes from Mo-SV (Mo-MuLV) transformed cells con-
tained only virus-specific mRNA with a sedimentation value of 35S. In con-
trast, two species of virus-specific mRNA, 35S and approximately 20S, were 
found in association with membrane-bound polyribosomes. These findings are 
in accordance with our data on the R-MuLV-specific mRNA in different types 
of polyribosomes. 
The finding of 35S mRNA in association with polyribosomes is not sur-
prising, since this mRNA is identical in size to the 35S subum'ts of the 
virion 60-70S RNA. Reliable experimental evidence exists for the assumption 
that the 35S RNA subunits of the virion RNA are identical (147,150). For that 
reason we may suggest that the virion 35S subunits and the virus-specific 35S 
mRNA encode the same polypeptides. This notion is substantiated by our re-
sults from studies concerning the cell-free translation of virus-specific RNA 
from polyribosomes (252, Chapter 5) and by those of Salden et al (157) on the 
translation of native and denatured RNA of R-MuLV. 
The physiological function of the virus-specific 20-22S and 14S RNA is 
more difficult to understand. It is important to find out whether the RNA po-
pulation sedimenting slower than 35S consists of functional virus-specific 
mRNAs or is a trivial cleavage product of the 35S messenger. Several possibi-
lities to explain degradation of 35S mRNA may be considered: 
1. The 20-22S and 14S RNA is an in vivo degradation product of the 35S RNA. 
2. RNA associated with polyribosomes is degraded by nucleases during the 
isolation of the polyribosomes. 
3. The 35S RNA is degraded during the deproteinization of the polyribosomes. 
If the third possibility is correct the extent of degradation should be the 
same in each polyribosomal fraction. The results presented in Fig. 18 and 
Fig. 19 show that this is not the case. In this moment no definite evidence 
is available to exclude possibility 2. We can only mention that the presence 
of purified RNAase inhibitor or of the nuclease inhibitors heparin and di-
ethyl pyrocarbonate during homogenization of the cells did not affect the re-
sults. In addition, Tsuchida et al (294) reported that Mo-SV(Ho-MuLV) 
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transformed cells contained two discrete species of virus-specific RNA with 
sedimentation coefficients of 35S and 20S, and almost no lower molecular 
weight RNA was detected. In contrast, virus-specific 33S RNA but no 20S RNA 
was found in hamster cells nonproductively transformed by Mo-SV (295). 
Finally, Fan and Besmer (295) detected two virus-specific RNA species, 38S 
and 27S, in uninfected JLS-V9 cells by hybridization of the cellular RNA 
with cDNA complementary to the RNA of endogenous virus, liberated from these 
cells by iododeoxyuridine treatment. Presumably, these RNA species corres-
pond to the 35S and 20-22S RNAs of cells productively infected with R-MuLV. 
The above observations do not support the possibility that the 14S and 
20-22S RNA fractions arose by degradation of the 35S RNA during the isola-
tion procedure, but more likely are a reflection of the in vivo situation. 
No experimental evidence is available to exclude the first alternative. Two 
approaches may be considered to study this possibility, first by examining 
in vivo whether the 14S and 20-22S RNA fractions function as messenger for 
virus-specific proteins and second, a more obvious approach, by demonstrating 
the cell-free synthesis of virus-specific proteins under the direction of 
these RNA fractions. 
It is generally accepted that attachment of ribosomes to membranes 
facilitates the synthesis and sequencial secretion of proteins destined for 
export or may even be required for that function (296-298). However, in cells 
which do not secrete proteins membrane-bound polyribosomes are present as 
well (299, 300). Furthermore, we could demonstrate the synthesis of almost 
the same set of polypeptides by free and membrane-bound polyribosomes from 
Ehrlich ascites tumor cells or JLS-V9 cells (299, chapter 5). Thus, although 
binding of polyribosomes appears to be a more general phenomenon, these ob-
servations do not exclude that certain messengers may be preferentially as-
sociated with free or membrane-bound polyribosomes. Our hybridization data 
indicated that both types of polyribosomes contained the same size classes 
of virus-specific RNA. However, the relative amount of virus-specific RNA 
was 4-10 times less on free polyribosomes than on membrane-bound polyriboso-
mes, suggesting the preferential synthesis of virus-specific polypeptides on 
the latter class of polyribosomes. 
If the virus-specific RNA species associated with free and membrane-
bound polyribosomes are representative for the situation in vivo, the pre-
sence of 35S mRNA in both types of polyribosomes, together with our 
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Observation that this RNA is almost absent in membrane-bound polyribosomes 
up to 230S, suggest that the virus-specific protein synthesis directed by 
this mRNA starts on free polyribosomes. That such a mechanism may be opera-
tive has been proposed by several authors (293,302,303). The synthesis of 
virus-specific proteins on membrane-associated polyribosomes may be necessary 
to facilitate the maturation process of virus-specific precursor polypep-
tides, involving proteolytic cleavage and glycosylation. Additional evidence 
for the role of membranes in the synthesis of virus-specific polypeptides is 
presented in chapter 5. 
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CHAPTER 4 
VIRUS-SPECIFIC RIBONUCLEIC ACID IN CELLS INFECTED WITH MURINE LEUKEMIA AND 
SARCOMA VIRUSES: EFFECT OF DENATURATION AND ISOLATION OF MESSENGER RNA 
4.1. INTRODUCTION 
Denaturation of the 60-70S RNA of RNA tumor viruses by heat or organic 
solvents gives rise to 30-40S RNA subunits (21,22,95), a discrete population 
of 4S, 5S and 7S RNA and heterogeneous RNA sedimenting between IOS and 30S 
(88-93,95,173,177,304,352-354). Avian sarcoma virions harvested from infected 
cells at 3 min intervals, yield a class of 60-70S RNA, a major class of 30-40S 
RNA and 4-12S RNA (105). Most of the 30-40S RNA in early harvest virus was 
converted to 60-70S RNA by incubation of the virus preparation at 40°. Upon 
denaturation, the RNA from early harvest virus is converted into a rather 
uniform population of 30-40S RNA and a heterogeneous population of 10-30S RNA 
molecules. The proportion of the latter fraction was strongly increased in 
RNA preparations derived from late harvest virus (104). Consequently, the 
heterogeneous population of small RNA is thought to be produced as a result 
of random nicking of the 35S RNA species, by nucleases present within the 
virion (305,306). 
When the polyribosomal RNA of Rauscher murine leukemia virus (R-MuLV) 
infected JLS-V9 cells was sedimented in sucrose gradients, peaks of virus-
specific RNA were detected sedimenting at 35S, 20-22S and in the 14S region 
(chapter 3). We could not exclude the possibility that the virus-specific 
RNAs, sedimenting slower than 30S, were cleavage products of the virus-spe-
cific 35S RNA. Therefore, and because probably also aggregation of virus-
specific RNA had occurred, we examined whether a different distribution of 
hybridizable RNA was obtained after denaturation of polyribosomal RNA, prior 
to centrifugation. In addition, we compared the size distribution of intra-
cellular virus-specific RNA of R-MuLV infected JLS-V9 cells and murine sar-
coma virus [Mo-SV ( M O - M U L V ) ! transformed rat embryo cells. 
The 60-70S RNA genome of RNA tumor viruses contains adenylic acid-rich 
sequences (111-114), which are covalently linked to the 3' end of the viral 
RNA (115,117-119). The molecular weight of each poly(A)-rich track was esti-
mated to be about 60,000, whereas the total molecular weight of the adenylic 
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acid-rich segments was about 250,000. Assuming that each 60-70S RNA consists 
of 3 to 4 30-40S subunits it was concluded that each subunit contains about 
one large poly(A) track (111,112,115). However, nothing is known about the 
actual presence of internal oligo(A) sequences. Scolnick et dl (307) have 
reported the presence of poly(A)-rich sequences in the virus-specific RNA 
isolated from rat cells nonproductively transformed by murine sarcoma virus. 
For these reasons, it seems likely that the virus-specific RNA associated 
with polyribosomes contains poly(A) tracks as well. 
The association of various virus-specific RNA species with polyriboso­
mes strongly suggests that these RNA molecules are involved in the synthesis 
of virus-specific polypeptides. However, more convincing evidence for their 
messenger function would be provided, if we were able to demonstrate the syn­
thesis of virus-specific polypeptides under the direction of these RNA 
fractions. In addition, analysis of the products formed by the various species 
of virus-specific mRNAs would provide valuable information on a phase of the 
'life-cycle' of RNA tumor viruses that is still poorly understood. In order 
to achieve this purpose, we attempted to purify the poly(A)-containing RNA 
from infected cells by oligo(dT)-cellulose affinity chromatography. 
4.2. MATERIALS AND METHODS 
4.2.1. Cells and virus 
R-MuLV infected cells were grown in monolayer as described in section 
3.2.1. The 78A, cell line, chronically infected with the Moloney strain of 
murine sarcoma virus [MO-SV(MO-MULV)^ was grown in monolayer in Eagle's Mini­
mal Essential Medium, completed with 10% foetal calf serum, penicillin (100 
I.U. χ ml" ) and streptomycin (50 pg χ ml" ). 
4.2.2. Isolation of total polyribosomes and purification of RNA 
Conditions for optimal growth of cells were chosen to obtain a maximal 
yield of polyribosomes. Thus, cells in logarithmic phase were replenished 
with fresh growth medium 16 h and 3 h, before harvesting. In addition 0.1 ug 
χ ml of 'cycloheximide was added 20 min before trypsinization of the cells. 
The isolation of total polyribosomes was described in section 3.2.4. 
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For the isolation of RNA, polyribosomal suspensions were deproteinized 
as described in section 3.2.6. In order to minimize processing of RNA chains 
in some experiments (as indicated in the legends to the figures) polyriboso­
mes were dissociated with 2% sodium dodecyl sulfate in TNE (10 mM Tris-HCl, 
pH 8.0, 100 mM NaCl and 1 mM EDTA) for 5 min at 37° and directly analyzed 
at 5° in a 15-43.5% (w/w) isokinetic glycerol gradient containing TNE by 
centrifugation at 95,000 χ g for 14 h in an SW 27 rotor. Fractions of 2 ml 
were collected from the bottom of the centrifuge tubes with continuous u.v. 
monitoring with an LKB optical unit. 
4 . 2 . 3 . laolation of cytoplasmia RNA 
Optimal growth conditions were as described before (section 4.2.2.). All 
operations up to swelling of cells in hypotonic buffer were carried out as 
described in section 3.2.3. After swelling, the cells were collected by cen­
trifugation for 5 min at 700 χ g. Packed cells (0.5 ml) were resuspended in 
6 ml lysis buffer (50 mM Tris-HCl, pH 7.5, 5 mM magnesium acetate, 150 mM 
NaCl and 2 mM 1,4 dithioerythritol). Subsequently 0.7 ml of a solution of 5% 
nonidet P-40 and 2.5% sodium deoxycholate was added to the cell suspension 
and cells were lysed by 10 strokes of a tight fitting Dounce homogenizer 
(B pestle). When indicated, the RNAase inhibitor diethyl pyrocarbonate was 
added to a final concentration of 0.1%, prior to disruption of the cells. 
Nuclei and cell debris were removed by 5 min centrifugation at 700 χ g. Be­
cause of the high amount of protein, the cytoplasmic supernatant was diluted 
to 30 ml with phenol extraction buffer (50 mM Tris-HCl, pH 8.0 at 20°, 150 mM 
NaCl, 1 mM EDTA and 0.5% sodium dodecyl sulfate) and deproteinized with 
phenol-chloroform (section 3.2.6.). 
4.2.4. Oligo(dl)-cellulose ehromatography 
Method 1 
01igo(dT)-cellulose chromatography of phenol extracted polysomal RNA was 
performed according to Aviv and Leder (308). All operations were performed at 
room temperature. Fifty Α 2 6 0 units of deproteinized polysomal RNA, dissolved 
in buffer A (10 mM Tris-HCl, pH 7.5 at 20°, 500 mM NaCl, and 0.05% of sodium 
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dodecyl sulfate) were applied onto a 2 ml oligo(dT)-cellulose column, pre­
pared according to Gilham (309), in buffer A and elution was started at a 
flow rate of 4 ml χ h~ . To remove all non-adsorbed material the elution was 
continued until the A26g level of the eluate had dropped below 0.025. The 
material retained to the column was eluted in two steps: In the first step 
RNA, weekly bound to the oligo(dT)-cellulose column was eluted with 10 ml 
of buffer В (10 mM Tris-HCl, pH 7.5 at 20° and 100 mM NaCl), whereas in the 
second step poly(A)-rich RNA was eluted with 3 ml of buffer С (10 mM Tris-
HCl, pH 7.5 at 20°). RNA-containing fractions eluted with buffer А, В and С 
were adjusted to 0.2 M in sodium acetate pH 5.2 and the RNA was precipitated 
with two volumes of ethanol at -20°. The amount of RNA retained and eluted 
with buffer С was 1-2% of the total RNA applied. 
Method 2 
Poly(A)-rich RNA used in cell-free systems was isolated according a 
slightly modified procedure. Fifty A^gQ units of polyribosomes were dissocia­
ted in 4 ml buffer A (10 mM Tris-HCl, pH 7.5 at 20°, 500 mM NaCl, 1 mM EDTA 
and 0.5% sodium dodecyl sulfate) at 37° for 5 min. The dissociated polyribo­
somes were directly applied onto a 2 ml oligo(dT)-cellulose column in buffer 
A. Elution with buffer A and buffer В (10 mM Tris-HCl, pH 7.5 at 20°, 100 mM 
NaCl, 1 mM EDTA and 0.05% sodium dodecyl sulfate) was performed as described 
for method 1. Poly(A)-rich RNA specifically bound to the column was eluted 
with buffer С and precipitated with ethanol at -20°. Routinely about 60-80 
ug of poly(A)-containing RNA was obtained by this procedure. 
4.2.5. Poly(dT)-cellulose chvomatography 
Poly(dT)-cellulose was a kind gift of Dr. U. Bertazzoni (Laboratoire de 
Génétique Moléculaire, Institut de Biologie Moléculaire, Paris, France) and 
was prepared as described by Bertazzoni et al (310). The approximate length 
of the poly(dT) chain was 50-70 nucleotides. 500-750 yg of phenol extracted 
polysomal RNA in 500 μΐ of buffer 1 (10 mM Tris-HCl, pH 7.5 at 20°, 100 mM 
NaCl, 1 mM EDTA and 0.05% sodium dodecyl sulfate) was applied at 20° to a 
200 μΐ column of poly(dT)-cenulose. Unadsorbed material was washed out with 
3 ml of buffer 1. Subsequently, RNA weekly bound to the column was eluted 
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with 1 ml of buffer 2 (10 mM Tris-HCl, pH 7.5 at 20° and 16 vg χ ml" 1 of wheat 
germ tRNA). Poly(A)-rich RNA was eluted at 50° with 0.75 ml of buffer 2. The 
eluted material was precipitated at -20° by addition of 0.1 volume of 2 M 
sodium acetate pH 5.2 and 2 volumes of ethanol. In this way 15-20 pg poly(A)-
containing RNA was recovered. 
4.3. F0RMAMIDE AND HEAT DENATURATI0N OF POLYRIBOSOMAL RNA 
Total polyribosomes from R-MuLV infected JLS-V9 cells were isolated and 
deproteinized with phenol-chloroform. When denaturation of polyribosomal RNA 
was omitted, the hybridization profile shown in Fig. 20C was obtained. As 
expected, the predominant RNA species that annealed with the R-MuLV-specific 
DNA probe sedimented in the 30-40S region of the gradient. A drastic change 
in the hybridization profile was revealed after pretreatment of the polyribo­
somal RNA with 85% formamide at 37° for 5 min prior to centrifugation. As 
shown in Fig. 20A, hybridizable RNA had accumulated in the 14S and 20-22S 
regions at the expense of the 30-40S region. Moreover, virtually no hybridi­
zable RNA was detected in the bottom fractions of this gradient (compare 
fractions 16, 17, 18 and 19 in Figs. 20A and C) indicating the effectiveness 
of the denaturation procedure. For comparison polyribosomal RNA was denatured 
at 55° for 5 min in 10 mM Tris-HCl, pH 7.5 at 20° (Fig. 1 B). Heat denatura­
tion, prior to centrifugation established a similar shift of hybridizable RNA 
from the 30-40S region of the gradient to the 10-30S region as the one ob­
served after formamide denaturation. These results indicate aggregate forma­
tion of virus-specific mRNA on sucrose gradients, which could be prevented 
by thermal or formamide denaturation, prior to centrifugation. It is hard to 
exclude the possibility, however, that hidden nicks are visualized through 
denaturation of intramolecular Η-bonds. Some of the following experiments 
suggest that hidden nicks caused at least part of the observed shift. 
In a second experiment polyribosomes were dissociated with 2% sodium 
dodecyl sulfate in TNE buffer for 5 min at 37°, and directly applied onto 
isokinetic gradients. RNA sedimenting faster than 28S (fraction 1), between 
28S and 18S (fraction 2) and slower than 18S (fraction 3), was pooled and 
precipitated with ethanol. The RNA of these pooled fractions was treated with 
85% formamide at 37° and separately analyzed in isokinetic gradients. Al­
though cross contamination of the pooled fractions occurred, it is evident 
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Fig. 20. Size distribution of R-MuLV specific mRNA after denaturation by 
heat of formamide. (A) Polyribosomal RNA was denatured at 37° for 5 min in 
85% formamide, 10 mM Tris-HCl, pH 7.5 at 20° and 0.5% sodium dodecyl sulfate. 
After dilution with 3 volumes of TNE buffer the sample was directly applied 
onto an isokinetic glycerol gradient; (B) Polyribosomal RNA after thermal 
denaturation at 50° for 5 min in 10 mM Tris-HCl, pH 7.5 at 20° and 0.5% 
sodium dodecyl sulfate. After dilution with TNE buffer the sample was direct­
ly analyzed in a glycerol gradient; (C) Polyribosomal RNA analyzed in a gly­
cerol gradient without prior denaturation. The 15-30.2% (w/v) isokinetic 
glycerol gradients in TNE buffer were centrifuged at 5° in a Spinco type 
Ti-SW 41 rotor for 13 h at 150,000 χ g. Fractions of 0.6 ml were collected 
and the relative amount of virus-specific RNA was determined as described 
before (Fig. 18). 
that virus-specific RNA from the 14S and 20-22S regions did not aggregate 
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under these conditions (Fig. 21B and С). Recentrifugation of the denatured 
RNA from fraction 1 revealed a broad heterogeneous distribution of virus-
specific RNA molecules and hybridization peaks were detectable in the 20-22S 
and 30-40S region of the gradient (Fig. 21A). 
10 15 
fraction number 
Fig. 21. Effect of formamide denaturation on the sedimentation pattern of 
different size classes of R-MuLV-specific mRNA.. Purified polyribosomes were 
dissociated with sodium dodecyl sulfate and the polyribosomal RNA was ana­
lyzed in glycerol gradients as described in section 4.2.2. RNA fractions se-
dimenting faster than 28S (1), between 18S and 28S (2) or slower than 18S 
(3) were pooled and precipitated with ethanol. RNA of the pooled fractions 
was denatured with 85% formamide (Fig. 20) and analyzed in an isokinetic 
gradient (section 3.2.6.). The relative amount of R-MuLV-specific RNA in 
each fraction was determined as described before (Fig. 18). (A) Size distribu­
tion of denatured RNA from fraction 1; (B) from fraction 2; (C) from 
fraction 3. 
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Fig. 22. (A) Size distribution of R-MuLV-specific RNA isolated from the cyto­
plasm of JLS-V9 cells. Cytoplasmic RNA was denatured with 85% formamide (Fig. 
20) and layered onto a 25-38.8% (w/v) isokinetic sucrose gradient in TNE buf­
fer. Gradient centrifugation was performed at 5° in a Spinco type Ti-SW 41 
rotor for 15 h at 160,000 χ g. RNA sedimenting in the 30-40S region was pooled 
and precipitated with ethanol after addition of 20 yg 28S RNA from rabbit re­
ticulocyte ribosomes. (B) Sedimentation of purified virus-specific 30-40S RNA 
in a sucrose gradient containing formamide. In order to remove contaminating 
RNA the 30-40S RNA fraction, isolated as described in the legend to Fig. 22A, 
was recentrifuged in sucrose; the 30-40S region of this gradient was pooled 
and the RNA was precipitated with ethanol after addition of 20 pg of 28S retic 
RNA. Pooled RNA was denatured with 85% formamide (Fig. 20) and applied onto 
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a 5-22.7% (w/v) isokinetic sucrose gradient in TNE buffer, and containing 50°' 
(v/v) for^amide. Centrifugation was performed at 4 in an Ti-SW 41 rotor for 
15 h at 200,000 χ g. The relative amount of R-MuLV-specific RNA was deter­
mined as described before (Fig. 18). 
Similar resuHs were obtained when cytoplasmic RNA isolated from R-MuLV 
infected JLS-V9 cells was treated with 85% formamide and analyzed in a su­
crose gradient. Fig. 22A shows that three distinct virus-specific RNA species 
were resolved, sedimenting in the 30-40S, 20-22S and 14S regions of the gra­
dient The hybridization profile has roughly the same shape as that shown in 
Fig. 20A for denatured polyribosomal RNA. A similar result was also obtained 
when the cytoplasmic RNA was isolated in the presence of the nuclease inhibi­
tor diethylpyrocarbonate (not shown), suggesting that de-aggregation rather 
than exposure of hidden nicks, introduced during isolation, explains the 
shift in the centrifugation profile seen after formamide treatment In order 
to substantiate further that the virus-specific RNA in the 30-405 region 
consisted of physically intact RNA molecules, the following experiment was 
performed RNA from the 30-40S region of the gradient shown in Fig 22A was 
pooled and recentrifuged in a sucrose gradient to remove contaminating 
material. The 30-40S region of the second gradient was pooled and analyzed 
in a gradient containing 50% formamide. The profile of the hybridizable RNA 
shows that at least part of the virus-specific RNA, isolated from the 30-40S 
region of the first gradient, consisted of physically intact molecules (Fig. 
22B). Since no detectable hybridization up to fraction 10 of the formamide 
containing gradient was observed, a random degradation of the virus-specific 
RNA during the handling of this preparation could be excluded. It should be 
noted that, although enough rRNA was present as carrier during all operations, 
we observed a substantial loss of virus-specific 30-40S RNA during handling. 
In summary, these results indicate a similar size distribution for the 
virus-specific RNA isolated eithet from polyribosomes or from the cytoplasm 
of JLS-V9 cells. Thermal or solvent denaturation resulted in a transition 
of part of the RNA from the 30-405 region to slower sedimenting fractions, 
mainly due to dissociation of noncovalent RNA aggregates. 
17 
4.4. INTRACELLULAR VIRUS-SPECIFIC RNA FROM CELLS TRANSFORMED BY THE MOLONEY 
MURINE SARCOMA VIRUS 
All preceding experiments were performed with material derived from the 
JLS-V9 cell line productively infected with R-MuLV. As an extension of these 
studies, we decided to examine the virus-specific RNAs of a rat embryo cell 
line (78A,) transformed by the Moloney strain of murine sarcoma virus and 
producing both Mo-SV and Mo-MuLV. Cytoplasmic RNA from these cells was pre­
pared and the size distribution of the virus-specific RNA in sucrose gra­
dients was determined with the labeled R-MuLV DNA probe. Fig. 23A shows the 
hybridization profile of the cytoplasmic RNA. A sharp peak of virus-specific 
RNA was observed in the 30-40S region. In addition, a rather heterogeneous 
population of hybridizable RNA sedimenting between IOS and 28S was detected. 
It is obvious that there was only a low background of hybridization due to 
aggregation of RNA (Fig. 23A, fractions 15 and higher). The effect of heat 
and formamide denaturation on the size distribution of hybridizable RNA is 
shown in Fig. 23B and С Most striking is the shift of virus-specific RNA 
from the 30-40S region to the 14S and 20-22S region of the gradient. The 
latter hybridization profiles strongly ressemble those obtained after dena­
turation of intracellular or polyribosomal RNA from the R-MuLV infected 
JLS-V9 cell line. 
Considering these results we may conclude that the experiments des­
cribed for the JLS-V9 cell line infected with R-MuLV do not reveal a situation 
unique for mammalian RNA tumor viruses. 
4.5. ISOLATION OF POLY(A)-CONTAINING VIRUS-SPECIFIC mRNA 
Separation of virus-specific RNA from the vast excess of ribosomal 18S 
and 28S is important if one wants to study the translation of viral messengers 
in cell-free systems. The most straightforward method for purification of 
mRNA is based on the observation that the RNA of RNA tumor viruses as well as 
many mammalian messengers contain poly(A)-rich regions which hybridize with 
oligo(dT) covalently bound to cellulose. Consequently, we attempted to purify 
virus-specific RNA from R-MuLV infected cells by oligo(dT)-cellulose (average 
chain length 10 nucleotides) and poly(dT)-cellulose (average chain length 60 
nucleotides) chromatography. Phenol extracted polyribosomal RNA was applied 
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Fig. 23. Size distribution of intracellular 
MuLV-specific RNA isolated from rat em­
bryo fibroblast cells (78A,) transformed by 
the Moloney murine sarcoma virus. Rate zo­
nal centrifugation of the cytoplasmic RNA, 
isolated in the presence of dietylpyrocar­
bonate, was performed in isokinetic sucrose 
gradients as described in the legend to 
Fig. 22A. The relative amount of virus-spe­
cific RNA was determined by hybridization 
with R-MuLV cDNA. (A) Size distribution of 
undenatured cytoplasmic RNA; (В) after heat 
denaturation at 55° for 3 min in 10 mM Tris-
HC1, pH 8.0 and 0.5% sodium dodecyl sulfate; 
(C) after denaturation with 85% formamide in 
10 mM Tris-HCl, pH 8.0 and 0.5% sodium dode­
cyl sulfate at 37° for 5 min. 
10 15 20 
fraction number 
onto the columns and the amount of virus-specific RNA in each eluted fraction 
was calculated from hybridization data. In table 3 the results of these ex­
periments are summarized. About 50-60 percent of the virus-specific RNA was 
bound to the oligo(dT)-cellulose column and represents the poly(A)-rich RNA 
fraction. Since poly(dT)-cellulose has a higher affinity for poly(A), it was 
not surprising that almost 70 percent of the virus-specific RNA could bind 
to this column. Assuming that the hybridizable RNA in total polyribosomes is 
about 0.2 percent (section 3.5., table 2), it can be calculated that a 
17 fold purification of virus-specific RNA was obtained. Thus, these experi­
ments indicate that 50 to 70 percent of the virus-specific RNA associated 
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with polyribosomes contained poly(A)-rich sequences. 
TABLE 3 
Distribution of virus-specific RNA in fractions of polyribosomal 
RNA separated by oligo(dT)-cellulose and poly(dT)-cellulose 
affinity chromatography 
oligo(dT)-
cellulose 
poly(dT)-
cellulose 
column 
fraction 
A 
В 
С 
I 
II 
III 
NaCl 
concen­
tration 
(M) 
0.5 
0.1 
0.0 
0.1 
0.0 
0.0 
temp 
0C 
20 
20 
20 
20 
20 
50 
Quantity 
of virus-
specific RNA 
(X) 
37 
6 
57 
23 
9 
68 
Virus-
specific 
RNA 
(% of total RNA 
in fraction) 
0.06 
1.20 
3.50 
N.D. 
N.D. 
N.D. 
Phenol extracted polyribosomal RNA was fractionated on oligo(dT)-cellulose 
(section 4.2.4., method 1) or poly(dT)-cellulose columns (section 4.2.5.). 
A fixed amount of RNA from each fraction was hybridized with 800 cpm of 
[ Hj-labeled R-MuLV specific cDNA for varying lengths of time. The percenta­
ge of virus-specific sequences was calculated as described in Table 2. 
For the preparative isolation of poly(A)-contaimng niRNA, we applied 
polyribosomes, dissociated in the presence of sodium dodecyl sulfate, di­
rectly onto the oligo(dT)-cellulose column. Since omission of deproteim-
zation of polyribosomes by means of phenol did not affect the yield of 
poly(A)-containing RNA, it seems likely that in the presence of sodium 
dodecyl sulfate proteins do not interfere with the binding of the polv ι ι 
tracks to the oligo(dT). 
4.6. SIZE DISTRIBUTION OF THE POLY(A)-CONTAINING VIRUS-SPECIFIC mRNA 
When the poly(A)-nch RNA fraction of the polynbosomal RNA was analy-
zed in a sucrose gradient, hybridizable RNA could be detected as a broad he-
terogeneous population throughout the gradient (not shown) Since this was 
possibly due to aggregation of RNA, the poly(A)-contaimng material was 
denatured with 85% formannde prior to centrifugation in a sucrose gradient 
Fig. 24 shows that two distinct peaks of hybridizable RNA were detected in 
the 30-40S and 20-22S region of the gradient In contrast to our earlier 
observations, formannde denaturation of the poly(A)-containing RNA did not 
result in a complete dissociation of noncovalent aggregates (Fig 24, 
fractions 15-20). Therefore, we tried to prevent aggregate formation of 
mRNA by using sucrose gradients containing 50% v/v of formamide The re-
sult of this experiment is shown in Fig 25. The size distribution of 
hybridizable RNA in this figure already indicates that aggregation of the 
poly(A)-rich RNA was precluded. Translation of the individual RNA containing 
fractions and analysis of the cell-free products supports this conclusion 
(chapter 5) The hybridization profile revealed two major classes of virus-
specific RNA in the 30-40S and 20-22S region of the gradient containing 
formannde. In addition, it is striking that less hybridizable RNA was detec-
ted in the 14S and 20-22S region of this gradient than in gradients of for-
mamide denatured polynbosomal RNA (Fig. 20A). This result suggests that 
part of the 14S and 20-22S virus-specific RNA contained no poly(A)-rich 
sequences. 
Finally, these results indicate that ol igo(dT)-cellulose chromatography 
is a useful tool for the isolation of poly(A)-containing virus-specific 
mRNA. 
DISCUSSION 
The change in size distribution of the virus-specific intracellular 
and polynbosomal RNA may be the result of mainly two effects: first, a 
change in size of the virus-specific RNA species due to dissociation of non-
covalent RNA aggregates and second, the appearance of smaller virus-specific 
RNA molecules due to hidden nicks in the 30-40S viral mRNA. In section 4.3. 
we described that heat or formamide denaturation of the polynbosomal RNA of 
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Fig 24 Rate zonal sedimentation of 
poly(A)-contaimng RNA isolated from 
polyribosomes of R-MuLV infected 
cells Poly(A)-contaimng RNA iso­
lated by oligo(dT)-cellulose chroma­
tography was denatured with formami-
de (Fig 20) and applied onto a 
25-38 8% (w/v) isokinetic sucrose 
gradient (Fig 22A) (section 4.2.4., 
method 1) Centrifugation was per­
formed at 5° in an Spinco type-SW 
41 rotor for 17 h at 175,000 χ g 
The relative amount of virus-speci­
fic RNA was determined as described 
before (Fig. 18). 
Fig. 25. Sedimentation analysis of 
poly(A)-contaimng RNA in sucrose gra­
dients containing 50% formamide 
Poly(A)-containing RNA isolated by 
olι go(dT)-eellulose chromatography 
(section 4 2 4 , method 2) was dena­
tured with formamide (Fig 20) and 
layered onto an isokinetic sucrose 
gradient containing 50" formamide 
(Fig 22B) Centrifugation was carried 
out for 15 h at 200,000 χ g in an 
Spinco type-SW 41 rotor The relative 
amount of virus-specific RNA was de­
termined as described before (Fig 18) 
R-MuLV infected cells dissociates aggregates of virus-specific RNA (Fig 20A 
and B; Fig. 21B and C). Since, however, in the gradient analysis of undena-
tured polynbosomal RNA aggregate formation was observed, it is not possible 
to make conclusions about the presence of hidden chain breaks, manifested by 
dissociation of intramolecular hydrogen bonds, in the mRNA fraction sedimen-
ting in the 30-40S region In the hybridization profile of the cytoplasmic 
RNA of Mo-SV(Mo-MuLV) transformed rat cells (78AJ), less noncovalent aggre­
gates of virus-specific RNA are seen (Fig. 23A). Therefore, the size 
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distribution of Mo-SV(Mo-MuLV)-specific intracellular RNA after denaturation 
suggests in this case the presence of hidden nicks in part of the 30-40S RNA. 
When the intracellular RNA of the 78A, cell line was denatured with 
dimethyl sulfoxide and then allowed to renature prior to Polyacrylamide gel 
electrophoresis, two distinct RNA species of 35S and 20S were detected (294). 
The hybridization profile of 78A. intracellular RNA we obtained after gra-
dient centrifugation is rather heterogeneous as compared to the electropho-
resis profile in that report. This may be due to the difference in denatura-
tion conditions or the technique used for the analysis of the size of the 
virus-specific RNA species. Moreover, the size distribution of intracellular 
dimethyl sulfoxide denatured RNA of mammalian sarcoma virus producer and non-
producer cells was more or less heterogeneous, dependent on the cell line 
studied and on whether zonal sedimentation or gel electrophoresis was used 
for size analysis (141,143,356). The results presented by these authors as 
well as those obtained by our group do not exclude the possibility that the 
10-30S RNA in virus producing cells is simply a cleavage product of the 
30-40S RNA, caused by cleavage of this RNA at specific site(s). 
The presence of poly(A)-rich sequences in the virus-specific RNA as-
sociated with polyribosomes was demonstrated by affinity chromatography on 
oligo(dT)-ceIlulose and poly(dT)-cellulose columns. Our data show that about 
50-70 percent of the virus-specific polyribosomal RNA in productively in-
fected cells contained poly(A). This finding is consistent with the observa-
tion of Scolnick et al (307) that the virus-specific RNA of mammalian sarco-
ma virus transformed nonproducer cells contained poly(A) and the presence of 
large poly(A) chains covalently bound to the virion subunit RNA molecules. 
Haines et al (311) reported aggregation of ovalbumine mRNA on both sucrose 
gradients and Polyacrylamide gels and a similar observation has been des-
cribed by Carter (312) for mRNA from Adenovirus-associated virus infected 
cells. Some preparations of conalbumine mRNA exist even for 70 percent as 
an aggregate complex (311). These examples indicate that aggregation of mRNA 
is not unusual. From our experiments it is evident that even formamide dis-
sociation of noncovalent aggregates, prior to centrifugation, may be in-
sufficient. Complete dissociation of aggregates is apparently obtained when 
RNA dissociated with formamide is analyzed under denaturing conditions. The 
distribution of virus-specific RNA present in the poly(A)-rich fraction of 
the polyribosomal RNA, shows that hybridizable RNA was present as a shoulder 
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in t^ ie 14S region and as two реокь in the 2C-?2S and 30-40S region. A compa­
rable size distribution with peaks at 38S and 27S was obtained for the un-
denatured intracellular poly(A)-contaimnq RNA in uninfected JLS-V9 ceils 
(295). With regard to our results it has to be noted, that the distribut-On 
of virus-specific poly(A)-containing RNA strongly suggests but de<:s not prove 
that hybridizable RNA in the 14S and 20-22S region contains poly(A). It 
remains possible, although in view of the results of Fan and Besmer (295) 
not likely, to argue that the latter RNA species are cleavage products of 
the poly(A)-containing 30-40S RNA, liberated from nicked molecules under 
denaturing conditions. 
CHAPTER 5 
CELL-FREE SYNTHESIS OF RAUSCHER LEUKEMIA VIRUS-
SPECIFIC POLYPEPTIDES 
5.1. INTRODUCTION 
At the present time, there is still uncertainty about the complexity 
of the 60-70S RNA genome of RNA tumor viruses. A sequence complexity of 
8-9 χ 10 daltons has been determined by measuring the annealing rate of la­
beled virus-specific DNA with an excess of viral RNA (145,146). In contrast, 
determination of the annealing rate of the viral RNA to cell DNA indicated a 
sequence complexity of 3 χ 10 daltons. This discrepancy between these two 
results from hybridization studies is not well understood. However, a sequen­
ce molecular weight of 3 χ 10 was also found by fingerprint analysis of 
unique oligonucleotides obtained after nuclease digestion of the viral 60-70S 
RNA (147-150). In addition, in favor of a sequence complexity of 3 χ 10 
daltons are results from studies of the minimum size of the integrated viral 
DNA which is infectious (313,314) and those from studies of deletions and 
recombinants (150,151,315). Consequently, most experimental evidence suggests 
that the genome of RNA tumor viruses consists of 2-4 identical subunits with 
a molecular weight of about 3 χ 10 . In that case the total information is 
sufficient to encode about 300,000 daltons of protein. It has been proposed 
that at least 4 genes consti tute most of the genome (316). These genes are the 
envelope (env) gene, encoding the viral envelope proteins; a gene (gag) en­
coding all of the major internal antigens of the virion; the polymerase (pol) 
gene, which specifies the reverse transcriptase and a gene (one) that encodes 
for a protein able to transform the growth property of cells. 
Some of the major proteins of RNA tumor viruses are derived from high 
molecular weight precursor polypeptides. Vogt and Eisenman (253) reported that 
the major internal antigens (p27, pl9, pl5 and pl2) of avian RNA tumor viruses 
are formed by cleavage of a common precursor polypeptide (76,000 M ). The 
second high molecular weight polypeptide synthesized in cells infected with 
these viruses is the incompletely glycosylated precursor (70,000 M ) of the 
major viral glycoprotein gp35. Recently, van Zaane et al (255) and Strand and 
Shapiro (257) reported the biosynthesis of two virus-specific precursor 
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polypeptides in cells infected with Rauscher leukemia virus. One polypeptide 
(65,000 M ) is the precursor of the low molecular weight virion proteins p30, 
pl5 and presumably pl2 and plO (257, van Zaane, personal communication), 
whereas the other polypeptide (82,000-85,000 M ) is the precursor of the 
viral glycoproteins gp69/71 (257, van Zaane, personal communication) and 
pl5(E) (van Zaane, personal communication). Since the virus-specific poly-
peptides constitute only 1-3% of the polypeptides synthesized in infected 
cells, immuno-precipitation techniques using antisera against disrupted vi-
rions or monospecific antisera were applied to visualize the newly formed 
virus-specific polypeptides. 
The virus-specific mRNA species associated with polyribosomes of RSV, 
Mo-SV(Mo-MuLV) and R-MuLV infected cells, which are most likely involved in 
the biosynthesis of virus-specific polypeptides, have been identified (160-
163). The major virus-specific messenger in productively infected cells is 
35S mRNA but evidence for virus-specific RNA molecules of smaller size 
(20-22S and 14S) has been found. The latter mRNA soecies appeared to be ore-
ferentially associated with membrane-bound polyribosomes (162,163). 
In this chapter we describe our investigations on the synthesis of 
R-MuLV-specific polypeptides in vitro. He were able to identify the virus-
specific products synthesized either in cell-free systems supplemented with 
purified free and membrane-bound polyribosomes or in crude cell-free lysates, 
fractionated in a membrane-free and membrane-rich fraction, from cells pro-
ductively infected with R-MuLV. Evidence was obtained that virus-specific 
polypeptides were preferentially synthesized in association with membranes. 
In addition, we examined the biosynthesis of virus-specific polypeptides in 
lysates from rabbit reticulocytes, supplemented with poly(A)-rich mRNA isola-
ted by affinity chromatography on oligo(dT)-cellulose columns. It could be 
demonstrated that addition of 35S mRNA or 20-22S mRNA to the subcellular sys-
tem resulted in the synthesis of virus-specific polypeptides. 
5.2. METHODS 
5.2.1. Experimental conditions 
To minimize RNAase contamination, sterile conditions were used as pre-
viously described (section 3.2.2.). All buffers were standardized at a given 
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pH with HCl at 4° and all manipulations were performed at 0 - 4 unless other­
wise stated. Centrifuqation gravity values quoted were the average g-values 
generated at particular speed of rotation. 
5.2.2. Isolation of polyribosomes 
Q 
For the isolation of polyribosomes, cells (3 χ 10 ) grown in spinner 
culture or monolayer cells, trypsimzed at 37 , were cooled rapidly by 
pouring them on crushed frozen isotonic buffer (35 mM Tris-HCl, pH 7.5, 
146 mM NaCl). Cells were harvested by centrifugation at 700 χ g for 5 min 
and washed three times with isotonic buffer. One ml of pelleted cells were 
suspended in 8 ml of hypotonic buffer (10 mM Tris-HCl, pH 7.4, 15 mM KCl and 
1.5 mM magnesium acetate). After swelling for 10 m m , the cells were collec­
ted by centrifugation, resuspended in 8 ml of lysis buffer (10 mM Tris-HCl, 
pH 7.4, 50 mM KCl, 5 mM magnesium acetate, 6 mM 2-mercaptoethanol, 0.1% 
Triton X-100 and 0,25 M sucrose) and disrupted by 20-30 strokes of a tight 
fitting Dounce homogemzer (B pestle). Nuclei and unbroken cells were removed 
by centrifugation at 125 χ g for 5 min. The 125 χ g supernatant was centri-
fuged in a Spinco type-Ti 50 rotor at 20,000 χ g for 10 min to pellet membrane-
bound polyribosomes. To exclude contamination with free polyribosomes, the 
20,000 χ g pellet fraction was washed once in 5 ml of lysis buffer. The 20,000 
χ g supernatant fractions were used as a source of free polyribosomes. For the 
isolation of nuclei-associated and membrane-boimd polyribosomes, the 125 χ q 
and 20,000 χ g pellets were resuspended in 5 ml lysis buffer and 0.5 ml of a 
solution of 5% sodium deoxycholate and 3% nomdet P-40 was added to solubilize 
the membranes These fractions were clarified by centrifugation at 12,000 χ α 
for 5 min in a Spinco type-Ti 50 rotor. Polyribosomes were purified from the 
latter supernatants and the 20,000 χ g supernatant, by centrifugation through 
a 0.7 ml cushion of 2 M sucrose in 20 mM Tris-HCl, pH 7.4, 50 mM potassium 
acetate, 3 mM magnesium acetate and 1 mM 1,4 dithioerythntol in a Spinco 
type-SW 41 rotor at 200,000 χ g for 4 h. 
A mixture of free and membrane-bound polyribosomes (total volyriboeomes) 
was isolated essentially as described previously (288): Cells were lysed in the 
presence of 2% nomdet P-40 in high salt buffer (50 mM Tris-HCl, pH 8.5, 225 mM 
K(I. 8 mM magnesium acetate and 2 mM 1,4 dithioerythntol) by 10 strokes of я 
tirht f Hing Dounce homoqemzer (B pestle). Nuclei were removed by 
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centrifugation at 750 χ g for 5 min and the supernatant was centrifugea in a 
Spinco type-Ti 50 rotor at 12,009 χ g for 5 min. Polyribosomes were isolated 
through a layer of 2 M sucrose as described before. Total polyribosomes to be 
used for the isolation of poly(A)-containing RNA, were prepared from cells 
pretreated with cycloheximide (0.1 pg χ ml" ) as described in section 3.2.3. 
5.2.3. Preparation of cell-free extracts 
Monolayer cells (JLS-V9) were harvested and washed as described in the 
preceding section. The packed cells were suspended in hypotonic buffer 
(10 mM Tris-HCl, pH 7.5 at 20°, 15 mM KCl, 1.5 mM magnesium acetate and 2 mM 
1,4 dithioerythritol), allowed to swell-for 10 min and collected by centri­
fugation at 750 χ g for 5 min. Cells (1.5 ml) were lysed in 2 volumes of 
hypotonic buffer by 30 strokes of a tight fitting Dounce homogenizer 
(B pestle). Nuclei were removed by centrifugation at 125 χ g for 5 min. Three 
ml of the supernatant fluid was further separated into a cytoplasmic super­
natant and a pellet by centrifugation at 20,000 χ g for 6 min in a Spinco 
type-Ti 50 rotor ν The membrane-rich 20,000 χ g pellet fraction was resuspen-
ded in 1 ml of hypotonic buffer. In this way, three fractions were obtained, 
a 125 χ g supernatant containing free and membrane-bound polyribosomes, a 
20,000 χ g supernatant enriched with free polyribosomes and a 20,000 χ g 
pellet fraction containing mainly membrane-bound polyribosomes. Since es­
pecially the synthesis of the virus-specific polypeptide of 82,000 M was 
reduced after freezing and thawing of the 125 χ g and 20,000 χ g pellet frac­
tions, they were used immediately to test their protein synthesizing capacity. 
5.2.4. Components of the cell-free protein synthesizing systems 
5.2.4.1. Preparation of cell-lysates and S-100 
Lysates of rabbit reticulocytes were prepared according to Berns (318). 
A ribosome-free supernatant, designated as S-100, was prepared from the 
30,000 χ g supernatant of lysed reticulocytes by centrifugation in a Spinco 
type-Ti 50 rotor at 150,000 χ g for 2 h. 
Postribosomal supernatants of JLS-V9 cells and Ehrlich ascites tumor 
cells were prepared by the following procedure. Cells were collected and 
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washed as described in section S.Z.2. Subsequently, the cells were disrupted 
by 30 strokes of a tight fitting Dounce homogenizer (B pestle) after suspen­
sion in 5 volumes of hypotonic buffer and swelling for 10 min. The extract 
was centrifuged at 750 χ g for 5 min to remove the nuclear fraction. In some 
experiments one volume of 10 mM Tris-HCl, pH 7.4, 20 mM KCl, 2 mM magnesium 
acetate, 1 mM 1,4 dithioerythritol and 0.5 M sucrose was added prior to low 
speed centri fugation of the cell-lysate. A ribosomal supernatant was prepa­
red from the 750 χ g supernatant by centrifugation in a Spinco type-Ti 50 
rotor at 150,000 χ g for 2 h. S-100 prepared by either method was suitable 
for preparing an active pH 5 enzyme fraction. Aliquots of the supernatant 
were frozen in liquid nitrogen and stored at -70°. For the preparation of 
pH 5 enzymes from the ribosome-free supernatant unfrozen S-100 was used. 
5.2.4.2. Preparation of pH 5 enzymes 
pH 5 enzymes were prepared from the ribosome-free supernatants from 
reticulocytes. Ehrlich ascites cells or JLS-V9 cells. To the S-100 superna­
tants, on ice, 1 M acetic acid was added dropwise until a pH of 5.2 was 
reached. The precipitate was collected by centrifugation at 1000 χ g for 
15 min and dissolved in 1/10 of the original volume of buffer containing 
10 mM Tris-HCl, pH 7.5 at 20°, 1 mM magnesium acetate, 20 mM KCl, 10% gly­
cerol, 1 mM 1,4 dithioerythritol and 100 μΜ phenol red. During resuspending, 
the pH was adjusted to about 7 by addition of 1 V K0H. Subsequently, in­
soluble material was removed by centrifugation at :000 χ g for 10 min and 
small aliquots of the supernatant were frozen in licuid nitrogen and stored 
at -70°. 
The optimal concentration of pH 5 enzymes to be used in cell-free sys­
tems supplemented with polyribosomes was determined for each batch of pH 5 
enzymes. 
5.2.4.3. Preparation of initiation factors 
Crude ribosomes of rabbit reticulocytes were prepared as described by 
Miller and Schweet (319). Polyribosomes were suspended in 0.25 M sucrose, 
10 mM Tris-HCl, pH 7.5, 10 mM KCl, 2 mM magnesium acetate and 1 mM 1,4 di­
thioerythritol at a concentration of about 450 A-CQ units χ ml" . There­
after, 4 M KCl was added dropwise with stirring to a final concentration of 
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0.5 M and stirring was continued at 0° for 60 min. The ribosomes were remo­
ved by centrifugation at 150,000 χ g for 3 h in a Spinco type-Ti 50 rotor. 
Small aliquots of the supernatant were frozen in liquid nitrogen and stored 
at -70°. 
5.2.5. Celt-free protein synthesis 
5.2.5.1. Assay aonditions for aell-free systems supplemented with 
potyribosomes 
Assays were performed in a standard reaction mixture of 25 μΐ and con­
tained, 0.6 A-CQ units of polyribosomes, 8 yl of S-100 from reticulocytes 
or about 10 vg of pH 5 enzymes, 4 μΐ energy and amino acid mixture (final 
concentrations in the incubation mixture were, 1 mM ATP, 0.2 mM GTP, 10 mM 
creatine phosphate, 0.2 mg χ ml" of creatine kinase, 19 unlabeled amino 
acids in concentrations used by Palmiter (320) and 50 to 200 vCi χ ml of 
L sJmethionine)and, unless otherwise stated 10 mM Tris-HCl, pH 7.5 at 
20°, 2.0 mM magnesium acetate, 60 mM KCl, 80 mM potassium acetate and 1 mM 
1,4 dithioerythritol. Reaction mixtures were incubated for 150 min at 26 . 
After incubation a 1 μΐ aliquot was diluted in 0.5 ml of 0.1 Μ Κ0Η and in­
cubated 'for an additional 15 min at 37 . Trichloroacetic acid precipitable 
radioactivity was determined as described before (section 2.2.4.). 
5.2.5.2. Assay aonditions for subcellular fractions of JLS-V9 cells 
A standard reaction mixture contained in a final volume of 25 μΐ, 15 mM 
Tris-HCl, pH 7.5 at 20°, 2.5 mM magnesium acetate, 75 mM KCl, 70 mM potassium 
acetate, 1 mM 1,4 dithioerythritol, 4 μΐ energy and amino acid mixture as 
described above; 3 μΐ (75 μg) of crude initiation factors, 10 μΐ S-100 from 
JLS-V9 cells, 3 μΐ (10 μg) of pH 5 enzymes and crude cell fractions (15 yl 
of the 125 χ g supernatant, 5 μΐ of the resuspended 20,000 χ g pellet or 
15 μΐ of the 20,000 χ g supernatant) were added as indicated in the legends 
to the figures. Incubation was performed at 30° for 150 min. 
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5.2.5.3. Assay conditions for· mBNA 
Cell-free translation of mRNA was routinely performed in a volume of 
25 μΐ, containing 12 μΐ of a rabbit reticulocyte lysate, 4 μΐ of energy and 
amino acid mixture as described above, 2 mM magnesium acetate, 65 mM KCl, 
60 mM potassium acetate and the test solutions as stated in the legends to 
the figures. Reaction mixtures were incubated at 26 for 150 min. 
5.2.6. Irmrunoprecipitation of virus-specific polypeptides labeled in vivo 
Precipitation of virus-specific products synthesized in vivo was per­
formed by the method of van Zaane et al. (255). To label polypeptides newly 
synthesized in vivo, 2 χ 10 cells in logarithmic growth were incubated in 
labeling medium (Hanks basic salt solution supplemented with 10% dialysed 
calf serum and amino acids except methionine). After 10 min the cells were 
replenished with fresh labeling medium containing 10 μ ^ χ ml of |_ sj-
methionine and incubated for 15 to 60 min at 37°. Cells were collected by 
rapid trypsinization at 37 and cooled to 0 by pouring them into a cen­
trifuge tube containing crushed frozen isotonic solution. Alternatively, 
monolayers were rapidly cooled by washing with ice-cold isotonic buffer and 
the cells were scraped from the glass with a rubber policeman. Cells were 
harvested by centrifugation at 750 χ g for 5 min and washed three times 
with isotonic buffer. Cells were lysed by addition of 1 ml of immunopreci-
pitation buffer (10 mM phosphate, pH 7.2, 0.9% NaCl, \% Triton X-100, 0.U 
sodium deoxycholate and 0.1% sodium dodecyl sulfate). The lysate was clari­
fied by centrifugation at 220,000 χ g for 10 min in a Spinco type-Ti 50 
rotor. The supernatant fraction was used for immunoprecipitation. 
Virus-specific proteins in samples from these lysates were precipitated 
by the indirect method: appropriate portions of the lysates were incubated 
at 4 for 16 h with 2 μΐ rabbit anti-R-MuLV serum, then 50 μΐ goat anti-
rabbit immunoglobulin serum was added, and the incubation was continued at 
4 for 2 h. As a blank, 1 μΐ rabbit anti-BSA serum was added to the same 
volume of cell lysate, followed by incubation with 25 μΐ goat anti-rabbit 
immunoglobulin serum. With both rabbit sera, precipitates containing 100 μg 
of protein were obtained. In pilot experiments the optimal concentration of 
rabbit anti-R-MuLV serum was determined. 
Precipitates were collected by centrifugation through a layer of 10% 
(w/v) sucrose in immunoprecipitation buffer for 5 min at 12,000 χ g, washed 
three times with inmunoprecipitation buffer and finally dissolved in sample 
buffer [б0 mM Tris-HCl, pH 6.8 at 20°, 2% sodium dodecyl sulfate, 5% mercap-
toethanol and 10% glycerol, Laemmli (259)J containing 6 M urea by heating 
for 2 h at 37° and 2 min at 95°. 
5.2.7. Irrmunopreaipitation of virus-specific polypeptides synthesized 
in vitro 
To the cell-free incubation mixtures immunoprecipitation buffer was 
added and the resulting solution was clarified by centrifugation at 
220,000 χ g for 10 min in a Spinco type-Ti 50 rotor. 
Indirect immunoprecipitation of virus-specific polypeptides was per­
formed as described above for proteins labeled in vivo. Since this latter 
method is only applicable to test samples containing very low concentrations 
of virus-specific antigens, in some experiments the direct inmunoprecipita­
tion technique was applied. For direct immunoprecipitation on cell-free in­
cubation mixtures, 60 pg of an extract of JLS-V9 cells (prepared in immuno­
precipitation buffer) and 75 μΐ of rabbit anti-R-MuLV serum (in immunopre­
cipitation buffer) was added and the reaction mixture was incubated for 
16 h at 4°. As a blank, 0.8 pg of BSA and 25 μΐ of rabbit anti-BSA serum 
(in inmunoprecipitation buffer) was added to the test sample. After incu­
bation, 20 yg of a suspension of carrier BSA anti-BSA precipitate was added 
and the inmunoprecipitate was collected, washed and dissolved as described 
above. 
Our initial attempts to characterize virus-specific polypeptides syn­
thesized in the in vitro subcellular system, by specific inmunoprecipitation 
with antisera directed against R-MuLV did not succeed. Centrifugation of the 
incubation mixtures after RNAase and EDTA treatment, resulted in loss of 50 
to 80 percent of the acid-precipitable radioactivity, and immunoprecipitation 
of the supernatant by the direct or indirect method showed no specificity. 
Conditions to solubilize the proteins in the in vitro reaction mixtures and 
to maintain them in solution during incubation with antiserum were there­
fore developed and established as described above. Thus, 70 to 90 percent 
of the acid precipitable radioactivity was left in the supernatant after 
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centri fugation for 10 min at 220,000 χ g. In addition, the specificity of 
the precipitation was strongly improved by the latter high speed centrifuga-
tion step and collection of the immunoprecipitate by centrifugation through 
a layer of sucrose. 
5.2.8. Polyacrylœrride gel electrophoresis 
Cell-free products and virus-specific polypeptides in inmunoprecipita-
tes were identified by electrophoresis on sodium dodecyl sulfate Polyacryl-
amide slab gels using the discontinuous buffer system as described by 
Laemmli (259). The slab gel system is superior to gel rods, since up to 20 
samples can be run under identical conditions, thus improving the ability 
to compare complex protein mixtures. Slabs of 15 χ 12 χ 0.15 cm or 
16 χ 11 χ 0.075 cm (Biorad) gels were made. Routinely, a linear gradient of 
7 to 18% Polyacrylamide was constructed. The gradient was stabilized against 
convection currents first by including a 3-20% glycerol gradient and second 
by including a higher concentration of ammonium persulfate in the 7% gel 
(0.2%) than in the 18% gel (0.1%) so that the gel polymerized from the top 
down. Buffer solutions for stacking and resolving gels and the electropho­
resis buffer were those described in section 2.2.5. In such a Polyacrylami­
de gradient gel, proteins of the whole range of molecular weights (300,000 
down to 8000) are resolved excellently. Shortly before use, a spacer gel 
(259) containing 14 or 20 slots was applied. Electrophoresis was performed 
at a constant current of 25 mA for 1.5 mm slabs or at 12.5 mA for 0.75 mm 
gels, until the bromophenol blue marker reached the bottom of the gel. 
After electrophoresis, the gel was stained during 15 to 60 min at 50° and 
destained overnight at 37° (section 2.2.5.). Destained gels were transfer­
red to a piece of Whatman 3 MM filter paper and dried under vacuum as des­
cribed (321). When indicated, destained gels were dehydrated in dimethyl 
sulphoxide, soaked in a solution of 22.2% (w/v) 2,5-diphenyl-oxazole (PP0) 
in dimethylsulphoxide, dried and exposed to Royal X-omatic film at -70° 
(322). 
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5.3. ASSAY CONDITIONS FOR CELL-FREE PROTEIN SYNTHESIS IN SYSTEMS SUPPLEMENTED 
WITH POLYRIBOSOMES 
5.3.1. Effect of ionia conditions 
Studies on the translation of marmaiian mRNA in homologous and hetero­
logous cell-free systems indicated that the optimal conditions for the syn­
thesis of specific polypeptides are rather critical (320,323-327). The op­
timum concentrations of K + and Mg ions are different for almost each 
cell-free extract and each mRNA (328). Differences were established between 
the optimal concentrations of К ions for the translation of globin and 
Encephalomyocarditis virus RNA in the ascites system (329). Therefore, we 
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Fig. 26. Effect of magnesium and potassium concentration on the incorpora­
tion of L sjmethionine in cell-free systems supplemented with polyriboso­
mes. Polyribosomes from JLS-V9 cells (section 5.2.2.) were incubated in the 
presence of S-100 from rabbit reticulocytes as described (5.2.5.1.), except 
that the Mg dependence of the incorporation was measured at а К ion con-
centration of 150 mM and the К dependence was determined at a Mg ion con­
centration of 2 mM. Similar ionic conditions were chosen for cell-free incu­
bation of the reticulocyte lysate (section 5.2.5.3.). After incubation 1 μΐ 
aliquots were withdrawn and trichloroacetic acid precipitable radioactivity 
2+ 
was determined (section 2.2.4.). (A) Mg dependency of the amino acid in 
corporation in a cell-free system supplemented with polyribosomes; (B) Mg 
dependency of the incorporation of amino acids in a reticulocyte lysate; 
(С) К dependency of the amino acid incorporation in a cell-free system 
supplemented with polyribosomes. 
2+ 
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Fig. 27. Autoradiogram of a Polyacrylamide slab gel analysis of polypepti­
des synthesized in cell-free systems supplemented with polyribosomes: 
2+ + 
effect of the Mg and К ion concentrations. Conditions for cell-free in­
cubation of polyribosomes in the presence of reticulocyte S-100 were as 
2+ + 
described in the legend to Fig. 26. (A) Mg ion· dependence; (В) К ion 
dependence. 
2+ + ' 
determined the optimum of Mg and К ions for cell-free systems supple­
mented with polyribosomes, by measuring the incorporation of [ sjmethioni-
ne into acid precipitable radioactivity. In addition, we analyzed the pro­
ducts synthesized in the subcellular system at different ionic conditions 
by Polyacrylamide gel electrophoresis. Finally, to check the possibility 
that the synthesis of viral polypeptides would depend in a different way 
on the ionic conditions, the same analysis was performed after 
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immunoprecipitation with anti-R-MuLV serum of the newly formed polypeptides. 
The Mg concentration optimum for the incorporation of [ sjmethionine 
in a cell-free system supplemented with reticulocyte S-100 and polyribosomes, 
isolated by the detergent method, was approximately 2 mM (Fig. 26A). As a 
2+ 
rule, this Mg curve showed a less sharp optimum than that observed for the 
synthesis of globin in the reticulocyte lysate (Fig. 26B). The effect of the 
К ion concentration on the cell-free protein synthesis is shown in Fig. 26C. 
The amount of incorporated |_ sj methionine increased up to 150 mM potassium 
acetate and levels off at higher potassium concentrations. In this context, 
it has to be noted that the use of potassium acetate instead of KCl elimina-
2+ tes the possibility of a Mg shift to lower concentrations due to a weak 
2+ 
association of CI with Mg (330). 
Additional information about the ionic conditions for cell-free protein 
synthesis is obtained when the newly synthesized polypeptides are analyzed 
on Polyacrylamide gels in the presence of sodium dodecyl sulfate. The auto-
2+ 
radiogram of the polypeptides synthesized at different Mg ion concentra­
tions and analyzed on a slab gel is shown in Fig. 27A. Almost identical 
2+ patterns of labeled bands were visible at Mg ion concentrations between 
1 and 3.5 mM. When the concentration of magnesium was raised to 5 mM or even 
higher, especially the synthesis of polypeptides in the 100.000 to 200.000 
molecular weight region was reduced (not shown). Likewise, analysis was per­
formed on the products synthesized at different К ion concentrations (Fig. 
27B). At potassium concentrations between 120 and 210 mM the same set of 
polypeptides was synthesized in comparable amounts. However, the synthesis 
of high molecular weight polypeptides was reduced, when the potassium con­
centration was lowered to 90 and 60 mM. 
For the identification of virus-specific polypeptides indirect immuno­
precipitation was performed on the in vitro reaction mixtures, using anti­
serum against purified R-MuLV. The gel analysis of the immunoprecipitates 
is shown in Fig. 28. Several bands were visible on the autoradiogram in the 
molecular weight range of 40,000 to 70,000. However, no critical dependence 
on a particular magnesium (Fig. 28,1-6) or potassium concentration (Fig. 
28,7-12) was observed. It is clearly visible that the amount of label in 
specific polypeptides followed the magnesium and potassium curves depicted 
in Fig. 26A and С 
The optimal salt concentrations for the synthesis of polypeptides in 
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Fig. 28. Polyacrylamide slab gel analysis of the R-MuLV-specific polypep­
tides synthesized in cell-free systems supplemented with polyribosomes: 
2+ + 
effect of the Mg and К ion concentration. Polypeptides synthesized in 
the cell-free systems supplemented with polyribosomes form JLS-V9 cells 
and S-100 form reticulocytes (legend to Fig. 26} were subjected to immuno-
precipitation with a rabbit antiserum to R-MuLV by the indirect precipi­
tation method (gel columns 1-12). Control precipitation with rabbit 
anti-BSA serum on an equal amount of the in vitro extract (gel column 13). 
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Fig. 29. Effect of crude initiation factors on the synthesis of R-MuLV-
specific polypeptides in cell-free systems supplemented with polyribosomes. 
Polyribosomes isolated from JLS-V9 cells by the detergent method were added 
to a cell-free system containing S-100 from reticulocytes (section 5.2.5.1. ), 
Incubation was performed at a potassium concentration of 150 mM (1) Poly-
2+ 2+ 
peptides synthesized by total polyribosomes at 2.0 mM Mg ; (2-4) Mg de­
pendence of the synthesis of R-MuLV-specific polypeptides in the absence 
2+ 
of crude initiation factors; (5-7) Mg dependence of the synthesis of 
R-MuLV-specific polypeptides in the presence of crude initiation factors. 
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cell-free systems supplemented with pH 5 enzymes from reticulocytes or 
JLS-V9 cells were 2.3 mM for magnesium acetate and 120 - 180 mM for potas­
sium acetate. 
Our results indicate that protein synthesis in cell-free systems sup­
plemented with polyribosomes was effective in a rather broad region of mag­
nesium and potassium concentrations. Moreover, there is no dependence on a 
2+ + 
critical Mg or К ion concentration for the synthesis of a particular 
virus-specific polypeptide, since at each concentration of ions we tested 
a similar set of virus-specific polypeptides was synthesized. 
5.3.2. Effect of erude initiation factors 
Abraham et al. (331) found no significant difference in the capacity of 
polyribosomes isolated from cells by the detergent technique or by nitrogen 
cavitation to incorporate radioactive amino acids. However, these workers 
showed, by measuring the incorporation of radioactive subunits into polyri­
bosomes, that polyribosomes prepared by the detergent technique were less 
effective in chain initiation than polyribosomes isolated by nitrogen cavi­
tation. Therefore, we examined the effect of crude initiation factors from 
rabbit reticulocytes on the synthesis of virus-specific products in a cell-
free system supplemented with polyribosomes prepared by the detergent tech­
nique. In the presence of initiation factors a slight stimulation (1.5 fold) 
of amino acid incorporation was observed. Identification of the virus-
specific products, synthesized in the presence or absence of initiation 
factors by imnunoprecipitation and gel analysis showed that in both cases 
the same virus-specific polypeptides were synthesized (Fig. 29). This experi­
ment indicates that the synthesis of virus-specific polypeptides was not 
essentially improved by the addition of crude reticulocyte initiation factors 
to cell-free systems supplemented with detergent treated polyribosomes. 
5.4. VIRUS-SPECIFIC POLYPEPTIDES SYNTHESIZED BY FREE AND MEMBRANE-BOUND 
POLYRIBOSOMES 
By means of hybridization experiments, it was demonstrated that the rela­
tive amount of virus-specific mRNA is 4 to 10 times higher in membrane-bound 
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than in free polyribosomes (162,163). In accordance with this observation we 
expected and actually established a similar distribution of newly synthesi­
zed virus-specific polypeptides in cell-free systems supplemented with free 
and membrane-bound polyribosomes. In addition, we identified the virus-
specific polypeptides synthesized by both classes of polyribosomes by gel 
analysis of polypeptides precipitated with rabbit antiserum against R-MuLV. 
For the isolation of free and membrane-bound polyribosomes cells were 
disrupted in hypotonic medium by homogenization in a tight fitting Dounce. 
TABLE 4 
Fractionation scheme of cells grown in tissue culture 
Cells 
Dounce-lysate 
125 χ g 
I 
nuclei 
D0C/NP40 
I 
detergent-lysate 
750 χ g 
I 
125 χ g 
sup. 
I 
20,000 χ g 
750 χ g 
sup. 
ι 
membrane 
fraction 
I 
D0C/NP40 
1 
membrane-free 
fraction 
I 
D0C/NP40 
nuclei 
sucrose gradients 
nuclear 
polysomes 
membrane-
bound 
polysomes 
free 
polysomes 
total 
polysomes 
oligo(dT) 
cellulose 
messenger 
RNA 
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Disruption of JLS-V9 cells grown in monolayer appeared to be difficult sin­
ce many cells remained intact and large membrane fragments were still at­
tached to nuclei. JLS-V9 cells grown in spinner culture were much better 
lysed and less cytoplasmic material sedimented with the nuclei. Consequent­
ly, polyribosomes present in the 125 χ g pellet fraction were also isolated. 
A complete scheme of the cell fractionation procedure for the isolation of 
crude cell fractions, free and membrane-bound polyribosomes, total poly­
ribosomes and poly(A)-rich RNA is presented in table 4. 
Fig. 30. Polyacrylamide gel autoradiogram of polypeptides synthesized in a 
cell-free system supplemented with polyribosomes isolated from different 
cell fractions. Polyribosomes, isolated from cell fractions of JLS-V9 cells 
grown in suspension culture (section 5.2.2.) were incubated in cell-free 
systems containing pH 5 enzymes from JLS-V9 cells (section 5.2.5.1.). After 
incubation, equal amounts of the in vitro extract (equivalent to 5 μΐ of 
each 75 μΐ reaction mixture) were prepared for direct analysis by 
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Polyacrylamide gel electrophoresis. For indirect iiranunoprecìpitation with 
rabbit antiserum to R-MuLV, aliquots containing equal amounts of radioacti-
vity (10 cpm) incorporated into protein were withdrawn from the reaction 
mixtures. Inmunoprecipitation on the extracts of cells labeled in vivo with 
[ sjmethionine was performed as described in section 5.2.6. (a) Polypep-
tides synthesized in the cell-free system supplemented with polyribosomes 
isolated from the 125 χ g pellet fraction; (b) with free polyribosomes; 
(c) with membrane-bound polyribosomes; (d) with total polyribosomes; (e) 
R-MuLV-specific polypeptides mediated by polyribosomes associated with the 
nuclear fraction; (f) by free polyribosomes; (g) by membrane-bound polyri­
bosomes; (h) by total polyribosomes; (i) proteins of R-MuLV labeled with 
L cjamino acids; (j) R-MuLV-specifiq polypeptides synthesized in vivo. 
Polyribosomes isolated from different cell fractions of JLS-V9 cells 
grown in spinner culture were allowed to translate their mRNAs in a cell-
free system supplemented with an optimal concentration of pH 5 enzymes. The 
autoradiogram of the Polyacrylamide gel displaying the polypeptides synthe­
sized in vitro is shown in Fig. 30. A large number of labeled bands in the 
molecular weight range of 8000 up to 150,000 can be seen. The most striking 
point, however, is the high degree of similarity among the polypeptide pat­
terns visualized on the autoradiogram. The different classes of polyribosomes 
programmed the synthesis of almost the same set of polypeptides, with the 
exception of one polypeptide band (molecular weight 25,000) which seems to 
be made exclusively on polyribosomes isolated from membrane-rich fractions 
(Fig. 30a and c). This polypeptide is present in a much less amount in the 
cell-free products of the total polyribosomes (Fig. 30d). 
The virus-specific polypeptides synthesized in vitro can be distinguished 
from labeled host polypeptides by immunoprecipitation with rabbit antiserum 
against R-MuLV. Therefore, specific immunoprecipitation was performed on equal 
amounts of [_ SJ methionine incorporated into polypeptides from each reaction 
mixture, by the indirect inmunoprecipitation technique, and the precipitates 
were analyzed on a Polyacrylamide slab gel (Fig. 30e,f,g and h). Radioactive 
material which migrates in front of the heavy chain (50,000 M ) of the immu­
noglobulins was always visible on the film as a curved band, due to over­
loading of the gel by almost 75 pg of the heavy chain. Since a labeled band, 
although less pronounced, was also visible in this region in the gel analysis 
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of control immunoprecipitations (Fig. 28,14), this indicates that at least 
part of the polypeptides in front of the heavy chain were aspecificaily pre-
cipitated. In some analysis a curved band was also visible in front of the 
light chain (23,500 M ) of the imnunoglobulins. Besides these more or less 
artificial bands, one major polypeptide with a molecular weight of 65,000 is 
clearly visible. This polypeptide was synthesized in vitro by all polyriboso-
mal fractions. However, comparison of Fig. 30f and Fig. 30g clearly shows 
that the synthesis of virus-specific polypeptides was significantly higher 
in systems supplemented with membrane-bound polyribosomes than in those with 
free polyribosomes. In addition to the 65,000 daltons polypeptide, two rather 
faint bands were recognized with molecular weights of 74,000 and 82,000. 
These polypeptides had apparent molecular weights corresponding to the virus-
specific precursor polypeptides of 65,000, 74,000 and 82,000 Mr, synthesized 
in vivo (Fig. 30j). Thus, these initial observations suggest that a similar 
set of virus-specific polypeptides was synthesized in vitro as in vivo. No 
evidence, however, was obtained for proteolytic cleavage of the polypeptide 
chains made in vitro to yield the inmunoprecipitable mature virion proteins 
p30 and pi5 (compare Fig. 30g and Fig. 30i). It seems possible, therefore, 
that either appropriate proteolytic enzymes were absent in the pH 5 enzyme 
fraction or incubation was performed at a temperature not optimal for pro-
cessing of precursor polypeptides. One of the larger virion proteins comigra-
ted with the virus-specific polypeptide of 65,000 M synthesized in vitro, 
suggesting the presence of one of the precursor polypeptides in mature virus 
(Fig. 30g and i). This idea is strengthened by studies of van Zaane (personal 
comnunication) showing the precipitation of the virion 65,000 M protein with 
monospecific antiserum against p30. 
In another set of experiments,we studied the synthesis of virus-specific 
polypeptides in cell-free systems supplemented with polyribosomes isolated 
from monolayer cells and pH 5 enzymes from these cells or reticulocyte S-100. 
In addition, in view of the observation of van Zaane et al. (255) that the 
arginine analog canavanine prevented formation of the 65,000 M polypeptide 
in vivo, we examined the effect of canavanine, p-fluorophenylalanine and 
azetidine-2-carboxylic acid on the synthesis of virus-specific polypeptides 
in vitro. 
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Fig. 31. Polyacrylamide slab gel analysis 
of R-MuLV-specific polypeptides synthesi­
zed in cell-free systems supplemented 
with polyribosomes from monolayer cells 
and pH 5 enzymes. Polyribosomes from 
JLS-V9 cells grown in monolayer (section 
5.2.2.) were incubated in cell-free sys­
tems containing pH 5 enzymes from JLS-V9 
cells (section 5.2.5.1.). Immunoprecipita-
tion was performed on equal samples of ra­
dioactivity incorporated into protein with 
antiserum to R-MuLV, by the direct immuno-
precipitation method. Prior to autoradio­
graphy the gel was treated with PPO. (a) 
R-MuLV-specific immunoprecipitate of poly­
peptides synthesized in the reaction mix­
ture supplemented with nuclear polyriboso­
mes; (b) with free polyribosomes; (c) with 
membrane-bound polyribosomes; (d) Specific 
immunoprecipitate of polypeptides synthe­
sized in vivo. 
In this case, immunoprecipitation on newly synthesized radioactive pro­
ducts was performed by the direct immunoprecipitation technique with anti­
serum against R-MuLV. Fig. 31a,b and с show the virus-specific products syn­
thesized by polyribosomes isolated from monolayer cells in a cell-free system 
supplemented with pH 5 enzymes. The 65,000 M polypeptide was present as a 
minor product in incubations supplemented with polyribosomes associated with 
the 125 χ g pellet (Fig. 31a) or membrane-bound polyribosomes (Fig. 31c), 
whereas several major bandswere visible in the low molecular weight range of 
20,000 - 50,000 M . Remarkably, these low molecular weight polypeptides were 
only minor products of cell-free systems supplemented with free polyribosomes 
(Fig. 31b) or membrane associated polyribosomes from cells grown in suspension 
culture (Fig. 30e and g). Since low molecular weight polypeptides were almost 
absent in 'the cell-free products mediated by free polyribosomes, the membrane 
associated polyribosomes isolated from monolayer cells were presumably 
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Fig. 32. Autoradiogram of the Polyacrylamide gel analysis of R-MuLV-specific 
polypeptides synthesized in cell-free systems supplemented with polyribosomes 
from monolayer cells and S-100 from reticulocytes. Isolation of polyribosomes 
and immunoprecipitation of the newly synthesized polypeptides was performed 
as described in the legend to Fig. 31. Purified polyribosomes were incubated 
in the presence of S-100 from reticulocytes. Prior to autoradiography the gel 
was treated with PPO. (a) R-MuLV-specific polypeptides synthesized in JLS-V9 
cells labeled with [ sj methionine for 60 min; (-b) aspecific immunoprecipita­
tion of in vivo labeled cell extract; (c) R-MuLV labeled with [ cjamino 
acids; (d) R-MuLV-specific polypeptides synthesized in the cell-free system 
supplemented with nuclear polyribosomes; (e) with free polyribosomes; 
(f) with membrane-bound polyribosomes; (g), (h) and (i) same as (d), (e) and 
(f) except that incubation was performed in the presence of 200 μΜ of amino 
acid analogs (p-fluorophenylalanine, canavanine and azetidine-2-carboxylic 
acid). 
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contaminateci with RNAase or proteases causing premature termination or pro­
teolytic cleavage of newly synthesized polypeptides. Anyway, it is obvious 
that both free and membrane-bound polyribosomes gave rise to the synthesis 
of virus-specific polypeptides with molecular weights of 55,000, 65,000 and 
74,000. From the latter products,the 55,000 and 74,000 M polypeptides were 
always present as minor bands in the protein pattern of cells labeled in 
vivo (Fig. 31d). Only in the gel analysis of the virus-specific in vitro pro­
ducts of membrane associated polyribosomes (Fig. 31a and c) a faint band is 
visible comigrating with the viral glycoprotein precursor of 82,000 M 
(Fig. 31d). 
A different result was obtained when polyribosomes isolated from mono­
layer cells were allowed to translate their mRNAs in the presence of reticu­
locyte S-100 (Fig. 32). Only one low molecular weight polypeptide of approxi­
mately 45,000 M was synthesized in minor amounts by membrane-bound poly­
ribosomes (Fig. 32f), whereas several low molecular weight bands were still 
present in the reaction mixtures supplemented with polyribosomes associated 
with the 125 χ g pellet fraction (Fig. 32d). Obviously, all polyribosomal 
fractions mediate the synthesis of a major polypeptide of 65,000 M (Fig. 
32d,e and f). In the same molecular weight range two minor bands were seen 
with molecular weights of 55,000 and 74,000, when polyribosomes isolated 
from membrane-rich cell fractions were incubated in vitro (Fig. 32d and f). 
Although evidence for the synthesis of these polypeptides by free polyribo­
somes was obtained in the preceding experiment (Fig. 31b), they were not 
detected among the specific polypeptides shown in Fig. 32e. However, we were 
able to demonstrate that the 55,000 and 74,000 M polypeptides were precipi­
tated from the cell-free products mediated by the same batch of polyribosomes 
by indirect immunoprecipitation (not shown). 
Addition of amino acid analogs (p-fluorophenylalanine, canavanine and 
azetidine-2-carboxylic acid) to the cell-free system supplemented with poly­
ribosomes did not result in the synthesis of higher molecular weight poly­
peptides. In addition, in contrast to the results obtained from in vivo 
studies (255) the synthesis of the 65,000 M precursor polypeptide was not 
prevented in vitro (Fig. 32д^ and i). One reason for this result is possi­
bly the essentially different experimental approach: while in the in vitro 
studies mainly nascent polypeptide chains were completed, in the in vivo 
studies amino acid analogs were added prior to the radioactive amino acids. 
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The above experiments indicate that both free and membrane-bound poly­
ribosomes gave rise to the synthesis of a virus-specific polypeptide, which 
is presumably identical to the virus-specific precursor polypeptide of 
65,000 M . Our finding that only occasionally a minor polypeptide band of 
82,000 M was observed in the gel analysis of membrane-bound polyribosomes, 
suggests that we had difficulties with the detection or the accurate syn­
thesis of the viral glycoprotein precursor. Variable amounts were observed 
of virus-specific polypeptides of 55,000 and 74,000 M , which comigrated 
with two minor polypeptides synthesized in vivo. Finally, in all experiments 
the relative content of virus-specific polypeptides mediated by membrane-
bound polyribosomes was much higher than in systems supplemented with free 
polyribosomes. 
5.5. VIRUS-SPECIFIC POLYPEPTIDES SYNTHESIZED IN FRACTIONATED CELL EXTRACTS 
Monolayer cells were lysed in hypotonic buffer and nuclei were removed 
by low speed centri fugation (Table 4). The supernatant was fractionated by 
centri fugation at 20,000 χ g into a pellet (membrane fraction) and superna­
tant fluid (membrane-free fraction). These crude fractions were tested for 
their protein synthesizing activity in the presence or absence of crude 
initiation factors from reticulocytes. 
Fig. 33a-j shows the patterns of labeled polypeptides made in vitro 
in the crude fractionated cell extracts. For comparison the pattern of newly 
synthesized polypeptides of cells labeled in vivo is included (Fig. 33k). 
Recognition of distinct polypeptide bands in the gel analysis of products 
made in the resuspended cytoplasmic pellet (Fig. 33c,d,e and h,i,j) is dif­
ficult due to the high background in these gels: This background radioacti­
vity may be caused by inaccurately synthesized polypeptide chains or the 
poorer resolution in this gel system of membrane associated proteins (332). 
In contrast, sharp separations were observed of those polypeptides that 
were made in the supernatant fractions (Fig. 33b and g) and to a lesser 
extent in the 125 χ g supernatant (Fig. 33a and f). The most obvious feature 
of this gel analysis is the high degree of similarity in polypeptide pat­
terns, independent of the fraction used for cell-free synthesis. A closer 
observation of the autoradiogram reveals that addition of initiation fac­
tors, S-100 or pH 5 enzymes, resulted in a slight stimulation of the 
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Fig. 33. Autoradiogram of the polypeptides synthesized in crude fractionated 
cell extracts from JLS-V9 cells electrophoresed on a Polyacrylamide slab 
gel. The procedures for the preparation of subcellular fractions from JLS-V9 
cells and for incubation in vitro were as described (sections 5.2.3. and 
5.2.5.2.). Prior to autoradiographic analysis the slab gel was treated with 
PPO. Polypeptides synthesized in a cell-free system supplemented with 
(a) the 125 χ g supernatant fraction; (b) the 20,000 χ g supernatant frac­
tion; (c) the resuspended 20,000 χ g pellet fraction; (d) the resuspended 
20,000 χ g pellet fraction and S-100 from JLS-V9 cells; (e) the resuspended 
20,000 χ g pellet fraction and pH 5 enzymes from JLS-V9 cells; (f) to (j) 
cell-free incubations specified in (a) to (e) repeated in the presence of 
crude initiation factors from reticulocyte ribosomes; (k) polypeptides syn­
thesized in JLS-V9 cells labeled with |_ sjmethionine for 60 min. 
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Fig. 34. Polyacrylamide gel electrophoresis of R-MuLV-specific polypeptides 
synthesized in cell-free systems supplemented with subcellular fractions 
from JLS-V9 cells. Virus-specific polypeptides were precipitated from the 
in vitro reaction mixtures (see legend to Fig. 33) with rabbit antiserum 
to R-MuLV (direct method). In this experiment, from each reaction mixture 
equal amounts of radioactivity incorporated into protein were used for 
specific and aspecific immunoprecipitation. Prior to autoradiographic ana­
lysis the gel was treated with PPO. R-MuLV-specific polypeptides synthe­
sized in a cell-free system supplemented with (a) the 125 χ g supernatant; 
(b) the 20,000 χ g supernatant; (с) the resuspended 20,000 χ g pellet; 
(d) the resusended 20,000 χ g pellet and S-100 from JLS-V9 cells; (e) the 
resuspended 20,000 χ g pellet and pH 5 enzymes from JLS-V9 cells; (f) to 
(j) cell-free incubations specified in (a) to (e) repeated in the presence 
of crude initiation factors; (k) R-MuLV-specific polypeptides synthesized 
in vivo; (1) aspecific immunoprecipitation of polypeptides synthesized in 
vitro in the 125 χ g supernatant fraction. 
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synthesis of several polypeptides in the 20,000 χ g pellet fraction (compare 
Fig. 33c with Fig. 33d,e and h). Finally, with the exception of a number of 
high molecular weight polypeptides, similar polypeptides were synthesized 
•in vivo and in the in vitro system (Fig. 33f and k). 
Virus-specific polypeptides synthesized in the crude extracts were pre­
cipitated by the direct iranunoprecipitation method, analyzed by sodium dode-
cyl sulfate-polyacrylamide gel electrophoresis and located by scintillation 
autoradiography of dried slab gels (Fig. 34). In the presence of crude initi­
ation factors predominantly three virus-specific polypeptides were synthe­
sized in the membrane-rich 125 χ g supernatant (Fig. 34f) and the resuspended 
20,000 χ g pellet fraction (Fig. 34h,i and j) with molecular weights of 
65,000, 76,000 and 82,000. Among the virus-specific polypeptides synthesized 
in vitro one polypeptide was present, designated 76,000 M
r
, which is not de­
tected in the gel analysis of virus-specific polypeptides made in vivo 
(compare Fig. 34h,i and j with Fig. 34k). Incubation of the resuspended 
20,000 χ g pellet in the presence (Fig. 34i and j) or absence (Fig. 34h) of 
S-100 or pH 5 enzymes from JLS-V9 cells resulted in the same set of poly­
peptides. 
When the crude initiation factors were omitted, especially the virus-
specific polypeptide synthesis in the cytoplasmic pellet fraction was re­
duced (Fig. 34c). However, addition of S-100 or pH 5 enzymes to this frac­
tion restored the specific polypeptide synthesis completely (Fig. 34d and 
e). This was apparently due to a deficiency of factors required for protein 
synthesis in the resuspended 20,000 χ g pellet fraction. Among the virus-
specific polypeptides synthesized in membrane-rich fractions a number of 
minor bands were visible with molecular weights of 55,000 and 20,000 -
50,000, similar to those observed in previous experiments employing membrane-
bound polyribosomes. 
A different result was obtained when the membrane-free 20,000 χ g su­
pernatant was incubated in vitro. Gel analysis of the iranunoprecipitate 
shows that a polypeptide of 65,000 M is the only virus-specific product 
synthesized (Fig. 34b and g). After direct immunoprecipitation the relative 
content of labeled polypeptides was 3 to 5 times less in the immunoprecipí-
tate of the 20,000 χ g supernatant than in that of the 20,000 χ g pellet. 
This observation is consistent with a previous result obtained with free 
and membrane-bound polyribosomes. In this context, it should be noted that 
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the proportion of input radioactivity in the immunoprecipitate is only a 
rough reflection of the exact percentage of virus-specific polypeptides new­
ly synthesized in vitro. From these results, we may conclude that in vitro 
incubation of all crude cytoplasmic fractions gave rise to the synthesis of 
the virus-specific precursor polypeptide of 65,000 M . On the other hand 
the synthesis of the viral glycoprotein precursor (82,000 M
r
)could only be de­
tected by specific inmunoprecipitation when membrane-rich fractions were 
incubated in vitro. 
5.6. TRANSLATION OF VIRUS-SPECIFIC mRNA PURIFIED ON 0LIG0(dT)-CELLUL0SE 
In previous studies the presence was reported of virus-specific RNA in 
free and membrane-bound polyribosomes from cells infected with Mo-SV(Mo-MuLV) 
or R-MuLV (162,163). Virus-specific 35S RNA appeared to be the predominant 
RNA species present in free polyribosomes. On the other hand, membrane-bound 
polyribosomes also contained smaller RNA molecules with sedimentation coef­
ficients of about 14S and 20-22S (162,163). However, these studies did not 
yet demonstrate that these virus-specific RNA species direct the synthesis 
of specific polypeptides. Therefore, evidence that these RNA species would 
be translated in certain virus-specific polypeptides could give valuable in­
formation about the interrelationship between the smaller RNAs and the 35S 
RNA. 
Fig. 35. Sedimentation analysis of 
poly(A)-containing RNA isolated from 
polyribosomes of R-MuLV infected 
cells in sucrose gradients containing 
50% formamide. Experimental details 
were described in the legend to Fig. 
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Fig. 36. Electrophoresis on a 7-18% Polyacrylamide slab gel of polypeptides 
newly synthesized -Ln vitro under the direction of mRNA fractionated accor­
ding to size. mRNA from fractions of the gradient shown in Fig. 35 was trans­
lated in a lysate from rabbit reticulocytes (section 5.2.5.3.). Equal amounts 
of the in vitro incubation mixtures (equivalent to 1 μΐ of a 25 yl reaction 
mixture)were prepared for gel electrophoresis by addition of sample buffer 
(section 5.2.8.) containing 6 M urea, heated at 95 for 2 min and applied to 
the sample wells. Prior to autoradiographic analysis the gel was treated 
with PRO. Polypeptides synthesized in the reticulocyte lysate without exo­
genous mRNA (1). Columns 5 to 17 refer to the fractions of the gradient 
shown in Fig. 35. Polypeptides synthesized in the reticulocyte lysate under 
the direction of 1 yg IOS lens mRNA (18). 
In chapter 4, we described the isolation of poly(A)-rich virus-specific 
RNA by oligo(dT)-cellulose chromatography. In order to prevent degradation 
of RNA by multiple step isolation procedures, polyribosomes were dissociated 
with sodium dodecyl sulfate and directly applied to the column. The poly(A)-
rich material recovered from the column had a E260^E280 r a t^ 0 0^ ^-1 t o 2-2, 
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indicating that a pure RNA preparation was obtained. Because of aggregation 
of this poly(A)-rich RNA, it appeared necessary to use denaturing agents 
during centrifugation (see chapter 4). Fig. 35 shows the profile of poly(A)-
rich RNA hybridizing with the labeled R-MuLV virus DNA probe after gradient 
centrifugation in the presence of 50% formamide. From the absence of hybri-
dizable material at the bottom of the gradient, it is obvious that no 
aggregation of virus-specific mRNA had occurred. 
Messenger RNA present in individual fractions of this gradient was 
translated in a reticulocyte cell-free system and the newly synthesized 
polypeptides were analyzed on a Polyacrylamide slab gel. The analysis con-
firms that there was no aggregation of the bulk of the mRNA in the gradient 
as there was a clear relationship between the molecular weights of the poly-
peptides which were synthesized and the sedimentation value of the corres-
ponding messenger fraction (Fig. 36 1,5-17). A large number of polypeptides 
were made, ranging in molecular weight from 10,000 up to 150,000. After ' 
longer exposure times of the dried slab gel even higher molecular weight 
polypeptides were visualized and a gradual increase of the molecular weights 
of newly synthesized polypeptides was clearly visible up to fraction 14 
(30 - 35S region). For comparison, the translation products of an optimal 
concentration of 10S calf lens mRNA is shown (Fig. 36,18). It is evident 
that this mRNA preparation was translated more efficiently than most of our 
poly(A)-containing RNA fractions. This is not surprising, since the 10S 
calf lens mRNA preparation is rather homogeneous. The poly(A)-containing 
mRNA fractions from infected cells, on the other hand, are essentially he-
terogeneous. Apparently, certain RNA molecules interfere with the transla-
tion of others since it follows from the data presented below that optimal 
synthesis of certain polypeptides was critically dependent on the concen-
tration of poly(A)-rich RNA added to the lysate. Because it was not feasible 
to determine the optimal concentration of mRNA present in each fraction of 
the gradient for the synthesis of each virus-specific product, mRNA from 
each fraction was translated at three arbitrary concentrations. 
Fig. 37 and 38 show the polypeptides precipitated from each reaction 
mixture by the indirect immunoprecipitation method, at the two highest con-
centrations of mRNA tested. As a reference, the analysis of virus-specific 
polypeptides synthesized in vivo was included (Fig. 37,18 and Fig. 38,18). 
In a control experiment, immunoprecipitation was carried out on polypeptides 
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made in the endogenous ret iculocyte lysate (F ig. 37,19). One polypeptide 
with a molecular weight of about 32,000 was precipitated a s p e c i f i c a l l y by 
the R-MuLV antiserum; i t was present in variable amounts in a l l analyses. 
18S 28S 
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.72,000 ^ pr65 
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Fig. 37. Autoradiographic analysis of the R-MuLV-specific polypeptides syn­
thesized in vitro under the direction of mRNA fractionated according to 
size. RNA from each fraction of the gradient shown in Fig. 35 was dissolved 
in 50 μΐ of distilled water and stored at -20°. The reticulocyte cell-free 
system was programmed with 3 yl of RNA from each fraction (section 5.2.5.3.] 
After incubation, the products synthesized in each 25 yl reaction mixture 
were subjected to indirect immunoprecipitation with rabbit antiserum to 
R-MuLV. As a control, immunoprecipitation was performed on the products 
synthesized in the lysate without exogenous RNA. Prior to autoradiographic 
analysis the gel was treated with PRO. Columns 4 to 17 refer to the frac­
tion of the gradient shown in Fig. 35. (18) R-MuLV-specific polypeptides 
synthesized in vivo. (19) Aspecific immunoprecipitation of polypeptides 
synthesized in the lysate in absence of exogenous RNA. 
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Fig. 38. Autoradiographic analysis of the R-MuLV-specific polypeptides syn­
thesized in vitro under the direction of mRNA fractionated according to 
size. Conditions for cell-free protein synthesis, immunoprecipitation and 
autoradiographic analysis were as described in the legend to Fig. 37, ex­
cept that 7 μΐ of RNA from each fraction was added to the lysate. Columns 
4 to 17 refer to the fractions of the gradient shown in Fig. 35. 
(18) R-MuLV-specific polypeptides synthesized in vivo. 
mRNA present in the 35S region directed predominantly the synthesis of 
two major specific polypeptides with molecular weights of 65,000 and 72,000 
(Fig. 37,14,15 and 16 and Fig. 38,14,15 and 16) of which the first comigra-
ted with the 65,000 M band made in vivo (Fig. 39a,b and c). At the highest 
concentration of mRNA two additional minor polypeptides were visible with 
molecular weights of 55,000 and approximately 45,000 (Fig. 38,15). No evi­
dence was obtained for the synthesis of the glycoprotein precursor 
(82,000 M ) under the direction of the 35S mRNA. The specificity of the po­
lypeptides directed by the 35S mRNA is strongly supported by recent studies 
of Salden et al. (157) on the translation of R-MuLV RNA. These investiga­
tors were able to demonstrate the synthesis of two major polypeptides with 
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Fig. 39. Comparison of in vitro and in vivo synthesized virus-specific poly-
peptides by electrophoresis on Polyacrylamide gels, (a) Imrnunoprecipitate of 
polypeptides synthesized in vitro by mRNA from fraction 15 (Fig. 35); (b) co-
electrophoresis of the immunoprecipitates of polypeptides synthesized in 
vivo and those synthesized in vitro under the direction of mRNA from fraction 
15; (c) and (e) immunoprecipitates of polypeptides synthesized in vivo; 
(d) co-electrophoresis of the immunoprecipitates of polypeptides synthesized 
in vivo and those synthesized in vitro under the direction of mRNA from 
fraction 10 (Fig. 35); (f) imrnunoprecipitate of polypeptides synthesized in 
the reticulocyte lysate programmed with 1 pg of denatured R-MuLV RNA. 
molecular weights of 65,000 and 72,000 in cell-free systems supplemented 
with native or denatured R-MuLV RNA (Fig. 39f). Minor virus-specific products 
were a 55,000 M polypeptide and some polypeptides in the 30,000-50,000 M 
region. This pattern of virus-specific products was strikingly similar to 
that observed after cell-free translation of 35s mRNA (compare Fig. 38,15 
with Fig. 39f). 
Virus-specific RNA in the 20-22S region gave rise to the synthesis of 
a 70,000 Mr polypeptide (Fig. 37,10 and 11 and Fig. 38,10 and 11), which 
was not detected among the virus-specific polypeptides synthesized in vivo 
(Fig. 39d and e). Upon close observation of the gel, it was seen that this 
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band was actually a double band. At the highest RNA concentration (Fig. 38) 
the slowest migrating component of both bands was also present in fraction 
12 and 13. Moreover, the total picture gives the impression that looking 
from the lower to the higher fractions the 70,000 M band in fraction 10 
undergoes gradually a transition to the 72,000 M band in fraction 15. The 
significance, however, of this suggestive observation is still unknown. 
Messenger RNA in the 14S region directed the synthesis of low molecular 
weight polypeptides, one polypeptide band of about 30,000 M and two bands 
in the 15,000 M region were visible (Fig. 37,7 and 8 and Fig. 38,7 and 8). 
Comparison of these figures clearly shows that the synthesis of the 30,000 
M band was strongly inhibited at the highest RNA concentration. Moreover, 
especially at the highest RNA concentration we observed the synthesis of 
high molecular weight polypeptides (100,000 - 200,000 Mr) directed by mRNA 
of approximately 28S (Fig. 38,13). More experimental evidence is required 
to explain the significance of this latter observation. 
Finally, it is worth noticing the percentage of newly synthesized poly-
peptides which could be precipitated with antiserum against R-MuLV. At most 
about 0.2% of the input radioactivity was precipitated from incubation mix-
tures supplemented with the different mRNA fractions and, thus, clearly 
shows the high sensitivity of the method we employed to detect virus-speci-
fic polypeptides. On the other hand, it is quite obvious that the slightest 
contamination of the immunoprecipitate, caused by coprecipitation or insuf-
ficient washing, may give rise to erroneous results. 
5.7. DISCUSSION 
The biosynthesis of RNA tumor virus-specific proteins in vivo and in 
vitro can be examined despite a vast background of cell proteins by employ-
ing antisera prepared against purified virions. Using this technique, two 
major high molecular weight polypeptides were detected in cells infected 
with Rauscher leukemia virus. The mature viral proteins p30 and pl5 are 
formed by proteolytic cleavage of a precursor polypeptide of 65,000 molecu-
lar weight (designated pr65). This was established by employing monospecific 
antisera to the purified viral proteins p30 and pl5, and by pulse-chase 
experiments (van Zaane, personal conmunication, 257). It is likely, however, 
that the mature virion proteins pl2 and plO are also derived from pr65. 
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Similarly, a high molecular weight polypeptide of 82,000 - 85,000 M
r
 (desig­
nated pr82) was detected with monospecific antiserum to gp69/71 (van Zaane, 
personal communication, 257). In further experiments, it was established 
that pr82 could be labeled with [_ Hjglucosamine. Moreover, in addition to 
the viral glycoprotein gp69/71, the viral protein pl5(E), which is most like­
ly a constituent of the viral envelope, was also demonstrated to arise by 
proteolytic cleavage of the intracellular precursor polypeptide pr82 (van 
Zaane, personal communication). 
TABLE 5 
R-MuLV-specific polypeptides synthesized in vitro 
fraction used for 
translation 
125 χ g sup 
20,000 g pellet 
20,000 χ g sup 
free polyribosomes 
membrane-bound 
polyribosomes 
14S mRNA 
20-22S mRNA 
35S mRNA 
35S viral RNA 
major products 
(molecular 
_3 
weight χ 10 ) 
65, 76, 82 
65, 76, 82 
65 
65 
45, 65 
10, 15, 30 
70 
65, 72 
65, 72 
minor 
(mo 
wei 
products 
ecular 
ght χ 10"3) 
30-50, 55 
30-50, 55 
55, 74 
30-50, 55, 74 
30-50, 55 
30-50, 55 
Polypeptides synthesized in vivo, major: 82,000 M and 65,000 Μ , minor: 
74,000 Μ
Γ
, 70,000 M
r
, 28,000 M
r
 and 16,000 l y 
In this chapter, we described the synthesis in vitro of R-MuLV-specific 
polypeptides in crude cell extracts, mediated by free and membrane-bound 
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polyribosomes or directed by mRNA fractionated according to size (compare 
table 5). All cytoplasmic fractions synthesized a polypeptide with a molecu­
lar weight of 65,000, presumably identical with the intracellular precursor 
polypeptide pr65. However, only the membrane-rich fractions synthesized a 
polypeptide of 82,000 Μ , probably identical to the intracellular precursor 
polypeptide pr82, and a polypeptide of 76,000 M
r
. Although other explana­
tions are possible, the absence of this latter polypeptide in the cell-free 
products of the cytoplasmic supernatant suggests that the 76,000 M poly­
peptide was either not completely glycosylated or represented one of the 
first intermediates in the processing of pr82 from which the viral glyco­
proteins gp69/71 and the envelope protein pl5(E) are derived. 
Among several immunoprecipitable polypeptides the 65,000 M polypeptide 
was detectable after cell-free incubation of all polyribosomal fractions. 
Whereas the glycosylated 82,000 M polypeptide was easily recognized as one 
of the major products synthesized by polyribosomes still attached to mem­
branes, only occasionally a minor labeled band was visible in the cell-free 
products of polyribosomes released from membranes and never in those of free 
polyribosomes. Besides, we were not able to detect the 82,000 M polypeptide 
in lysates supplemented with the different mRNA fractions. The simplest ex­
planation for these observations is that although the protein moiety was 
synthesized in cell-free systems supplemented with the cytoplasmic superna­
tant, purified polyribosomes or mRNA, this polypeptide was not precipitated 
by the antiserum, since the protein moiety is less antigenic than the car­
bohydrate moiety. However, Halpern et al. (317) reported that the incomple­
tely glycosylated precursor (70,000 M ) of the AMV viral glycoprotein 
(85,000 M ) was precipitated by a monospecific antiserum against purified 
gp85, suggesting that at least in that case part of the antigenic determi­
nants are located in the protein moiety. On the other hand, it could be 
speculated that association with membranes is a prerequisite for the correct 
synthesis of the glycoprotein. In this context, it is interesting to notice 
that other groups have also had difficulty in demonstrating the synthesis 
of viral glycoproteins in vitro (333-336). 
That membranes are involved in the synthesis of virus-specific poly­
peptides is evident from the more general observations that they were syn­
thesized in relatively high amounts in membrane-rich fractions or by poly­
ribosomes isolated from these fractions. The earlier finding of our group 
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(163) and others (162) that the relative content of virus-specific RNA, as 
measured by hybridization, was 4 - 1 0 times less on free polyribosomes than 
on membrane-bound polyribosomes is consistent with these results. Analysis 
of the cell-free products directed by the R-MuLV-specific mRNA fractionated 
according to size, shows that at least the 35S mRNA and the 20-22S mRNA 
fractions directed the synthesis of virus-specific products. Employing anti-
R-MuLV serum the same set of polypeptides (65,000 and 72,000 M
r
) was detec­
ted after translation of 35S mRNA and native or denatured viral RNA. More­
over, in recent experiments evidence was obtained that both polypeptides 
were also precipitated form the cell-free products directed by denatured 
viral RNA, using a monospecific antiserum against purified p30 (Salden, per­
sonal communication). Together with the finding that a 72,000 M polypeptide 
was synthesized instead of pr65 in canavam'ne treated cells (van Zaane, 
personal communication), this implies that the 72,000 M polypeptide shares 
common amino acid sequences with the precursor polypeptide pr65. We never 
observed the synthesis of the 72,000 M polypeptide by purified polyriboso­
mes. On the other hand, we also never observed the synthesis of a 74,000 M 
polypeptide under direction of viral RNA or 35S mRNA, while this polypeptide 
was actually a minor product synthesized by purified polyribosomes. In addi­
tion, preliminary evidence indicates that a monospecific antiserum against 
p30 precipitated the 65,000 and 74,000 M polypeptides from lysates of cells 
labeled in vivo and from the cell-free products made by purified polyriboso­
mes (van Zaane and Gielkens, unpublished observations). If the difference in 
molecular weight of the 72,000 and 74,000 polypeptides is real, we may spe­
culate that pr65 is derived from a higher molecular weight polypeptide of 
at least 74,000. 
RNA sedimenting in the 20-22S region directed the synthesis of a poly­
peptide of 70,000 Μ , which was not detected among the cell-free products 
directed by the viral RNA and 35S mRNA. Although a definite proof is still 
lacking, it is attractive to speculate that the 70,000 M polypeptide shares 
amino acid sequences with the 72,000 and 65,000 M polypeptides. More experi­
mental evidence is also needed to support the virus-specificity of the poly­
peptides synthesized by mRNA in the 14S region. Since 14S RNA, presumably, 
has a coding capacity of about 40,000 daltons of protein and a number of low 
molecular weight polypeptides are synthesized under its direction, it follows 
that this RNA fraction consists of different virus-specific RNA species or 
115 
that the polypeptides are derived from a coranon precursor. This question 
should also be settled by further experiments. 
In the in vitro reaction mixtures several immunoprecipitable polypep-
tides were detected with molecular weights of 30,000 - 55,000 dependent on 
the RNA containing fraction added to the cell-free system. Variable amounts 
of these polypeptides were made. This group of polypeptides may result from 
premature termination or cleavage of high molecular weight polypeptides due 
to proteases. Striking is that most of these polypeptides are also visible 
as faint bands in the lysates of cells labeled in vivo (compare Fig. 32a 
with Fig. 32d and f; Table 5). It is conceivable that the high proportion 
of these polypeptides in the cell-free products of purified membrane associ-
ated polyribosomes is caused by contamination of these polyribosomes with 
RNAase and proteases released from the membranes by the detergent treatment. 
Several pathways are feasible for the synthesis of mature virion proteins, 
1. The formation of mature viral proteins by the device of posttranslational 
cleavage of a single large precursor polypeptide, encoded by the viral RNA, 
which functions as messenger RNA in the infected cells. 
2. The population of messengers required for the synthesis of viral proteins 
is heterogeneous: some are smaller and others are identical in size to the 
viral genome; some of the viral proteins are formed by cleavage of precursor 
polypeptides. 
3. Mature virion proteins are synthesized by small monocistronic messengers. 
The first possibility, posttranslational cleavage of a single large poly-
peptide to bypass the apparent inability of manmalian cells to initiate and 
terminate translation at internal points of the mRNA (337) is known to occur 
in cells infected with picornaviruses (337-339).The second possibility seems 
to be, at least partially, met in cells infected with Sindbis or Semliki 
Forest virus (Togaviruses). In cells infected with these viruses the viral 
42S RNA was found in association with polyribosomes. However, the most promi-
nent virus-specific mRNA associated with polyribosomes was smaller in size 
(26S) than the viral 42S RNA genome (340-343) and contained sequences identi-
cal to a part of the viral genome (344). Both mRNAs stimulated the synthesis 
in vitro of core and envelope proteins of the virus (335,336,345,346). However, 
no translation products of the nonstructural part of the 42S RNA genome have 
been identified. On account of these observations. Smith et al. (335) 
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suggested that the 26S mRNA is an amplified form of the genes coding for 
the structural proteins, while translation of the non-amplified portion of 
the 42S RNA provides the other virus coded proteins, that are required in 
only small amounts. The fact that 26S mRNA was almost 20 times more active 
in cell-free systems than the 42S mRNA substantiates this idea (347). Final-
ly, pathway 3 is most likely the mechanism which is operative for Rhabdovi-
ruses which contain a RNA genome of negative polarity. Several messengers 
with sedimentation values of 12S to 18S have been identified in vesicular 
stomatitis virus infected cells (348,349). 
If the entire genome of RNA tumor viruses would be translated into a 
single polyprotein of about 300,000 M which is cleaved by proteolytic enzy-
mes to form the functional virus proteins, only one virus-specific messenger 
RNA species should be associated with polyribosomes. However, apart from the 
35S mRNA which is identical in size to the RNA subunits of these viruses, 
lower molecular weight mRNAs of 20-22S and about 14S have been found (160-
163). Furthermore, we provided evidence that apart from the 35S RNA also the 
RNA species of smaller size served as messenger and directed the synthesis 
of virus-specific polypeptides in vitro. In these studies and those on the 
identification of intracellular virus-specific polypeptides no evidence was 
obtained for the synthesis of a giant polypeptide of about 300,000 M . In 
fact, the precursor for the mature virus capsid proteins and the viral enve-
lope proteins had molecular weights smaller than 85,000 (253-257). Thus, 
these observations do not support the possibility that the entire genome of 
RNA tumor viruses is translated into a single polypeptide. It should be noted, 
of course, that higher molecular weight precursor polypeptides would escape 
detection if they would lack the proper antigenic determinants. Finally, if 
the entire genome is translated into a single polypeptide, differential ex-
pression of virus genes (29,350) would be difficult to explain, since such 
a mechanism predicts that the viral proteins should always be synthesized in 
equal molar amounts. Therefore, although these data are not yet complete 
enough to allow final conclusions on the functions of the intracellular vi-
ral mRNAs of different size classes, they do favor model 2 in our opinion. 
This view is based, largely, on the observation that in addition to the viral 
35S mRNA smaller messengers also code for virus-specific proteins in our 
cell-free system. 
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SUMMARY 
Evidence for the etiological role of certain RNA-containing viruses in 
the development of tumors in some animals has been provided by many investi-
gators. The viral theory of cancer has led to an enormous research on the 
biochemistry and the mode of replication of RNA tumor viruses. 
A short review on some of the main topics of the molecular biology of 
these particles is presented in Chapter 1. The most essential characteristic 
of RNA tumor viruses is their mode of replication via a double-stranded DNA 
intermediate, which becomes integrated as a provirus in the cellular DNA of 
the host. A second striking feature of these viruses is their widespread oc-
currence, suggesting that these particles may be involved in the development 
of cancer in human as well. 
The Rauscher leukemia virus, a murine-type RNA tumor virus, causes an 
erythroid leukemia in mice. We have used tissue culture cells infected with 
this virus as a model system to study the biosynthesis of virus proteins. 
When these investigations were started details on this phase of the 'life-
cycle' of RNA tumor viruses were still lacking. 
In the experimental part of Chapter 1, we described the separation of 
the proteins of purified Rauscher leukemia virus particles by electrophoresis 
in Polyacrylamide gels containing sodium dodecyl sulfate. By this method 
virion proteins are separated according to the molecular weights of their 
polypeptide chains. The autoradiograph of the gels containing a linear gra-
dient of acrylamide, clearly shows that the virion contains in addition to 
the major structural proteins a large number of minor proteins, which have 
not yet been characterized. Apparently, the minor bands do not represent con-
tamination since they were present in virions isolated from different cell 
lines as well as from plasma of leukemic mice. Furthermore, we obtained evi-
dence for heterogeneity in virion protein pio, which was found to consist of 
two or three distinct protein components. 
In order to establish whether the viral RNA genome itself acts as mes-
senger for the synthesis of viral proteins, purified RNA from Rauscher leuke-
mia virus, avian myeloblastosis virus and mammary tumor virus was translated 
in a cell-free system from bacteria (Chapter 2). We could show that addition 
of the individual viral RNAs from these three unrelated RNA tumor viruses 
resulted in the synthesis of a specific set of polypeptides. Thus, the viral 
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RNA has messenger properties and most likely contains the sequences of the 
virus-specific messenger RNA in infected cells. 
Convincing evidence for the presence in infected cells of virus-speci-
fic messenger RNA, containing sequences identical to the viral genome, was 
provided in Chapter 3. By hybridization with radioactive DNA complementary 
to the viral RNA, we were able to detect virus-specific RNA sequences in 
free and membrane-bound polyribosomes of cells infected with the Rauscher 
leukemia virus. Determination of the relative content of virus-specific RNA 
sequences in free and membrane-bound polyribosomes indicated that virus-spe-
cific proteins are preferentially synthesized in association with membranes. 
Size analysis of the virus-specific RNA associated with polyribosomes by den-
sity gradient centrifugation revealed the presence of three size classes of 
virus-specific messenger RNA. The most prominent class of virus-specific 
messenger RNA has a sedimentation value of approximately 35S and is identical 
in size and polarity to the virion RNA subunits produced by thermal or sol-
vent dissociation of the 60-70S viral RNA genome. In addition, in the 20-22S 
and 14S region of the gradient two minor classes of virus-specific RNA were 
found, suggesting that virus-specific RNA components smaller in size than the 
viral RNA subunit of 35S may serve as messengers for the synthesis of viral 
proteins. After separation of the cellular ribosomes in free and membrane-
bound polyribosomes a striking difference in the size distribution of virus-
specific RNA of both types of polyribosomes was observed. Whereas one major 
virus-specific RNA species (35S) was associated with free polyribosomes, 
three major size classes (35S, 20-22S and 14S) were found in membrane-bound 
polyribosomes. 
In Chapter 4 we described the effect of heat and formamide dissociation 
on the size distribution of virus-specific RNA. Dissociation of intermolecular 
and intramolecular hydrogen bonds resulted in a drastic change of the size 
distribution of virus-specific RNA. Upon exposure to high temperatures or to 
organic solvents virus-specific RNA accumulated in the 14S and 20-22S region 
at the expense of the 35S RNA indicating the presence of noncovalent aggrega-
tes of virus-specific RNA in the latter part of the gradient. This shift in 
the size distribution was also observed when cytoplasmic RNA of cells trans-
formed by a mouse sarcoma virus was analyzed. 
In addition,we provided evidence for the presence of poly(A)-rich tracks, 
presumably located at the 3'terminal end, in virus-specific mRNA isolated 
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from polyribosomes. Analysis of this RNA in sucrose gradients containing 
formamide indicated the presence of two prominent classes of virus-specific 
RNA with sedimentation values of 35S and 20-22S. 
Although these observations provided very suggestive evidence for the 
messenger properties of the various virus-specific RNA species, definite 
proof could only be provided by demonstrating the synthesis of virus-speci-
fic polypeptides directed by these RNA fractions. Since the virus-specific 
polypeptides constitute a few percent only of the total protein content 
of infected cells, they should be distinghuished from the vast background 
of cellular proteins by immunoprecipitation with specific antisera directed 
against purified virus. Thus, we could detect the virus-specific polypepti-
des synthesized in cell-free systems supplemented with polyribosomes, frac-
tionated cell extracts or fractionated mRNA (Chapter 5). Purified free and 
membrane-bound polyribosomes mediated the synthesis in vitro of a polypeptide 
with a molecular weight of 65,000, which is immunologically and electropho-
retically identical to the intracellular precursor polypeptide (pr65) of 
several mature structural virus proteins. In contrast, cell-free incubation 
of polyribosomes still attached to membranes resulted in the synthesis of an 
additional polypeptide (82,000 M ) which appears to be identical to the in-
tracellular precursor polypeptide (pr82) of two viral proteins located in 
the virion envelope. This precursor polypeptide (82,000 M ), however, was 
not detected among the cell-free products synthesized in a cell fraction 
containing free polyribosomes only. In addition, virus-specific polypeptides 
appeared to be preferentially synthesized on membrane-bound polyribosomes. 
This observation was consistent with our results from hybridization experi-
ments . 
Finally, by translation of mRNA fractionated in sucrose gradients con-
taining formamide in a manrialian cell-free system, we were able to verify 
the messenger properties of the virus-specific RNA associated with polyribo-
somes. Messenger RNA sedimenting in the 35S region directed the synthesis in 
vitro of two polypeptides of 65,000 and 72,000 molecular weight. The former 
polypeptide is identical in size to the intracellular precursor polypeptide 
(pr65) of several low molecular weight virus proteins. No evidence, however, 
was obtained for the synthesis of a polypeptide corresponding in size to the 
virus-specific glycosylated precursor of 82,000 molecular weight (pr82). One 
polypeptide of 70,000 molecular weight was detected among the cell-free 
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products directed by mRNA sedimenting in the 20-22S region. However, this 
virus-specific polypeptide was not found among the virus-specific polypep-
tides synthesized in infected cells. The synthesis of some low molecular 
weight virus-specific polypeptides of approximately 30,000 and 15,000 mole-
cular weight was observed, when the cell-free system was programmed with 
mRNA from the 14S region. 
These findings further substantiate our idea that in addition to the 
virus-specific 35S mRNA smaller virus-specific RNA species may serve as mes-
sengers for the synthesis of virus proteins in cells infected with Rauscher 
leukemia virus. 
121 
SAMENVATTING 
Het bestaan van een causaal verband tussen infecties met een aantal 
RNA-bevattende virussen en het ontstaan van tumoren bij de besmette dieren 
is door een groot aantal onderzoekers overtuigend bewezen. De theorie, dat 
virussen betrokken zijn bij de ontwikkeling van kanker heeft er dan ook toe 
geleid dat vele moleculair biologen hun aandacht gericht hebben op de bio-
chemische eigenschappen en het replicatie-mechanisme van RNA tumorvirussen. 
In hoofdstuk 1 worden de belangrijkste moleculair biologische aspecten 
van deze virusdeeltjes besproken. De belangrijkste ontdekking, die het on-
derzoek aan deze virussen heeft opgeleverd, is ongetwijfeld de replicatie 
van de genetische informatie van deze virussen via een dubbel-strengig DNA 
intermediair, dat als provirus geïntegreerd wordt in het cellulaire DNA van 
de gastheer. Opvallend is ook het voorkomen van RNA tumorvirussen in een 
grote verscheidenheid van diersoorten, hetgeen suggereert dat deze virussen 
eveneens betrokken kunnen zijn bij de ontwikkeling van kanker bij de mens. 
Het Rauscher leukemie-vi rus, dat behoort tot de groep van RNA tumorvi-
russen, veroorzaakt leukemie in een aantal muizenstammen. Als een model-
systeem voor de bestudering van de biosynthese van Rauscher leukemie-virus-
eiwitten kozen wij weefselkweek-cellen die geïnfecteerd waren met dit virus. 
Aan deze phase uit de 'levens-cyclus' van RNA tumorvirussen, was vrijwel 
geen onderzoek verricht toen wij dit onderzoek aanvingen. 
In het experimentele gedeelte van hoofdstuk 1 beschrijven wij de karak-
terisering van de virale eiwitten van gezuiverd Rauscher leukemie virus met 
behulp van polyacrylami de-gel electroforese in aanwezigheid van natrium 
dodecylsulfaat. Deze techniek maakt het mogelijk de virale eiwitcomponenten 
te scheiden op basis van het molecuulgewicht van hun polypeptideketens. De 
resultaten van de gelanalyse tonen aan dat het virus naast een aantal hoofd-
componenten ook een groot aantal eiwitten bevat die slechts in geringe hoe-
veelheden vertegenwoordigd zijn. Dit zijn kennelijk geen verontreinigingen, 
want een aantal van deze laatste eiwitcomponenten bleken aanwezig te zijn 
zowel in virusdeeltjes die geproduceerd werden in verschillende cellijnen, 
als ook in gezuiverd virus uit het plasma van leukemische muizen. Verder 
vonden wij aanwijzingen dat een van de virale eiwitten, namelijk plO, be-
staat uit twee of drie eiwitcomponenten, die slechts zeer geringe verschil-
len in molecuul gewicht vertoonden. 
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Teneinde vast te stellen of het virale RNA genoom van RNA tumorvirussen 
als boodschapper kan fungeren, werd het virale RNA van Rauscher leukemie-
virus, kippen leukose-virus en manna tumor-virus toegevoegd aan een cel-vrij 
systeem verkregen uit bacteriën. Vertaling van het gezuiverde RNA van deze 
drie niet immunologisch verwante virussen in het bacteriele systeem leidde 
tot de synthese van Polypeptiden, die na gelanalyse specifiek bleken voor 
het toegevoegde virale RNA. Hiermede was bewezen dat het virale RNA als 
boodschapper kan fungeren en daarom zeer waarschijnlijk dezelfde base-se-
quenties bevat als de virus-specifieke boodschapper in de geïnfecteerde cel. 
Het definitieve bewijs voor de aanwezigheid in geïnfecteerde cellen 
van virus-specifieke boodschappers, die dezelfde sequenties bevatten als het 
virale RNA genoom, werd verkregen door middel van hybridisatie-experimenten 
(hoofdstuk 3). Met radioactief DNA, dat de complementaire base-sequenties 
van het virale RNA bevat, waren wij aldus in staat virus-specifieke RNA se-
quenties aan te tonen in vrije en membraan-gebonden polyribosomen, verkregen 
uit cellen geïnfecteerd met het Rauscher leukemie-virus. Bovendien verkregen 
wij met behulp van deze hybridisatie-experimenten duidelijke aanwijzingen 
dat de biosynthese van virale eiwitten preferentieel in associatie met mem-
branen plaats vindt. 
Na fractionering van het polyribosomale RNA in glycerol-gradienten werd 
met behulp van hybridisatie de verdeling van het virus-specifieke RNA in de 
gradient vastgesteld. Deze experimenten lieten zien dat er in de geïnfecteer-
de cel drie grootte-klassen van virale boodschappers aanwezig zijn. De belang 
rijkste virale boodschapper heeft een sedimentatiewaarde van ongeveer 35S, en 
is wat lengte en polariteit betreft identiek aan de virale RNA subunits die 
ontstaan na verbreken van de intermoleculaire waterstofbruggen in het 60-70S 
RNA van het virus. Daarnaast vonden wij virus-specifieke RNA componenten met 
sedimentatiewaarden van ongeveer 20-22S en 14S. Deze waarneming suggereert 
dat deze laatste RNA fracties evenals het 35S RNA fungeren als boodschapper 
voor de synthese van virale eiwitten. 
Na scheiding van de cellulaire ribosomen in vrije en membraan-gebonden 
polyribosomen, werd een opvallend verschil waargenomen in de grootte-verde-
ling van de virus-specifieke RNAs uit beide typen polyribosomen. De virus-
specifieke RNA populatie geassocieerd met vrije polyribosomen bestond voor-
namelijk uit 35S RNA. Daarentegen waren drie virus-specifieke RNA componen-
ten duidelijk te onderscheiden na sedimentatie in glycerol-gradienten van het 
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RNA dat geassocieerd is met membraan-gebonden polyribosomen. 
In hoofdstuk 4 beschreven wij de gevolgen die dissociatie van intermo-
leculaire en intramoleculaire waterstofbruggen heeft op de verdeling van de 
virus-specifieke RNA moleculen in gradiënten. Dissociatie van waterstofbrug-
gen werd bewerkstelligd door het virus-specifieke RNA te incuberen bij hoge 
temperatuur of in aanwezigheid van formamide. Na analyse van het behandelde 
RNA in glycerol-gradienten bleek een duidelijke verandering in de verdeling 
van virus-specifieke RNA moleculen te hebben plaatsgevonden. De virus-speci-
fieke RNA-populatie in het 14S en 20-22S gebied van de gradient, was duide-
lijk toegenomen ten koste van het 35S RNA. Deze bevinding wijst op de aan-
wezigheid van niet covalent gebonden aggregaten van virus-specifiek RNA, 
die onder niet-denaturerende condities sedimenteren in het 35S gebied van de 
gradient. 
Tevens toonden wij aan dat het virus-specifieke RNA in polyribosomen 
poly(A)-rijke base-sequenties bevat, die zeer waarschijnlijk covalent gebon-
den zijn aan het S'einde van de virale boodschappers. Het poly(A)-bevattende 
RNA bleek na analyse in suiker-gradiënten te bestaan uit twee grootte-klassen 
met sedimentatiewaarden van 35S en 20-22S. 
Hoewel deze waarnemingen duidelijk wijzen op de mogelijkheid dat de ver-
schillende virus-specifieke RNA moleculen een boodschapper functie vervullen, 
kan de definitieve bewijsvoering voor een dergelijke functie slechts geleverd 
worden door translatie-experimenten. Aangezien de virus-specifieke eiwitten 
echter slechts 1-3 procent uitmaken van de totale eiwitpopulatie in geïnfec-
teerde cellen, is het alleen mogelijk de virale eiwitten van de overmaat 
cellulaire eiwitten te onderscheiden door middel van immunoprecipitatie met 
specifieke antilichamen gericht tegen gezuiverd virus. Met deze techniek 
bleek het mogelijk de virus-specifieke eiwitten te identificeren, die nieuw 
gesynthetiseerd werden in cel-vrije systemen waaraan polyribosomen, gefrac-
tioneerde cel extracten of gefractioneerd boodschapper RNA werd toegevoegd 
(hoofdstuk 5). 
Toevoeging van vrije en membraan-gebonden polyribosomen aan een cel-
vrij systeem leidde tot de synthese van voornamelijk een polypeptide met 
een molecuulgewicht van 65.000. Dit nieuw gesynthetiseerde eiwit bleek 
electroforetisch en immunologisch identiek aan het intracellulaire precur-
sor-eiwit (pr65) waaruit een aantal laag moleculaire viruseiwitten ontstaan 
door proteolytische afsplitsing. Wanneer echter aan het cel-vrije 
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incubatiemengsel polyribosomen werden toegevoegd die niet vrijgemaakt waren 
van de membranen, werd de synthese waargenomen van een additioneel eiwit 
met een molecuul gewicht van 82.000. Dit cel-vrije produkt is waarschijn-
lijk identiek aan de intracellulaire precursor (pr82) van twee eiwitten die 
in de buitenmembraan van het virus gelokaliseerd zijn. Het 82.000 eiwit kon 
niet aangetoond worden na toevoeging van een cel-fractie die alleen vrije 
polyribosomen bevat. In deze experimenten werd bovendien aangetoond dat de 
virale eiwitsynthese preferentieel in de membraan-gebonden polyribosomale 
fractie plaatsvindt. Deze laatste waarneming bevestigt onze resultaten ver-
kregen door middel van hybridisatie proeven. 
Tenslotte waren wij in staat de boodschapperfunctie van in gradiënten 
gefractioneerd virus-specifiek RNA te bevestigen door vertaling in een cel-
extract van konijnen-reticulocyten. Toevoeging van 35S boodschapper RNA 
leidde tot de synthese van twee eiwitten met molecuulgewichten van 65.000 
en 72.000. Het 65.000 eiwit is waarschijnlijk identiek aan de intracellulaire 
precursor pr65 van een aantal laag moleculaire viruseiwitten. Geen aanwij-
zingen werden verkregen, dat deze RNA fractie in staat is de synthese te be-
werkstelligen van het precursoreiwit met een molecuul gewicht van 82.000 
(pr82), dat in de geïnfecteerde cel aangemaakt wordt. De 20-225 boodschapper-
fractie gaf aanleiding tot de synthese van een virus-specifiek eiwit met een 
molecuulgewicht van 70.000. Er zijn geen duidelijke aanwijzingen dat een 
virus-specifiek produkt van deze grootte in gemakkelijk te detecteren hoeveel-
heden in de geïnfecteerde cel wordt gemaakt. De synthese van enkele laag mo-
leculaire virus-specifieke eiwitten met een molecuulgewicht van ongeveer 
30.000 en 15.000 werd waargenomen na toevoeging van de 14S boodschapperfrac-
tie. Opgrond hiervan poneren wij, dat naast het virus-specifieke 35S bood-
schapper RNA ook kleinere virus-specifieke boodschappers betrokken zijn bij 
de synthese van virale eiwitcomponenten in cellen geïnfecteerd met het 
Rauscher leukemie-virus. 
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